DE10260880A1 - Färbetablette - Google Patents

Abstract

The present invention relates to moldings which contain at least one compound having a reactive carbonyl group as a dye precursor, the use of these compositions for the production of hair dye preparations and a process for dyeing keratin-containing fibers with these moldings and a kit for use in this process.

Description

The present invention relates to Moldings, the at least one compound with a reactive carbonyl group included as a dye precursor, the use of these agents for the preparation of hair dye preparations and a method of dyeing fibers containing keratin with these shaped bodies and a kit for use in this process.

Human hair is used in many different ways today treated with hair cosmetic preparations. These include, for example cleaning the hair with shampoos, care and regeneration with douches and cures as well as bleaching, dyeing and shaping the hair with colorants, Tints, Corrugating agents and styling preparations. Thereby, means to change play or nuance of the color of the scalp hair plays a prominent role.

For temporary colorations are common dyeing or tinting agents used that as a coloring Component so-called direct pull included. This is what it is about are dye molecules, which pull directly on the hair and no oxidative process for training need the color. One of these dyes for example that from antiquity for coloring body and hair known henna. These colors are against shampooing usually significantly more sensitive than the oxidative stains, so then a much more undesirable shift in nuances much faster or even a visible "discoloration" occurs.

For permanent, intensive coloring So-called oxidation colorants are used with appropriate color fastness used. Such colorants usually contain Oxidation dye intermediates of the developer or coupler type. The developer components form under the influence of oxidizing agents or of atmospheric oxygen among themselves or under coupling with one or the actual dyes from several coupler components. Under The term “color fastness” is understood by those skilled in the art to be resistance the coloring across from environmental influences such as. Laundry, Friction, light, cold wave agents and sweat. The oxidation colorants are distinguished by excellent, and despite the above environmental influences long-lasting staining results out. For Naturally effective colorings usually has to a mixture of a larger number of oxidation dye precursors are used; in many make direct dyes are still used for shading.

After all, a novel dyeing process has received great attention recently. In this process, precursors of the natural hair dye melanin are applied to the hair; These then form naturally analogous dyes in the hair as part of oxidative processes. Such a process with 5,6-dihydroxyindoline as a dye precursor was in the EP-B1-530 229 described. When using agents with 5,6-dihydroxyindoline, in particular several times, it is possible for people with gray hair to reproduce the natural hair color. Coloring can take place with atmospheric oxygen as the only oxidizing agent, so that no further oxidizing agents have to be used. In people with originally medium blonde to brown hair, indoline can be used as the sole dye precursor. For use with people with originally red and in particular dark to black hair color, on the other hand, satisfactory results can often only be achieved by using additional dye components, in particular special oxidation dye precursors.

Another possibility is keratin fibers to color offers the use of a combination of components

• A Compounds that have a reactive carbonyl group included with component
• B connections selected from (a) CH-acidic compounds, (b) compounds with primary or secondary Amino group or hydroxy group selected from primary or secondary aromatic amines, nitrogen-containing heterocyclic compounds and aromatic hydroxy compounds, (c) amino acids, (d) composed of 2 to 9 amino acids Oligopeptides.

This dyeing method (hereinafter called oxo dyeing) is described, for example, in the publications WO-A1-99 / 18916, WO-A1-00 / 38638, WO-A1-01 / 34106 and WO A1-01 / 47483 described. The colors have partly color fastness on the keratin-containing fiber those of oxidation staining are comparable. The range of shades that can be achieved with gentle oxo dyeing is very wide and the color obtained is often acceptable Brilliance and depth of color.

The above-mentioned components A and B are generally not themselves dyes and are therefore not suitable for dyeing keratin fibers on their own. In combination, they form dyes in a non-oxidative process. Corresponding oxidation dye precursors of the developer and / or coupler type with or without the use of an oxidizing agent can, however, also be used among compounds of component B. Thus, the method of oxo staining can easily be done with the Combine oxidative staining system.

Usually become hair dyes in the form of aqueous emulsions or staining gels formulated. This is particularly important with regard to the latter oxo dyeing storage stability of the formulations is a problem and leaves in terms of dosing and the simple handling still leaves something to be desired. An optimal one Packaging of cosmetic formulations containing the components A and B in dissolved form included, takes place when components A and B separately be kept. This will result in premature dye formation avoided.

Another option is to use hair dye formulated as a solid in powder or tablet form. Right away Before application, these hair dyes are usually submerged in water stir solved. The resulting ready-to-use colorant is usually gel or in cream form and then applied to the hair. When formulating the colorants is the solution behavior as a solid crucial. There must be no clumping of the solid come what is the effectiveness of the ready-to-use colorant impaired. In addition to the optimal rheological properties of the ready-to-use colorant is a quick resolution the coloring tablet desirable.

In the published application DE-A-36 09 962 A tablet-shaped coloring agent based on henna and oxidation dye precursors was proposed, which should enable intense black coloring with the shortest possible exposure time. However, this document does not contain any reference to the colored moldings according to the invention.

In the published application DE-A1-199 61 910 Shaped bodies for coloring keratin fibers are disclosed which, as a multi-phase tablet, contain at least one oxidation dye precursor in one phase and an oxidizing agent in a further phase.

In WO-A1-01 / 45655 become molded articles for coloring of keratin fibers disclosed, the indole or indoline derivatives as Oxidation dye precursors of the developer type included. These moldings will be in a dyeing process used by keratin fibers.

In WO-A1-01 / 45654 become colorants in the form of a shaped body discloses the at least one synthetic substantive dye contain. These moldings are in a dyeing process of keratin fibers used, in which the shaped body for Production of the ready-to-use colorant is dissolved in water.

The object was to contain a shaped body Compounds with a reactive carbonyl group as a dye precursor to provide that have a quick solution behavior. The from the solution of the shaped body resulting application mixture should be rheological at least the requirements and standards of the well-known cream and gel-like made-up colorants suffice and at the same time optimal dyeing Achieve properties.

It has now surprisingly been found that by the use of the moldings of the invention dyeings obtained in terms of their intensity and authenticity properties can be significantly improved and the molded body characterized by a significantly reduced dissolution time.

Shaped articles containing the person skilled in the art Compounds with a reactive carbonyl group as a dye precursor not known.

A first subject of the present Invention are therefore molded articles for coloring Keratin-containing fibers, which in addition to a cosmetically acceptable carrier at least a compound with a reactive carbonyl group as a dye precursor contain.

Among keratin fibers are furs according to the invention, To understand wool, feathers and especially human hair. Even though the moldings according to the invention in primarily as part of a coloring of keratin-containing fibers is used in principle Use contrary to anything.

Compounds according to the invention with a reactive Carbonyl group (hereinafter also reactive carbonyl compounds or called component A) have at least one carbonyl group as a reactive group, which with the compounds of the component B to form a chemical bond linking both components responding. Such compounds are furthermore also according to the invention comprises as component A, in which the reactive carbonyl group is derivatized or masked in this way is that the Reactivity the carbon atom of the derivatized or masked carbonyl group across from component B is always present. These derivatives are preferred Condensation compounds by reaction of the carbonyl group reactive carbonyl compound with

• a) Amines and their derivatives with formation of imines or oximes as a condensation compound or
• b) of alcohols with the formation of acetals or ketals as Condensation compound.

wobeiIt is preferred to select the compound having a reactive carbonyl group from a group which is formed from compounds of the formulas I, IV, V, VIa and VIb,

in which

• - AR stands for Benzene, naphthalene, pyridine, pyrimidine, pyrazine, pyridazine, carbazole, Pyrrole, pyrazole, furan, thiophene, 1,2,3-triazine, 1,3,5-triazine, Quinoline, isoquinoline, indole, indoline, indolizine, indan, imidazole, 1,2,4-triazole, 1,2,3-triazole, tetrazole, benzimidazole, 1,3-thiazole, benzothiazole, Indazole, benzoxazole, quinoxaline, quinazoline, quinolizine, cinnoline, Acridine, julolidine, acenaphthene, fluorene, biphenyl, diphenylmethane, benzophenone, Diphenyl ether, azobenzene, chromone, coumarin, diphenylamine, stilbene, where the N-heteroaromatics can also be quaternized,
• - R ³ represents a hydrogen atom, a C ₁ -C ₆ alkyl, C ₂ -C ₆ acyl, C ₂ -C ₄ alkenyl, C ₁ -C ₄ perfluoroalkyl, an optionally substituted aryl - or heteroaryl group,
• - R ⁴ , R ⁵ and R ⁶ each independently represent a hydrogen atom, a halogen atom, a C ₁ -C ₆ alkyl, C ₁ -C ₆ alkoxy, C ₁ -C ₆ aminoalkyl, C ₁ -C ₆ -hydroxyalkyl group, a C ₁ -C ₆ -alkoxy-C ₁ -C ₆ -alkyloxy group, a C ₂ -C ₆ -acyl group, an acetyl, carboxyl, carboxylato, carbamoyl, sulfo, Sulfato, sulfonamide, sulfonamido, C ₂ -C ₆ alkenyl, an aryl, an aryl C ₁ -C ₆ alkyl group, a hydroxy, a nitro, a pyrrolidino, a morpholino, a Piperidino, an amino or ammonio or a 1-imidazole (in) io group, the last three groups having one or more C ₁ -C ₆ alkyl, C ₁ -C ₆ carboxyalkyl, C ₁ - C ₆ hydroxyalkyl, C ₂ -C ₆ alkenyl, C ₁ -C ₆ alkoxy C ₁ -C ₆ alkyl, with optionally substituted benzyl groups, with sulfo (C ₁ -C ₄ ) alkyl - Or heterocycle (C ₁ -C ₄ ) alkyl groups can be substituted, two of the radicals from R ⁴ , R ⁵ , R ⁶ and -ZYR ^{3 also} condensing together with the rest of the molecule ten optionally substituted 5-, 6- or 7-ring, which can also carry a fused-on aromatic ring, the system AR, depending on its size, can carry further substituents, each of which can independently represent the same groups as R ⁴ , R ⁵ and R ⁶ ,
• Z stands for a direct bond, a carbonyl, a carboxy (C ₁ -C ₄ ) alkylene, an optionally substituted C ₂ -C ₆ alkenylene, C ₄ -C ₆ alkadienylene, furylene, Thienylene, arylene, vinylene arylene, vinylene furylene, vinyl thienylene group, where Z together with the -YR ³ group can also form an optionally substituted 5-, 6- or 7-ring,
• Y represents a group which is selected from carbonyl, a group according to formula II and a group according to formula III,
  
  in which
• - R ⁷ represents a hydrogen atom, a hydroxy group, a C ₁ -C ₄ alkoxy group, a C ₁ -C ₆ alkyl group, a C ₁ -C ₆ hydroxyalkyl group, a C ₂ -C ₆ polyhydroxyalkyl group, a C ₁ -C ₆ alkoxy-C ₁ -C ₆ alkyl group,
• - R ⁸ and R ⁹ independently of one another represent a C ₁ -C ₆ alkyl group, an aryl group or together with the structural element OCO of the formula III form a 5- or 6-membered ring.

worinAldehydes of the formula (IV)

wherein

• - R ¹⁰ and R ¹¹ each independently represent a hydrogen atom, a C ₁ -C ₆ alkyl group, a C ₁ -C ₄ hydroxyalkyl group, a C ₂ -C ₈ polyhydroxyalkyl group, a C ₁ -C ₄ alkoxy- C ₁ -C ₄ alkyl group, a C ₁ -C ₄ alkoxy group, a group -OCF ₃ or a group -CF ₃ , where the radicals R ¹⁰ and R ¹¹ together with the vinylene unit in the bracket represent a 5- or 6- can form membered, aromatic or aliphatic, carbocyclic or heterocyclic ring,
• - n is 0, 1, 2 or 3
• R ¹² stands for a hydrogen atom, a C ₁ -C ₆ alkyl group, a hydroxy group, a C ₁ -C ₄ hydroxyalkyl group, a C ₂ -C ₈ polyhydroxyalkyl group, a C ₁ -C ₄ alkoxy-C ₁ - C ₄ alkyl group, a C ₁ -C ₄ alkoxy group, a formyl group, a group -OCF ₃ or a group -CF ₃ ,

worinKetones with the formula (V)

wherein

• - R ¹³ represents a hydrogen atom, a C ₁ -C ₆ alkyl group, a C ₁ -C ₄ hydroxyalkyl group, a C ₂ -C ₈ polyhydroxyalkyl group, a C ₁ -C ₄ alkoxy-C ₁ -C ₄ - alkyl group, a C ₁ -C ₄ alkoxy group, a group -OCF ₃ or a group -CF ₃
• R ¹⁴ stands for a C ₁ -C ₆ alkyl group, a C ₁ -C ₄ monohydroxyalkyl group, a C ₂ -C ₈ polyhydroxyalkyl group,
• - m is equal to 1 or 2 where R ¹³ and R ^{1 4} together with the carbonyl unit can form a 5- or 6-membered, aliphatic or aromatic, carbocyclic or heterocyclic ring, which in turn optionally forms a fused-on 5- 6-membered, aliphatic or carries aromatic, carbocyclic or heterocyclic ring, with the proviso that each heterocyclic ring contains nitrogen or sulfur atoms as heteroatoms,

worinDiimino-isoindoline or 3-amino-isoindolone derivatives according to formulas VIa and VIb,

wherein

• - A stands for an oxygen atom or a group NH,
• - R ¹⁵ and R ¹⁶ each independently represent a hydrogen atom, a C ₁ -C ₄ alkyl group, a C ₁ -C ₄ hydroxyalkyl group, a C ₂ -C ₆ polyhydroxyalkyl group, a group R ^I R ^II N- ( CH ₂ ) _q , in which R ^I and R ^II each independently represent a C ₁ -C ₆ alkyl group, or an aryl C ₁ -C ₆ alkyl group and q represents a number 1, 2, 3, 4, 5 or 6, where R ^I and R ^II together with the nitrogen atom can form an aromatic or aliphatic 5-, 6- or 7-membered heterocycle,
• - R ¹⁷ and R ¹⁸ together with the rest of the molecule form a 5- or 6-membered aromatic or heteroaromatic ring, which can optionally be substituted.

worinIn a further embodiment, the compound having a reactive carbonyl group is preferably selected from compounds of the formula VII,

wherein

• - R ^16a , R ^17a and R ^18a each independently represent a hydrogen atom, a halogen atom, a sulfo group, a carboxyl group, a nitro group, a C ₁ -C ₆ alkyl, a C ₁ -C ₆ alkoxy, C ₁ -C ₆ carboxyalkyl, C ₁ -C ₆ hydroxyalkyl, C ₂ -C ₆ alkenyl, C ₁ -C ₆ alkoxy-C ₁ -C ₆ alkyl group and,
• R ^15a represents one of the groups defined under R ¹⁵ according to formula VI, a C ₂ -C ₆ alkenyl group, a carboxy-C ₁ -C ₆ -alkyl group, a sulfo-C ₁ -C ₆ -alkyl group, a sulfo-C ₁ -C ₆ -alkylaminomethyl group, a monohydroxy-C ₁ -C ₆ -alkyl group, a carboxy-C ₁ - C ₆ alkylaminomethyl group, an optionally substituted benzyl group and a heterocycle C ₁ -C ₆ alkyl group.

It is particularly preferred to select the compound having a reactive carbonyl group from the group consisting of is formed from isatin, 5-chloroisatin, 5-nitroisatin, 5,7-dichloroisatin, isatin-5-sulfonic acid, isatin-4-carboxylic acid and Isatin-5-carboxylic acid, N-substituted Isatin derivatives such as N-hydroxymethyl isatin, N- (2-hydroxyethyl) isatin N- (2-hydroxypropyl) -isatin, N- (3-hydroxypropyl) isatin, N- (2,3-dihydroxypropyl) isatin, N- (2-sulfoethyl) isatin, N- (3-sulfopropyl) -isatin, N-allylisatin, N-vinylisatin, N-benzylisatin, N- (4-methoxybenzyl) -isatin, N- (4-carboxybenzyl) isatin, N- (4-sulfobenzyl) isatin, N- (2-dimethylaminoethyl) isatin, N- (2-pyrrolidinoethyl) isatin, N- (2-piperidinoethyl) isatin, N- (2-furylmethyl) isatin, N- (2-thienylmethyl) isatin, N- (2-pyridylmethyl) isatin, N- (3-pyridylmethyl) -isatin, N- (4-pyridylmethyl) isatin, N-allylisatin-5-sulfonic acid, 5-chloro-N- (2-hydroxyethyl) isatin, 5-methyl-N- (2-hydroxyethyl) -isatin, 5,7-dichloro-N-allylisatin, 5-nitro-N-allylisatin, N-hydroxymethyl-5-methylisatin, N-hydroxymethyl-5-chloroisatin, N-hydroxymethyl-5-sulfoisatin, N-hydroxymethyl-5-carboxyisatin, N-hydroxymethyl-5-nitroisatin, N-hydroxymethyl-5-bromisatin, N-hydroxymethyl-5-methoxyisatin, N-hydroxymethyl-5,7-dichloroisatin, N-dimethylaminomethylisatin, N-diethylaminomethylisatin, N- (bis (2-hydroxyethyl) aminomethyl) isatin, N- (2-hydroxyethylaminomethyl) isatin, N- (bis (2-hydroxypropyl) aminomethyl) isatin, N- (2-pyrrolidino) isatin, N- (2-piperidino) isatin, N-pyrrolidinomethylisatin, N-piperidinomethylisatin, N-morpholinomethylisatin, N- (2-morpholinoethyl) isatin, N- (1,2,4-triazol-1-ylmethyl) isatin, N- (1-imidazolyl) methylisatin, N-carboxymethylaminomethylisatin, N- (2-carboxyethylaminomethyl) isatin, N- (3-carboxypropylaminomethyl) isatin, N- (bis (2-hydroxyethyl) aminomethyl) -5-methylisatin, N-piperidinomethyl-5-chloroisatin, N- (2-sulfoethylaminomethyl) isatin, and the alkali and optionally Ammonium salts of the acidic compounds.

worinIn a further embodiment, it is preferred to select the compound having a reactive carbonyl group from compounds of the formula VIII,

wherein

• R ¹⁹ stands for the groups which are defined under R ³ according to formula I,
• R ²⁰ , R ²¹ and R ²² each independently represent the groups defined under R ⁴ according to formula I, or two of the radicals R ²⁰ , R ²¹ and R ²² together with the rest of the molecule form a 5-, 6- or 7-membered carbocyclic or heterocyclic, aromatic or aliphatic ring,
• R ²³ represents a hydrogen atom, a C ₁ -C ₆ -alkyl group, an aryl group or a heteroaryl group,
• X represents a direct bond, an arylene group, an optionally substituted C ₂ -C ₆ alkenylene group and a C ₄ -C ₆ alkadienylene group,
• - Y - stands for halide, Benzenesulfonate, p-toluenesulfonate, methanesulfonate, trifluoromethanesulfonate, Perchlorate, 0.5 sulfate, hydrogen sulfate, methyl sulfate, hexafluorophosphate, Tetrachlorozincate or tetrafluoroborate.

Compounds according to formula VIII are preferred in which X denotes a direct bond. Those compounds according to formula VIII in which R ^{19 represents} a hydrogen atom are also preferably present in the shaped body according to the invention. Furthermore, those compounds according to formula VIII are preferred in which the group X binds at position 2,6 or 4 of the pyridinium base body.

According to this embodiment furthermore preferably pyridinium and / or quinolinium derivatives as Compounds according to formula VIII incorporated into the moldings according to the invention.

The compounds according to formula VIII can can also be contained as a hydrate in the moldings according to the invention.

Furthermore, it is particularly preferred to select the compounds with a reactive carbonyl compound of the formula VIII from the group which is formed from benzenesulfonates, p-toluenesulfonates, methanesulfonates, perchlorates, 0.5 sulfates, chlorides, bromides, iodides and / or tetrachlorozincates of 4-formyl -1-methylpyridinium, 3-formyl-1-methylpyridinium, 2-formyl-1-methylpyridinium, 4-formyl-1-ethylpyridinium, 2-formyl-1-ethylpyridinium, 4-formyl-1-benzylpyridinium, 2-formyl-1 -benzylpyridinium, 4-formyl-1,2-di methylpyridinium, 4-formyl-1,3-dimethylpyridinium, 4-formyl-1-methylquinolinium, 2-formyl-1-methylquinolinium, 4- (2-formylvinyl) -1-methylquinolium, 4-acetyl-1-methylpyridinium, 2- Acetyl-1-methylpyridinium, 4-acetyl-1-methylquinolinium and 4- (2-formylvinyl) -1-methylpyridinium, 2,6-dichloro-4-formyl-1-methylpryridinium, 2,6-diphenyl-4-formyl- 1-methylpyridinium, 4-benzoyl-1-methylpyridinium, 4-propionyl-1-methylpyridinium, 4-pyridinaldehyde-N-oxide and N-methylpyridoxal and any mixtures of the above compounds.

In a further embodiment, the compounds having a reactive carbonyl group are preferably selected from the group consisting of 2-pentendial, acetophenone, propiophenone, 2-hydroxyacetophenone, 3-hydroxyacetophenone, 4-hydroxyacetophenone, 2-hydroxypropiophenone, 3-hydroxypropiophenone, 4-hydroxypropiophenone, 2-hydroxybutyrophenone, 3-hydroxybutyrophenone, 4-hydroxybutyrophenone, 2,4-dihydroxyacetophenone, 2,5-dihydroxyacetophenone, 2,6-dihydroxyacetophenone, 2,3,4-trihydroxyacetophenone, 3,4,5-trihydroxyacetophenone, 2,4, 6-trihydroxyacetophenone, 2,4,6-trimethoxyacetophenone, 3,4,5-trimethoxyacetophenone, 3,4,5-trimethoxyacetophenone diethyl ketal, 4-hydroxy-3-methoxyacetophenone, 3,5-dimethoxy-4- hydroxyacetophenone, 4-aminoacetophenone, 4-dimethylaminoacetophenone, 4-morpholinoacetophenone, 4-piperidinoacetophenone, 4-imidazolinoacetophenone, 2-hydroxy-5-bromoacetophenone, 4-hydroxy-3-nitroacetophenone, acetonophenone, 2 carboxylic acid, benzophenone, 4-hydroxybenzophenone, 2-aminobenzophenone, 4,4'-dihydroxybenzophenone, 2,4-dihydroxybenzophenone, 2,4,4'-trihydroxybenzophenone, 2,3,4-trihydroxybenzophenone, 2-hydroxy-1-acetonaphthone, 1-hydroxy-2- Acetonaphthon, Chromon, Chromon-2-carboxylic acid, Flavon, 3-Hydroxyflavon, 3,5,7-Trihydroxyflavon, 4 ', 5,7-Trihydroxyflavon, 5,6,7-Trihydroxyflavon, Quercetin, 1-Indanon, 9-Fluorenon , 3-hydroxyfluorenone, anthrone, 1,8-dihydroxyanthrone, salicylaldehyde, vanillin, coniferylaldehyde, 2-methoxybenzaldehyde, 3-methoxybenzaldehyde, 4-methoxybenzaldehyde, 2-ethoxybenzaldehyde, 3-ethoxybenzaldehyde, 4-ethoxybenzaldehyde, 4-hydroxy-2 -dimethoxy-benzaldehyde, 4-hydroxy-2,5-dimethoxy-benzaldehyde, 4-hydroxy-2,6-dimethoxy-benzaldehyde, 4-hydroxy-2-methyl-benzaldehyde, 4-hydroxy-3-methyl-benzaldehyde, 4 -Hydroxy-2,3-dimethylbenzaldehyde, 4-hydroxy-2,5-dimethyl-benzaldehyde, 4-hydroxy-2,6-dimethyl-benzaldehyde, 4-hydroxy-3,5-dimethoxy-benzaldehyde, 4-hydroxy-3 , 5-dimethyl-benzaldehyde, 3,5-diethoxy-4-hydroxy-benzaldehyde, 2,6-diethoxy-4-hydroxy-benzaldehyde hyd, 3-hydroxy-4-methoxy-benzaldehyde, 2-hydroxy-4-methoxy-benzaldehyde, 2-ethoxy-4-hydroxybenzaldehyde, 3-ethoxy-4-hydroxy-benzaldehyde, 4-ethoxy-2-hydroxy-benzaldehyde, 4-ethoxy-3-hydroxy-benzaldehyde, 2,3-dimethoxybenzaldehyde, 2,4-dimethoxybenzaldehyde, 2,5-dimethoxybenzaldehyde, 2,6-dimethoxybenzaldehyde, 3,4-dimethoxybenzaldehyde, 3,5-dimethoxybenzaldehyde, 2,3, 4-trimethoxybenzaldehyde, 2,3,5-trimethoxybenzaldehyde, 2,3,6-trimethoxybenzaldehyde, 2,4,6-trimethoxybenzaldehyde, 2,4,5-trimethoxybenzaldehyde, 2,5,6-trimethoxybenzaldehyde, 2-hydroxybenzaldehyde, 3- Hydroxybenzaldehyde, 4-hydroxybenzaldehyde, 2,3-dihydroxybenzaldehyde, 2,4-dihydroxybenzaldehyde, 2,5-dihydroxybenzaldehyde, 2,6-dihydroxybenzaldehyde, 3,4-dihydroxybenzaldehyde, 3,5-dihydroxybenzaldehyde, 2,3,4-trihydroxybenzaldehyde, 2,3,5-trihydroxybenzaldehyde, 2,3,6-trihydroxybenzaldehyde, 2,4,6-trihydroxybenzaldehyde, 2,4,5-trihydroxybenzaldehyde, 2,5,6-trihydroxybenzaldehyde, 4-hydroxy-2-methoxybenzaldehyde, 4- Dimethylaminobenzaldehyde, 4-diethylaminobe azaldehyde, 4-dimethylamino-2-hydroxybenzaldehyde, 4-diethylamino-2-hydroxybenzaldehyde, 4-pyrrolidinobenzaldehyde, 4-morpholinobenzaldehyde, 2-morpholinobenzaldehyde, 4-piperidinobenzaldehyde, 2-methoxy-1-naphthaldehyde, 4-methoxy-1-naphthaldehyde 2-hydroxy-1-naphthaldehyde, 2,4-dihydroxy-1-naphthaldehyde, 4-hydroxy-3-methoxy-1-naphthaldehyde, 2-hydroxy-4-methoxy-1-naphthaldehyde, 3-hydroxy-4-methoxy- 1-naphthaldehyde, 2,4-dimethoxy-1-naphthaldehyde, 3,4-dimethoxy-1-naphthaldehyde, 4-hydroxy-1-naphthaldehyde, 4-dimethylamino-1-naphthaldehyde, 4-dimethylaminocinnamaldehyde, 2-dimethylaminobenzaldehyde, 2- Chloro-4-dimethylaminobenzaldehyde, 4-dimethylamino-2-methylbenzaldehyde, 4-diethylamino-cinnamaldehyde, 4-dibutylamino-benzaldehyde, 4-diphenylamino-benzaldehyde, 4-dimethylamino-2-methoxybenzaldehyde, 4- (1-imidazolyl) benzaldehyde Piperonal, 2,3,6,7-tetrahydro-1H, 5H-benzo [ij] quinolizine-9-carboxaldehyde, 2,3,6,7-tetrahydro-8-hydroxy-1H, 5H-benzo [ij] quinolizine- 9-carboxaldehyde, N-ethylcarbazole-3-aldehyde, 2-formylmethyl n-1,3,3-trimethylindoline (Fischer's aldehyde or tribase aldehyde), 2-indolaldehyde, 3-indolaldehyde, 1-methylindol-3-aldehyde, 2-methylindol-3-aldehyde, 1-acetylindol-3-aldehyde, 3 -Acetylindole, 1-methyl-3-acetylindole, 2- (1,3,3-trimethyl-2-indolinylidene) -acetaldehyde, 1-methylpyrrole-2-aldehyde, 1-methyl-2-acetylpyrrole, 4-pyridine aldehyde, 2 -Pyridine aldehyde, 3-pyridine aldehyde, 4-acetylpyridine, 2-acetylpyridine, 3-acetylpyridine, pyridoxal, quinoline-3-aldehyde, quinoline-4-aldehyde, antipyrin-4-aldehyde, furfural, 5-nitrofurfural, 2-thenoyl-trif -acetone, chromon-3-aldehyde, 3- (5-nitro-2-furyl) -acrolein, 3- (2-furyl) -acrolein and imidazole-2-aldehyde, 1,3-diacetylbenzene, 1,4-diacetylbenzene , 1,3,5-triacetylbenzene, 2-benzoyl-acetophenone, 2- (4-methoxybenzoyl) -acetophenone, 2- (2-furoyl) -acetophenone, 2- (2-pyridoyl) -acetophenone and 2- (3- Pyridoyl) acetophenone, benzylidene acetone, 4-hydroxybenzylidene acetone, 2-hydroxybenzylidene acetone, 4-methoxybenzylidene acetone, 4-hydroxy-3-methoxybenzylidene acetone, 4-dimethylaminobenzyl idenacetone, 3,4-methylenedioxybenzylidene acetone, 4-pyrrolidinobenzylidene acetone, 4-piperidinobenzylidene acetone, 4-morpholinobenzylidene acetone, 4-diethylaminobenzylidene acetone, 3-benzylidene-2,4-pentanedione, 3- (4-hydroxybenzylidene) -2,4-pentane (4-dimethylaminobenzylidene) -2,4-pentanedione, 2-benzylidene cyclohexanone, 2- (4-hydroxybenzylidene) cyclohexanone, 2- (4-dimethylaminobenzylidene) cyclohexanone, 2-benzylidene-1,3-cyclohexanedione, 2- (4th -Hydroxybenzylidene) -1,3-cyclohexanedione, 3- (4-dimethylaminobenzylidene) -1,3-cyclohexane dione, 2-benzylidene-5,5-dimethyl-1,3-cyclohexanedione, 2- (4-hydroxybenzylidene) -5,5-dimethyl-1,3-cyclohexanedione, 2- (4-hydroxy-3-methoxybenzylidene) - 5,5-dimethyl-1,3-cyclohexanedione, 2- (4-dimethylaminobenzylidene) -5,5-dimethyl-1,3-cyclohexanedione, 2-benzylidene cyclopentanone, 2- (4-hydroxybenzylidene) cyclopentanone, 2- (4th -Dimethylaminobenzylidene) -cyclopentanone, 5- (4-dimethylaminophenyl) penta-2,4-dienal, 5- (4-diethylaminophenyl) penta-2,4-dienal, 5- (4-methoxyphenyl) penta-2,4-dienal , 5- (3,4-dimethoxyphenyl) penta-2,4-dienal, 5- (2,4-dimethoxyphenyl) penta-2,4-dienal, 5- [4- (1-piperidinyl) phenyl] -2, 4-pentadienal, 5- [4- (1-morpholinyl) phenyl] -2,4-pentadienal, 5- [4- (1-pyrrolidinyl) phenyl] -2,4-pentadienal, 6- (4-dimethylaminophenyl) hexa -3,5-dien-2-one, 6- (4-diethylaminophenyl) hexa-3,5-dien-2-one, 6- (4-methoxyphenyl) hexa-3,5-dien-2-one, 6 - (3,4-Dimethoxyphenyl) hexa-3,5-dien-2-one, 6- (2,4-dimethoxyphenyl) hexa-3,5-dien-2-one, 6- [4- (1-piperidinyl ) phenyl] -hexa-3,5-dien-2-one, 6- [4- (1-morpholinyl) phenyl] -hexa-3,5-dien-2-one, 6- [4- (1-pyrrolidinyl) phenyl] hexa-3,5-dien-2-one, 5- (4-dimethylamino-1-naphthyl) penta-2,4-dienal, 2-nitrobenzaldehyde, 3- Nitrobenzaldehyde, 4-nitrobenzaldehyde, 4-methyl-3-nitrobenzaldehyde, 3-hydroxy-4-nitrobenzaldehyde, 4-hydroxy-3-nitrobenzaldehyde, 5-hydroxy-2-nitrobenzaldehyde, 2-hydroxy-5-nitrobenzaldehyde, 2-hydroxy- 3-nitrobenzaldehyde, 2-fluoro-3-nitrobenzaldehyde, 3-methoxy-2-nitrobenzaldehyde, 4-chloro-3-nitrobenzaldehyde, 2-chloro-6-nitrobenzaldehyde, 5-chloro-2-nitrobenzaldehyde, 4-chloro-2- nitrobenzaldehyde, 2,4-dinitrobenzaldehyde, 2,6-dinitrobenzaldehyde, 2-hydroxy-3-methoxy-5-nitrobenzaldehyde, 4,5-dimethoxy-2-nitrobenzaldehyde, 6-nitropiperonal, 2-nitropiperonal, 5-nitrovanillin, 2, 5- dinitrosalicylaldehyde, 5-bromo-3-nitrosalicylaldehyde, 3-nitro-4-formylbenzenesulfonic acid, 4-nitro-1-naphthaldehyde, 2-nitrocinnamaldehyde, 3-nitrocinnamaldehyde, 4-nitrocinnamaldehyde, 9-methyl-3-carbazolaldehyde, 9- Ethyl 3-carbazolaldehyde, 3-acetylcarbazole, 3,6-diacetyl-9-ethylcarbazole, 3-acetyl-9-methylcarbazole, 1,4-dimeth yl-3-carbazolaldehyde, 1,4,9-trimethyl-3-carbazolaldehyde, 4-formyl-1-methylpyridinium-, 2-formyl-1-methylpyridinium-, 4-formyl-1-ethylpyridinium-, 2-formyl-1 -ethylpyridinium-, 4-formyl-1-benzylpyridinium-, 2-formyl-1-benzylpyridinium-, 4-formyl-1,2-dimethylpyridinium-, 4-formyl-1,3-dimethylpyridinium-, 4-formyl-1- methylquinolinium, 2-formyl-1-methylquinolinium, 4-acetyl-1-methylpyridinium, 2-acetyl-1-methylpyridinium, 4-acetyl-1-methylquinolinium, 5-formyl-1-methylquinolinium, 6- Formyl-1-methylquinolinium, 7-formyl-1-methylquinolinium, 8-formyl-1-methylquinolinium, 5-formyl-1-ethylquinolinium, 6-formyl-1-ethylquinolinium, 7-formyl-1-ethylquinolinium , 8-formyl-1-ethylquinolinium, 5-formyl-1-benzylquinolinium, 6-formyl-1-benzylquinolinium, 7-formyl-1-benzylquinolinium, 8-formyl-1-benzylquinolinium, 5-formyl-1- allylquinolinium, 6-formyl-1-allylquinolinium, 7-formyl-1-allylquinolinium and 8-formyl-1-allylquinolinium, 5-acetyl-1-methylquinolinium, 6-acetyl-1-methylquinoli nium, 7-acetyl-1-methylquinolinium, 8-acetyl-1-methylquinolinium, 5-acetyl-1-ethylquinolinium, 6-acetyl-1-ethylquinolinium, 7-acetyl-1-ethylquinolinium, 8-acetyl -1-ethylquinolinium, 5-acetyl-1-benzylquinolinium, 6-acetyl-1-benzylquinolinium, 7-acetyl-1-benzylquinolinium, 8-acetyl-1-benzylquinolinium, 5-acetyl-1-allylquinolinium, 6 -Acetyl-1-allylquinolinium-, 7-acetyl-1-allylquinolinium- and 8-acetyl-1-allylquinolinium, 9-formyl-10-methylacridinium-, 4- (2-formylvinyl) -1-methylpyridinium-, 1,3 -Dimethyl-2- (4-formylphenyl) benzimidazolinium, 1,3-dimethyl-2- (4-formylphenyl) imidazolinium, 2- (4-formylphenyl) -3-methylbenzothiazolium, 2- (4-acetylphenyl ) -3-methylbenzothiazolium-, 2- (4-formylphenyl) -3-methylbenzoxazolium-, 2- (5-formyl-2-furyl) -3-methylbenzothiazolium-, 2- (5-formyl-2-furyl) -3 -methylbenzothiazolium-, 2- (5-formyl-2-thienyl) -3-methylbenzothiazolium-, 2- (3-formylphenyl) -3-methylbenzothiazolium-, 2- (4-formyl-1-naphthyl) -3-methylbenzothiazolium- , 5-chloro-2- (4-formylphenyl) - 3-methylbenzothiazolium, 2- (4-formylphenyl) -3,5-dimethyl-benzothiazolium-benzenesulfonate, -p-toluenesulfonate, -methanesulfonate, -perchlorate, -sulfate, -chloride, -bromide, -iodide, -tetrachlorozincate, - methyl sulfate, trifluoromethanesulfonate, tetrafluoroborate, isatin, 1-methyl-isatin, 1-allyl-isatin, 1-hydroxymethyl-isatin, 5-chloroisatin, 5-methoxy-isatin, 5-nitroisatin, 6-nitro-isatin, 5- Sulfo-isatin, 5-carboxy-isatin, quinisatin, 1-methylquinisatin, as well as any mixtures of the above compounds.

All of the above connections with a reactive carbonyl group are each preferably in an amount of 1 to 60% by weight, in particular 5 to 40% by weight, based on the weight of the entire molded body incorporated into the molded body.

• (a) CH-aciden Verbindungen,
• (b) Verbindungen mit primärer oder sekundärer Aminogruppe oder Hydroxygruppe, ausgewählt aus primären oder sekundären aromatischen Aminen, stickstoffhaltigen heterozyklischen Verbindungen und aromatischen Hydroxyverbindungen,
• (c) Aminosäuren,
• (d) aus 2 bis 9 Aminosäuren aufgebauten Oligopeptiden

als Komponente B. Dabei ist der Einsatz von CH-aciden Verbindungen in den erfindungsgemäßen Formkörpern bevorzugt.In a preferred embodiment of the extension, the shaped articles additionally contain at least one compound selected from

• (a) CH-acidic compounds,
• (b) compounds having a primary or secondary amino group or hydroxy group selected from primary or secondary aromatic amines, nitrogen-containing heterocyclic compounds and aromatic hydroxy compounds,
• (c) amino acids,
• (d) Oligopeptides composed of 2 to 9 amino acids

as component B. The use of CH-acidic compounds in the moldings according to the invention is preferred.

Those compounds which carry a hydrogen atom bonded to an aliphatic carbon atom are generally regarded as CH-acidic, activation of the corresponding carbon-hydrogen bond being effected on account of electron-withdrawing substituents. Under CH-acid Ver According to the invention, bonds also form enamines which arise from quaternized N-heterocycles with a CH-acidic alkyl group conjugated to the quaternary nitrogen by alkaline treatment. Compounds with the general formula C22 are mentioned below as examples of these enamines.

It is preferred to use the CH-acidic compounds of the formulas C1-C22 in the moldings according to the invention. Compounds of the formula C1 M ¹ - CH ₂ - M ² (C1) wherein

• M ^{1 is} a group -C (O) M ³ , -C (O) OM ³ , -S (O) M ³ or -SO ₂ M ³ , where M ^{3 represents} a hydrogen atom, an aryl group or a C ₁ - C ₆ alkyl group, or a group -C (M) = C (C≡N) ₂ , in which M represents a hydrogen atom, a C ₁ -C ₄ alkyl group or an aryl group,
• M ^{2 has} the same meaning as M ¹ or is a cyano group, a substituted or unsubstituted aryl group or aryl-C ₁ -C ₄ -alkyl group, a substituted or unsubstituted, saturated or unsaturated heterocycle,

worinCompounds with the formula C2

wherein

• - M ^{5 is} a cyano group, a substituted or unsubstituted aryl group or an aryl-C ₁ -C ₄ -alkyl group, a substituted or unsubstituted, saturated or unsaturated heterocycle or a group -COM ⁷ or -C (O) OM ⁷ , where M ^{7 represents} a hydrogen atom or a C ₁ -C ₈ alkyl group,
• - M ^{6 is} a substituted or unsubstituted C ₁ -C ₆ alkyl group, an acetyloxy group, a C ₃ -C ₆ cycloalkyl group, a substituted or unsubstituted aryl group or aryl-C ₁ -C ₄ alkyl group, a substituted or unsubstituted, saturated or is unsaturated heterocycle,

worinCompounds with the formula C3

wherein

• - M ^{8 is} a cyano group, a substituted or unsubstituted aryl group or aryl-C ₁ -C ₄ -alkyl group, a substituted or unsubstituted, saturated or unsaturated heterocycle or a group -COM ¹⁰ or C (O) OM ¹⁰ , where M ^{10 is} represents a hydrogen atom or a C ₁ -C ₆ alkyl group,
• M ^{9 is} a substituted or unsubstituted aryl group or aryl-C ₁ -C ₄ -alkyl group, a substituted or unsubstituted aminoaryl group, a substituted or unsubstituted, saturated or unsaturated heterocycle,

worinPyrazole derivatives (a): selected from the following formulas C4 and C5

wherein

• - M ¹¹ and M ^{1 2} each independently of one another for a substituted or unsubstituted C ₁ -C ₆ alkyl group, a C ₃ -C ₆ cycloalkyl group, a substituted or unsubstituted aryl group or aryl-C ₁ -C ₄ alkyl group, a substituted one or unsubstituted aminoaryl group, a substituted or unsubstituted, saturated or unsaturated heterocycle, where M ¹¹ additionally represents a C ₁ -C ₆ alkoxy group,
• M ^{13 is} a hydrogen atom or a substituted or unsubstituted C ₁ -C ₆ alkyl group,

(b): two pyrazole rings with the formula C4 or C5 bonded via M ¹¹ or M ¹²

worinBarbituric acid derivatives with the following formula C6

wherein

• M ¹⁴ and M ¹⁵ each independently represent a hydrogen atom, a C ₁ -C ₆ -alkyl group, a C ₂ -C ₆ -alkenyl group, a C ₃ -C ₆ -cycloalkyl group, an aryl-C ₁ -C ₄ - alkyl group, a substituted or unsubstituted aryl group, or a bicyclic bonded via the radicals M ¹⁴ or M ¹⁵ ,
• - X stands for an oxygen or a sulfur atom,

worinPyridine derivatives with the formulas C7a and C7b

wherein

• M ^{16 is} a substituted or unsubstituted C ₁ -C ₆ alkyl group or substituted or unsubstituted aryl group,
• M ^{17 is} a hydrogen atom, a substituted or unsubstituted C ₁ -C ₆ alkyl group or a substituted or unsubstituted aryl group,
• - M ^{18 represents} a hydrogen atom, a cyano group, a substituted or unsubstituted C ₁ -C ₆ alkyl group, a group COOM ¹⁹ , wherein M ^{19 represents} a hydrogen atom or a substituted or unsubstituted C ₁ -C ₆ -Al kylgruppe means is

worinCompounds with the following formula C8

wherein

• A represents an oxygen atom, a sulfur atom, a methylene group, a sulfoxyl group, a sulfonyl group or a group NM ^20a , where M ^{20 a represents} a hydrogen atom, a substituted or unsubstituted C ₁ -C ₆ alkylene group,
• M ²⁰ and M ²¹ each independently represent a hydrogen, a chlorine, a bromine atom, a hydroxy group, a nitro group, a C ₁ -C ₆ alkyl group, a C ₁ -C ₆ alkoxy, a carboxamide , a sulfonamide, a carboxyl, a C ₁ -C ₄ acyl, a cyano group or an amino group -NM ²² M ²³ , in which M ²² and M ²³ each independently represent a hydrogen atom or a C ₁ -C ₆ alkyl group,

worinCompounds with the formulas C9 and C10

wherein

• A 'represents an oxygen atom, a sulfur atom, a carbonyl group or a group NM ²⁵ , in which M ^{25 represents} a hydrogen atom or a substituted or unsubstituted C ₁ -C ₆ -alkyl group,
• M ²⁴ stands for a hydrogen, a chlorine, a bromine atom, a hydroxyl group, a nitro group, a C ₁ -C ₆ alkyl, a C ₁ -C ₆ alkoxy, a carboxamide, a sulfonamide, a carboxyl, a C ₁ -C ₄ acyl, a cyano group or an amino group -NM ²⁶ M ²⁷ , in which M ²⁶ and M ²⁷ each independently represent hydrogen and a C ₁ -C ₆ alkyl group

worinCompounds with the formula C11

wherein

• M ^{28 is} a hydrogen atom, a halogen atom, a nitro group, a hydroxy group, a substituted or unsubstituted C ₁ -C ₆ alkyl group or a substituted or unsubstituted aryl or C ₁ -C ₆ alkylaryl group;
• - M ²⁹ represents a hydrogen atom or a C ₁ -C ₄ alkyl group

worinIndanedione derivatives with the formula C12

wherein

• - M ^{30 is} a hydrogen, a fluorine, a chlorine, a bromine atom, a nitro, a C ₁ -C ₆ alkyl, a C ₁ -C ₆ alkoxy, a carboxamide, a sulfonamide or is a cyano group

worinCompounds with the formula C13

wherein

• Z represents an oxygen atom or a group NM ³² , where M ^{32 represents} a hydrogen atom or a C ₁ -C ₆ alkyl group,
• Z 'represents a sulfur atom or a group NM ³³ , in which M ^{33 represents} a hydrogen atom or a C ₁ -C ₆ alkyl group,
• M ³¹ represents a hydrogen atom, a C ₁ -C ₆ alkyl group or a C ₁ -C ₄ carboxyalkyl group,

worinDioxopyrazole compounds with the formula C14

wherein

• - M ³⁴ and M ³⁵ each independently represent a hydrogen, a fluorine, a chlorine, a bromine atom, a hydroxyl group, a nitro group, a C ₁ -C ₆ alkyl, a C ₁ -C ₆ alkoxy -, a carboxamide, a sulfonamide, a carboxyl, a C ₁ -C ₄ acyl, a cyano group or an amino group -NM ³⁶ M ³⁷ , in which M ³⁶ and M ³⁷ each independently represent hydrogen or a C. ₁ -C ₆ alkyl group,

worin5-oxoimidazole derivatives with the formula C15

wherein

• - M ³⁸ and M ³⁹ each independently represent a hydrogen, a fluorine, a chlorine, a bromine atom, a hydroxy group, a nitro group, a C ₁ -C ₆ alkyl, a C ₁ -C ₆ alkoxy , a carboxamide, a sulfonamide, a carboxyl, a C ₁ -C ₄ acyl, a cyano group or an amino group -NM ⁴¹ M ⁴² , in which M ⁴¹ and M ⁴² each independently represent a hydrogen atom or a C. ₁ -C ₆ alkyl group,
• M ⁴⁰ represents a hydrogen atom or a C ₁ -C ₆ alkyl group,

worinDerivatives of dehydrobutyrolactone with the formula C16

wherein

• - M ⁴³ and M ⁴⁴ each independently represent a hydrogen, a fluorine, a chlorine, a bromine atom, a hydroxy group, a nitro group, a C ₁ -C ₆ alkyl, a C ₁ -C ₆ alkoxy -, a carboxamide, a sulfonamide, a carboxyl, a C ₁ -C ₄ acyl, a cyano group or an amino group -NM ⁴⁵ M ⁴⁶ , in which M ⁴⁵ and M ⁴⁶ each independently represent a hydrogen atom or a C ₁ -C ₆ alkyl group

worinCompounds with the formula C17

wherein

• D ¹ is a fused aromatic or heteroaromatic ring,
• - D ² is a carbonyl group, a group C = CD ^I D ^II or a group CD ^I D ^II , in which D ^I or D ^II each have a substituent with a Hammett constant between 0.4 and 2.0 or both substituents in the sum have a Hammett constant between 0.4 and 2.0;
• - D ³ stands for a carbonyl group, an oxygen, a sulfur atom, a group NM ⁴⁷ if D ^{2 is} not oxygen, or for a group C = S, a group C = NM ⁴⁸ , a sulfinyl group, a sulfonyl group, where M ⁴⁷ and M ⁴⁸ each independently represent a hydrogen atom or a C ₁ -C ₆ alkyl radical,

worin

• – M⁴⁹ und M⁵⁰ jeweils unabhängig voneinander ein Wasserstoffatom oder eine substituierte oder unsubstituierte C₁-C₆-Alkylgruppe sind,
• – E¹ für ein Sauerstoff, ein Schwefelatom oder eine Gruppe NH steht,
• – E² für eine Gruppe NH oder ein Sauerstoffatom steht,
• – E³ für eine Aminogruppe oder eine Hydroxygruppe steht, mit der Maßgabe, daß a) wenn E1 und E2 für ein Sauerstoffatom stehen, E3 keine Hydroxygruppe ist, und b) wenn E1 ein Schwefelatom und E2 ein Sauerstoffatom ist, E3 keine Hydroxygruppe ist,

quaternierte Stickstoffverbindungen der Formel C19

Pyrimidine derivatives with the formula C18

wherein

• M ⁴⁹ and M ^{50 are} each independently a hydrogen atom or a substituted or unsubstituted C ₁ -C ₆ alkyl group,
• E ^{1 represents} an oxygen, a sulfur atom or a group NH,
• E ^{2 represents} a group NH or an oxygen atom,
• E ^{3 represents} an amino group or a hydroxy group, with the proviso that a) if E1 and E2 represent an oxygen atom, E3 is not a hydroxy group, and b) if E1 is a sulfur atom and E2 is an oxygen atom, E3 is not a hydroxy group,

quaternized nitrogen compounds of formula C19

• M ⁵¹ and M ⁵² each independently represent a hydrogen atom, a halogen atom, a hydroxy group, a C ₁ -C ₄ hydroxyalkyl group, a C ₁ -C ₆ aminoalkyl group, a C ₁ -C ₄ dialkylamino-C ₁ - C ₄ alkyl group, a linear or branched C ₁ -C ₆ alkyl group, a C ₂ -C ₆ alkenyl group, an optionally substituted aryl group, a sulfonic acid group, a carboxyl group, a formyl group, a nitro group, a cyano group or a group -NM ⁵⁴ M ⁵⁵ , where M ⁵⁴ and M ⁵⁵ each independently represent a hydrogen atom, a C ₁ -C ₆ alkyl group, a C ₂ -C ₆ alkenyl group, an aryl-C ₁ -C ₄ alkyl group or a C ₁ -C ₄ -hydroxyalkyl group, where M ⁵⁴ and M ⁵² together can form a fused-on 5- or 6-membered, aliphatic or aromatic or heteroaromatic ring, which in turn is substituted by the radicals M ⁵⁶ and M ⁵⁷ , where M ⁵⁶ and M ⁵⁷ each independently represent the residues, defined under M ⁵¹
• M ⁵³ represents a hydrogen atom, a C ₁ -C ₄ hydroxyalkyl group, a C ₁ -C ₆ aminoalkyl group, a C ₁ -C ₄ dialkylamino-C ₁ -C ₄ alkyl group, a linear or branched C ₁ - C ₆ alkyl group, a C ₂ -C ₆ alkenyl group, an optionally substituted aryl group, a C ₁ -C ₄ sulfoalkyl group, a C ₁ -C ₄ carboxyalkyl group or a C ₂ -C ₆ polyhydroxyalkyl group,
• Y stands for an oxygen atom, a sulfur atom, an optionally substituted methylene group or a group NM ⁶⁰ , where M ⁶⁰ can stand for the same groups which are defined under M ⁵⁵ ,
• - A ^- is a chloride, bromide, iodide, methyl sulfate, hexafluorophosphate, tetrachlorozincate, tetrafluoroborate, trifluoromethanesulfonate, methanesulfonate, benzenesulfonate or p-toluenesulfonate,

wobei M⁵¹, M⁵² M⁵³ und A^– aus den Gruppen ausgewählt werden, die unter Verbindung C19 definiert sind.Compounds of the formulas C20 and C21

where M ⁵¹ , M ^52, M ⁵³ and A ^- are selected from the groups defined under Compound C19.

worinCompounds with the general formula C22

wherein

• M ⁶¹ represents an aromatic radical, in particular an aryl radical which is optionally substituted by a C ₁ -C ₄ -alkyl, C ₁ -C ₄ -hydroxyalkyl, hydroxyl, methoxy or halogen group, preferably a phenyl radical, or a 5 -linked or 6-membered, fused, aliphatic or aromatic, carbocyclic or heterocyclic ring, preferably a phenyl radical, a quinoline or pyridyl radical,
• - M ⁶² stands for a hydrogen atom, a linear or branched C ₁ -C ₈ alkyl, a linear or branched C ₁ -C ₈ hydroxyalkyl or a C ₁ -C ₈ alkoxyalkyl group, the between the C atoms Alkyl chain can sit an oxygen atom, and
• - M ⁶³ stands for a linear or branched C ₁ -C ₈ alkyl group, a C ₁ -C ₆ alkoxy-C ₁ -C ₆ alkyl group, a C ₁ -C ₆ alkylamino-C ₁ -C ₆ alkyl group , a C ₁ -C ₆ alkylmercapto-C ₁ -C ₆ alkyl group, a C ₁ -C ₆ alkoxy-C ₁ -C ₆ alkylene group, a C ₁ -C ₆ alkylamino-C ₁ -C ₆ - alkylene group, a C ₁ -C ₆ alkyl mercapto-C ₁ -C ₆ alkylene group, a straight-chain or branched C ₁ -C ₈ alkylene group, or an oxygen atom, a nitrogen atom or a sulfur atom, with the proviso that the radicals M ⁶¹ and M ⁶³ together with the nitrogen atom and the carbon atom of the basic enamine structure form a cyclic compound if M ^{63 is} equal to a linear or branched C ₁ -C ₈ alkylene group, a C ₁ -C ₈ alkoxyalkylene group, a C ₁ -C ₆ - Is alkylamino-C ₁ -C ₆ -alkylene group, a C ₁ -C ₆ -alkylmercapto-C ₁ -C ₆ -alkylene group, an oxygen atom, a nitrogen atom or a sulfur atom, preferably M ⁶³ on the aromatic radical M ⁶¹ is connected to the carbon which is ortho to the enamine-substituted carbon,

wobeiCompounds of formula C23

in which

• M ⁶⁴ and M ⁶⁸ independently of one another represent a linear or cyclic C ₁ -C ₆ alkyl group, a C ₂ -C ₆ alkenyl group, an optionally substituted aryl group, an optionally substituted heteroaryl group, an aryl C ₁ -C ₆ - alkyl group, a C ₁ -C ₆ hydroxyalkyl group, a C ₂ -C ₆ polyhydroxyalkyl group, a C ₁ -C ₆ alkoxy-C ₁ -C ₆ alkyl group, a group R ^I R ^II N- (CH ₂ ) _m -, where R ^I and R ^II independently of one another represent a hydrogen atom, a C ₁ -C ₆ alkyl group, a C ₁ -C ₆ hydroxyalkyl group or an aryl-C ₁ -C ₆ alkyl group, where R ^I and R ^II can form a 5-, 6- or 7-membered ring together with the nitrogen atom and m represents a number 2, 3, 4, 5 or 6,
• M ⁶⁵ and M ⁶⁷ independently of one another represent a hydrogen atom or a C ₁ -C ₆ alkyl group, at least one of the radicals M ⁶⁵ and M ^{67 representing} a C ₁ -C ₆ alkyl group,
• - M ⁶⁶ represents a hydrogen atom, a C ₁ -C ₆ alkyl group, a C ₁ -C ₆ hydroxyalkyl group, a C ₂ -C ₆ polyhydroxyalkyl group, a C ₁ -C ₆ alkoxy group, a C ₁ -C ₆ -Hydroxyalkoxygruppe, a group R ^III R ^IV N- (CH ₂ ) _q -, wherein R ^III and R ^IV independently of one another represent a hydrogen atom, a C ₁ -C ₆ alkyl group, a C ₁ -C ₆ hydroxyalkyl group or one Aryl-C ₁ -C ₆ -alkyl group and q represents a number 1, 2, 3, 4, 5 or 6, the radical M ⁶⁶ together with one of the radicals M ⁶⁴ or M ^{65 being} a 5- or 6-membered aromatic Ring can form, optionally with a halogen atom, a C ₁ -C ₆ alkyl group, a C ₁ -C ₆ hydroxyalkyl group, a C ₂ -C ₆ polyhydroxyalkyl group, a C ₁ -C ₆ alkoxy group, a C ₁ - C ₆ -hydroxyalkoxy group, a nitro group, a hydroxy group, a group R ^V R ^VI N- (CH ₂ ) _s -, where R ^V and R ^VI independently of one another represent a hydrogen atom, a C ₁ -C ₆ alkyl group, a C ₁ -C ₆ -hydroxyalkyl group or an aryl-C ₁ -C ₆ -alkyl group and s represents a number 0, 1, 2, 3, 4, 5 or 6 can be substituted,
• Y represents an oxygen atom, a sulfur atom or a group NR ^VII , in which R ^VII represents a hydrogen atom, an aryl group, a heteroaryl group, a C ₁ -C ₆ alkyl group or a C ₁ -C ₆ arylalkyl group,
• - X ^- stands for halide, benzenesulfonate, p-toluenesulfonate, C ₁ -C ₄ alkanesulfonate, trifluoromethanesulfonate, perchlorate, 0.5 sulfate, hydrogen sulfate, tetrafluoroborate, hexafluorophosphate or tetrachlorozincate.

The CH-acidic compounds with the Formulas C1, C2 and C3 are preferably selected from benzoylacetonitrile, malonic, malonates and their derivatives and acetoacetic acid, acetoacetic acid esters and their derivatives.

Examples of CH-acidic compounds with the formulas C4 and C5 are pyrazol-5-one, 3-methyl-pyrazol-5-one, 1-phenyl-3-methyl-pyrazol-5-one, 1- (β-cyanoethyl) -3-methyl-pyrazol-5-one, 1,3-dimethyl-pyrazol-5-one, 1- (β-acetoxyethyl) -3-methyl-pyrazol-5-one, 1- (o-chlorophenyl) -3-methyl-pyrazol-5-one, 1-phenyl-3-carbomethoxy-pyrazol-5-one, 1- (3-aminophenyl-pyrazol-5-one, 1- (4-aminophenyl) pyrazol-5-one, 3-methyl-pyrazol-5-one-1-carboxamide, 1-phenyl-pyrazol-5-one-3-carboxamide, 1-phenyl-5-amino-pyrazole, 1-benzyl-5-amino-pyrazole, 1-cyclohexyl-5-aminopyrazole, 1-ethyl-3-methyl-5-aminopyrazole, 1-Benzyl-3-phenyl-5-amino-pyrazol, 1-isopentyl-5-aminopyrazole, 1-furfuryl-5-aminopyrazole, 2-methyl-4H-pyrazolo (5) - [2,3-a] benzimidazole, [1- (3-thia-cyclopentyl ) -3-methy1-pyrazol-5-on-S-dioxide], 2-methyl-1H-3,3a, 8-triaza-cyclopenta [a] indene.

The barbituric acid derivatives with the formula C6 are preferably selected from di-n-butyl barbituric acid, di-iso-butyl barbituric acid, di-N-amyl barbituric acid, di-iso-amyl barbituric acid, di-n-hexyl barbituric acid, di-benzyl barbituric acid, di-β-phenylethyl -barbituric acid, di-cyclohexyl-barbituric acid, di-phenyl-barbituric acid, di-p-tolylbarbituric acid, di-p-methoxybenzyl-barbituric acid, N-methyl-N'-n-butyl-barbituric acid, N-methyl-N'-benzy1 -barbituric acid, N-methyl-N'-β-phenylethyl barbituric acid, N-methyl-N'-γ-phenylpropyl barbituric acid, N-methyl-N'-γ-phenylbutyl barbituric acid, N-methyl-N'-α -isobutyl-γ-phenylpropyl barbituric acid, N-methyl-N'-cyclohexyl barbituric acid, N-methyl-N'-phenyl barbituric acid, N-methyl-N'-p-toloyl barbituric acid, N-methyl-N ' -norbomylmethyl-barbituric acid as well the corresponding N-ethyl and N-n-butyl derivatives of the above.

As preferred examples of the pyridine derivatives with the formulas C7a and C7b, 2,6-dihydroxy-3-cyano-4-methyl-pyridine are mentioned, Cyanopyridones, aminonitropyridones and aminocyanpyridones, in particular N-methyl-3-cyan-4-methyl-6-hydroxy-pyridon-2, N-ethyl-3-cyano-4-methyl-6-hydroxy-pyridone-2, N-β-methoxyethyl-3-cyano-4-methyl-6-hydroxy-pyridone-2, 2,6-dihydroxy-3-cyan-4-methyl-pyridine, N-β-hydroxyethyl-3-cyan-4-methyl-6-hydroxy-pyridon-2, N-butyl-3-cyan-4-methyl-6-hydroxy-pyridone-2 and N-phenyl-3-cyan-4-methyl-6-hydroxy-pyridone-2.

The compounds with the formula C8 can selected are from 6-hydroxy-2H-benzofuran-one or 2H-benzofuran-on.

The CH-acidic compounds with the Formula C9 can selected are made from 1,3-dihydro-indol-2-one, 3H-benzofuran-2-one (2-coumaranone), 1-methyl-1,3-dihydro-indol-2-one, 5-methoxy-3H-benzofuran-2-one, 5-nitro-1,3-dihydro-indol-2-one, 1-methyl-5-vitro-l, 3-dihydro-indol-2-one, 6-methoxy-1,3-dihydro-indol-2-one, 5-chloro-1,3-dihydro-indol-2-one, 5,6-difluoro-1,3-dihydro-indol-2-one, 6-hydroxy-5-methoxy-1,3-dihydro-indol-2-one, 5,6-dimethoxy-1,3-dihydro-indol-2-one and 6-trifluoromethyl-1,3-dihydro-indol-2-one.

Examples of CH-acidic compounds with the formula C10 are imidazo [1,2-a] pyridin-2-one, and 6-bromo-imidazo [1,2-a] pyridin-2-one.

The CH-acidic compounds with the formula C11 are preferably selected from the derivatives in which in the formula C11 M ^{29 represents} a hydrogen atom, such as 2,4-dihydroxyquinoline.

A suitable example of an indione derivative with the formula C12 is 1,3-indanedione.

The CH-acidic compounds with the Formula C13 are preferably selected from rhodamine and 4-imino-4,5-dihydro-thiazol-2-ylamine.

As the preferred CH-acidic compound with the formula C14 can be called 1,2-diphenyl-3,5-dioxopyrazole.

The CH-acidic compounds with the Formula C15 are preferably selected from 2-phenyl-3,5-dihydro-imidazol-4-one and 3-methyl-2-p-toloyl-3,5-dihydro-imidazol-4-one.

A preferred example of a CH-acidic Compound with formula C16 is phenyldihydrobutyrolactone.

The CH-acidic compounds with the Formula C17 are preferably selected from 1,1-dioxo-1,2-dihydro-11,6-benzo [b] -thiophen-3-one and 2- (1,1-dioxo-1,2-dihydro-11,6-benzo [b] thiophene-3-ylidene) malonitrile.

Examples of pyrimidine derivatives with the Formula C18 are 2,4-diamino-6-hydroxypyrimidine, 2,6-diamino-4-hydroxypyrimidine, 4-amino-2,6-dihydroxypyrimidine, 4-amino-6-hydroxy-2-sulfanylpyrimidine, 2-amino-4,6-dihydroxypyrimidine, 4,6-dihydroxy-1-mercaptopyrimidine and 2,4,6-trihydroxypyrimidine, where 2,4-diamino-6-hydroxypyrimidine is particularly preferred.

As examples of preferred compounds with the formula C19 are mentioned: 1,2,3,3-tetramethyl-3H-indolium, 2,3-dimethylbenzothiazolium, 2,3-dimethyl-6-nitrobenzothiazolium-, 3-benzyl-2-benzothiazolium-, 2-methyl-3-propylbenzothiazolium-, 2,4-dimethyl-3-ethylthiazolium-, 3- (2-carboxyethyl) -2,5-dimethylbenzothiazolium-, 1,2,3-trimethylbenzimidazolium-, 5,6-dichloro-1,3-diethyl-2-methylbenzimidazolium-, 3-ethyl-2-methylbenzothiazolium-, 3-ethyl-2-methylnaphtho [1,2-d] thiazolium-, 5-chloro-3-ethyl-2-methylbenzothiazolium-, 3-ethyl-2-methylbenzoxazolium salts, e.g. B. as chlorides, bromides, Iodides, methanesulfonates, benzenesulfonates, p-toluenesulfonates, trifluoromethanesulfonates, Methyl sulfates, tetrafluoroborates can be present, and 2-methyl-3- (3-sulfopropyl) benzothiazolium hydroxide, inner salt, 4-methyl-1- (3-sulfopropyl) pyridinium hydroxide, inner Salt, 4-methyl-1- (3-sulfopropyl) quinolinium hydroxide, inner salt, 5-methoxy-2-methyl-3- (3-sulfopropyl) benzothiazolium hydroxide, interior Salt and any mixtures of the above compounds.

Examples of preferred compounds according to formulas C20 and C21 are:
1,4-dimethylquinolinium, 1,2-dimethylquinolinium, 1,4-dimethylpyridinium, 1,2-dimethylpyridinium, 2,4,6-trimethylpyrilium, 2-methyl-1-ethylquinolinium, 2,3- Dimethylisoquinolinium salts, e.g. B. as chlorides, bromides, iodides, methanesulfonates, benzenesulfonates, p-toluenesulfonates, trifluoromethanesulfonates, methyl sulfates, tetrafluoroborates and any mixtures of the above compounds.

Examples of preferred compounds according to formula C23 are: 1,2-dihydro-1,3,4,6-tetramethyl-2-oxopyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4,6-dimethyl-2-oxopyrimidinium chloride, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-oxopyrimidinium chloride chloride, 1,2-dihydro-1,3,4,6-tetramethyl-2-oxopyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diethyl-4,6-dimethyl-2-oxo-pyrimidinium hydrogensulphate, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-oxo-pyrimidinium hydrogensulphate, 1,2-dihydro-1,3,4-trimethyl-2-oxopyrimidinium chloride, 1,2-dihydro-1,3,4-trimethyl-2-oxopyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diethyl-4-methyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4-methyl-2-oxo-pyrimidinium hydrogensulphate, 1,2-dihydro-1,3-dipropyl-4-methyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-dipropyl-4-methyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3,4,6-tetramethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4,6-dimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3,4,6-tetramethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3,4-trimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3,4-trimethyl-2-thioxo-pyrimidinium hydrogensulphate, 1,2-dihydro-1,3-diethyl-4-methyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4-methyl-2-thioxo-pyrimidinium hydrogen sulfate, 1, 2-dihydro-1,3-dipropyl-4-methyl-2-thioxo-pyrimidinium chloride and 1,2-dihydro-1,3-dipropyl-4-methyl-2-thioxopyrimidinium hydrogen sulfate.

The CH-acidic compounds of component B are very particularly preferably selected from the group consisting of 1,2,3,3-tetramethyl-3H-indolium iodide, 1,2,3,3-tetramethyl-3H-indolium-p-toluenesulfonate, 1,2,3,3-tetramethyl-3H-indolium methanesulfonate, 1,3,3-trimethyl-2-methylene indoline (Fischer's base), 2,3-dimethyl-benzothiazolium iodide, 2,3-dimethyl-benzothiazolium-p- toluenesulfonate, 2,3-dimethyl-naphtho [1,2-d] thiazolium-p-toluenesulfonate, 3-ethyl-2-methyl-naphtho (1,2-d] thiazolium-p-toluenesulfonate, rhodanine, rhodanine-3- acetic acid, 1,4-dimethylquinolinium iodide, 1,2-dimethylquinolinium iodide, barbituric acid, thiobarbituric acid, 1,3-dimethylthiobarbituric acid, 1,3-diethylthiobarbituric acid, 1,3-diethylbarbituric acid, oxindole, 3-indoxy acetate, 2-coumaranone, 5-hydroxy-2-coumaranone, 6-hydroxy-2-coumaranone, 3-methyl-1-phenyl-pyrazolin-5-one, indan-1,2-dione, indan-1,3-dione, indan-1- on, benzoylacetonitrile, 3-dicyanomethylene indan-1-one, 2-ami no-4-imino-1,3-thiazoline hydrochloride, 5,5-dimethylcyclohexane-1,3-dione, 2H-1,4-benzoxazin-4H-3-one, 3-ethyl-2-methyl-benzoxazolium iodide, 3-ethyl-2-methyl-benzothiazolium iodide, 1-ethyl-4-methyl-quinolinium iodide, 1-ethyl-2-methylquinolinium iodide, 1,2,3-trimethylquinoxalinium iodide, 3-ethyl-2-methyl-benzoxazolium p-toluenesulfonate, 3-ethyl-2-methyl-benzothiazolium-p-toluenesulfonate, 1-ethyl-4-methyl-quinolinium-p-toluenesulfonate, 1-ethyl-2-methyl-quinolinium-p-toluenesulfonate, 1,2,3-trimethylquinoxalinium-p- toluenesulfonate 1,2-dihydro-1,3,4,6-tetramethyl-2-oxopyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4,6-dimethyl-2-oxopyrimidinium chloride , 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3,4,6-tetramethyl-2-oxo-pyrimidinium hydrogen sulfate , 1,2-dihydro-1,3-diethyl-4,6-dimethyl-2-oxopyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-oxopyrimidinium -hydrogen sulfate, 1,2-dihydro-1,3,4-trimethyl-2-oxopyrimidinium chloride, 1,2-dihydro-1,3,4-trime thyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diethyl-4-methyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4-methyl- 2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4-methyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-dipropyl-4-methyl-2- oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3,4,6-tetramethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4,6-dimethyl-2- thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3,4,6-tetramethyl-2- thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3,4-trimethyl-2-thioxo- pyrimidinium chloride, 1,2-dihydro-1,3,4-trimethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diethyl-4-methyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4-methyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4-methyl-2-thioxo-pyrimidinium chloride and 1, 2-dihydro-1,3-dipropyl-4 -methyl-2-thioxo-pyrimidinium hydrogensulphate.

in derThe primary and secondary aromatic amines of component B are preferably selected from the group consisting of N, N-dimethyl-p-phenylenediamine, N, N-diethyl-p-phenylenediamine, N- (2-hydroxyethyl) -N-ethyl-p -phenylene diamine, N, N-bis- (2-hydroxyethyl) -p-phenylene diamine, N- (2-methoxyethyl) -p-phenylene diamine, 2,3-dichloro-p-phenylene diamine, 2,4-dichloro-p-phenylene diamine , 2,5-dichloro-p-phenylenediamine, 2-chloro-p-phenylenediamine, 2,5-dihydroxy-4-morpholinoaniline, 2-aminophenol, 3-aminophenol, 4-aminophenol, 2-aminomethyl-4-aminophenol, 2 -Hydroxymethyl-4-aminophenol, o-phenylenediamine, m-phenylenediamine, p-phenylenediamine, 2,5-diaminotoluene, 2,5, -diaminophenol, 2,5-diaminoanisole, 2,5, diaminophenethole, 4-amino-3- methylphenol, 2- (2,5-diaminophenyl) ethanol, 2,4-diaminophenoxyethanol, 2- (2,5-diaminophenoxy) ethanol, 3-amino-4- (2-hydroxyethyloxy) phenol, 3,4-methylenedioxyphenol , 3,4-methylenedioxyaniline, 3-amino-2,4-dichlorophenol, 4-methylaminophenol, 2-methyl-5-aminophenol, 3-methyl-4-aminophenol, 2-met hyl-5- (2-hydroxyethylamino) phenol, 3-amino-2-chloro-6-methylphenol, 2-methyl-5-amino-4-chlorophenol, 5- (2-hydroxyethylamino) -4-methoxy-2-methylphenol , 4-amino-2-hydroxymethylphenol, 2- (diethylaminomethyl) -4-aminophenol, 4-amino-1-hydroxy-2- (2-hydroxyethylaminomethyl) benzene, 1-hydroxy-2-amino-5-methyl-benzene , 1-Hydroxy-2-amino-6-methyl-benzene, 2-amino-5-acetamido-phenol, 1,3-dimethyl-2,5-diaminobenzene, 5- (3-hydroxypropylamino-) 2-methylphenol, 5 -Amino-4-methoxy-2-methylphenol, N, N-dimethyl-3-aminophenol, N-cyclopentyl-3-aminophenol, 5-amino-4-fluoro-2-methylphenol, 2,4-diamino-5-fluorotoluene , 2,4-diamino-5- (2-hydroxyethoxy) toluene, 2,4-diamino-5-methylphenetol, 3,5-diamino-2-methoxy-1-methylbenzene, 2-amino-4- (2- hydroxyethylamino) anisole, 2,6-bis (2-hydroxyethylamino) -1-methylbenzene, 1,3-diamino-2,4-dimethoxybenzene, 3,5-diamino-2-methoxy-toluene, 2-aminobenzoic acid, 3 -Aminobenzoic acid, 4-aminobenzoic acid, 2-aminophenylacetic acid, 3-aminophenylacetic acid, 4-aminophenylacetic acid, 2,3-dia minobenzoic acid, 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid, 3,4-diaminobenzoic acid, 3,5-diaminobenzoic acid, 4-aminosalicylic acid, 5-aminosalicylic acid, 3-amino-4-hydroxy-benzoic acid, 4-amino-3-hydroxy -benzoic acid, 2-aminobenzenesulfonic acid, 3-aminobenzenesulfonic acid, 4-aminobenzenesulfonic acid, 3-amino-4-hydroxybenzenesulfonic acid, 4-amino-3-hydroxynaphthalene-1-sulfonic acid, 6-amino-7-hydroxynaphthalene-2-sulfonic acid, 7-amino -4-hydroxynaphthalene-2-sulfonic acid, 4-amino-5-hydroxynaphthalene-2,7-disulfonic acid, 3-amino-2-naphthoic acid, 3-aminophthalic acid, 5-aminoisophthalic acid, 1,3,5-triaminobenzene, 1,2 , 4-triaminobenzene, 1,2,4,5-tetraaminobenzene, 2,4,5-triaminophenol, pentaaminobenzene, hexaaminobenzene, 2,4,6-triaminoresorcinol, 4,5-diaminobenzate catechol, 4,6-diaminopyrogallol, 1- ( 2-hydroxy-5-aminobenzyl) -2-imidazolidinone, 4-amino-2 - ((4 - [(5-amino-2-hydroxyphenyl) methyl] piperazinyl) methyl) phenol, 3,5-diamino-4- hydroxycatechol, 1,4-bis (4-aminophenyl) -1,4-diazacycloheptane, aro Matic nitriles, such as 2-amino-4-hydroxybenzonitrile, 4-amino-2-hydroxybenzonitrile, 4-aminobenzonitrile, 2,4-diaminobenzonitrile, nitro group-containing amino compounds, such as 3-amino-6-methylamino-2-nitro-pyridine, Picramic acid, (8 - [(4-amino-2-nitrophenyl) azo] -7-hydroxynaphth-2-yl] trimethylammonium chloride, [8 - ((4-amino-3-nitrophenyl) azo) -7-hydroxynaphth -2-yl] trimethylammonium chloride (Basic Brown 17), 1-hydroxy-2-amino-4,6-dinitrobenzene, 1-amino-2-vitro-4- [bis- (2-hydroxyethyl) amino) benzene, 1-Amino-2 - [(2-hydroxyethyl) amino] -5-nitrobenzene (HC Yellow No. 5), 1-Amino-2-nitro-4 - ((2-hydroxyethyl) amino) benzene (HC Red No. 7), 2-chloro-5-nitro-N-2-hydroxyethyl-1,4-phenylenediamine, 1 - [(2-hydroxyethyl) amino) -2-nitro-4-amino-benzene (HC Red No. 3 ), 4-amino-3-nitrophenol, 4-amino-2-nitrophenol, 6-nitro-o-toluidine, 1-amino-3-methyl-4 - [(2-hydroxyethyl) amino] -6-nitrobenzene (HC Violet No. 1), 1-Amino-2-nitro-4 - ((2,3-dihydroxypropyl) amino] -5-chlorobenzene (HC Red No. 10), 2- (4-Amino-2-nitroanilino ) -benzoic acid, 6-nitro-2,5-diaminopyridine, 2-amino-6-chloro-4-nitrophenol, 1-amino-2- (3-nitrophenyla zo) -7-phenylazo-8-naphthol-3,6-disulfonic acid disodium salt (Acid blue No. 29), 1-amino-2- (2-hydroxy-4-nitrophenylazo) -8-naphthol-3,6-disulfonic acid Disodium salt (Palatinchrome green), 1-amino-2- (3-chloro-2-hydroxy-5-nitrophenylazo) -8-naphthol-3,6-disulfonic acid disodium salt (gallion), 4-amino-4'-nitrostilben-2 , 2'-disulfonic acid disodium salt, 2,4-diamino-3 ', 5'-dinitro-2'-hydroxy-5-methyl-azobenzene (Mordant brown 4), 4'-amino-4-nitrodiphenylamine-2-sulfonic acid, 4'-amino-3'-nitrobenzophenone-2-carboxylic acid, 1-amino-4-nitro-2- (2-nitrobenzylidenamino) benzene, 2- [2- (diethylamino) ethylamino] -5-nitroaniline, 3-amino -4-hydroxy-5-nitrobenzenesulfonic acid, 3-amino-3'-nitrobiphenyl, 3-amino-4-nitroacenaphthene, 2-amino-1-nitronaphthalene, 5-amino-6-nitrobenzo-1,3-dioxole, anilines, in particular nitro group-containing anilines, such as 4-nitroaniline, 2-nitroaniline, 1,4-diamino-2-nitrobenzene, 1,2-diamino-4-nitrobenzene, 1-amino-2-methyl-6-nitrobenzene, 4-nitro -1,3-phenylenediamine, 2-nitro-4-amino-1- (2-hydroxyethy lamino) benzene, 2-nitro-1-amino-4- [bis- (2-hydroxyethyl) amino] benzene, 4-amino-2-nitrodiphenylamine-2'-carboxylic acid, 1-amino-5-chloro 4- (2-hydroyethylamino) -2-nitrobenzene, aromatic anilines or phenols with a further aromatic radical, as represented in the formula IX

in the

• - R ²⁴ for a hydroxy or an amino group which is substituted by C ₁ -C ₆ alkyl, C ₁ -C ₆ hydroxyalkyl, C ₁ -C ₆ alkoxy or C ₁ -C ₆ alkoxy-C ₁ -C ₆ alkyl groups may be substituted,
• - R ²⁵ , R ²⁶ , R ²⁷ , R ²⁸ and R ²⁹ independently of one another for a hydrogen atom, a hydroxyl or an amino group, which can be substituted by C ₁ -C ₆ -alkyl-, C ₁ -C ₆ -hydroxyalkyl-, C ₁ -C ₆ alkoxy, C ₁ -C ₆ aminoalkyl or C ₁ -C ₆ alkoxy-C ₁ -C ₆ alkyl groups may be substituted, and
• - Z '' for a direct bond, a saturated or unsaturated carbon chain with 1 to 4 carbon atoms, optionally substituted by hydroxyl groups, a carbonyl, sulfonyl or imino group, an oxygen or sulfur atom, or a group with the formula X
  
  in the
• Q is a direct bond, a CH ₂ or CHOH group,
• - Q 'and Q''independently of one another for an oxygen atom, an NR ³⁰ group, wherein R ^{30 is} a hydrogen atom, a C ₁ -C ₆ alkyl group or C ₁ -C ₆ hydroxyalkyl group, both groups together with the rest of the molecule can form a 5-, 6- or 7-ring means the group O- (CH ₂ ) _p -NH or NH- (CH ₂ ) _p '-O, where p and p' are 2 or 3, and
• - o means a number from 1 to 4, such as 4,4'-diaminostilbene and its hydrochloride, 4,4'-diaminostilbene-2,2'-disulfonic acid mono- or di-Na salt, 4-amino-4'-dimethylaminostilben and its hydrochloride, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfide, 4,4'-Diaminodiphenylsulfoxid, 4,4'-diaminodiphenylamine, 4,4'-diaminodiphenylamine-2-sulfonic acid, 4,4'-diaminobenzophenone, 4,4'-diaminodiphenyl ether, 3,3 ', 4,4'-tetraamino-diphenyl, 3,3', 4,4'-tetraamino-benzophenone, 1,3-bis (2,4-diaminophenoxy) propane, 1,8-bis (2,5-diaminophenoxy) -3,6-dioxaoctane, 1,3-bis (4-aminophenylamino) propane, 1,3-bis (4-aminophenylamino) -2-propanol, 1,3-bis [N- (4-aminophenyl) -2-hydroxyethylamino] -2 propanol, N, N-bis- [2- (4-aminophenoxy) ethyl] methylamine, N-phenyl-1,4-phenylenediamine and bis (5-amino-2-hydroxyphenyl) methane.

The nitrogen-containing heterocyclic compounds of component B are preferably selected from the group consisting of 2-aminopyridine, 3-aminopyridine, 4-aminopyridine, 2-amino-3-hydroxy-pyridine, 2,6-diamino-pyridine, 2,5-diamino -pyridine, 2- (aminoethylamino) -5-aminopyridine, 2,3-diamino-pyridine, 2-dimethylamino-5-aminopyridine, 2-methylamino-3-amino-6-methoxy-pyridine, 2,3-diamino-6 -methoxy-pyridine, 2,6-dimethoxy-3,5-diamino-pyridine, 2,4,5-triamino-pyridine, 2,6-dihydroxy-3,4-dimethylpyridine, N- [2- (2,4 -Diaminophenyl) aminoethyl) -N- (5-amino-2-pyridyl) amine, N- [2- (4-aminophenyl) aminoethyl] -N- (5-amino-2-pyridyl) amine, 2.4 -Dihydroxy-5,6-diaminopyrimidine, 4,5,6-triaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2,4,5,6-tetraaminopyrimidine , 2-methylamino-4,5,6-triaminopyrimidine, 2,4-diaminopyrimidine, 4,5-diaminopyrimidine, 2-amino-4-methoxy-6-methylpyrimidine, 3,5-diaminopyrazole, 3,5-diamino -1,2,4-triazole, 3-aminopyrazole, 3-amino-5-hydroxypyrazole, 1-pheny l-4,5-diaminopyrazole, 1- (2-hydroxyethyl) -4,5-diaminopyrazole, 1-phenyl-3-methyl-4,5-diaminopyrazole, 4-amino-2,3-dimethyl-1-phenyl- 3-pyrazolin-5-one (4-aminoantipyrine), 1-phenyl-3-methylpyrazol-5-one, 2-aminoquinoline, 3-aminoquinoline, 8-amino quinoline, 4-aminoquininaldine, 2-aminonicotinic acid, 6-aminonicotinic acid, 5-aminoisoquinoline, 5-aminoindazole, 6-aminoindazole, 5-aminobenzimidazole, 7-aminobenzimidazole, 5-aminobenzothiazole, 7-aminobenzothiazole, 2,5-dihydroxy-4- morpholino-aniline and indole and indoline derivatives such as 4-aminoindole, 5-aminoindole, 6-aminoindole, 7-aminoindole, 5,6-dihydroxyindole, 5,6-dihydroxyindoline and 4-hydroxyindoline. According to the invention, furthermore as heterocyclic compounds, those in the DE-U1-299 08 573 disclosed hydroxypyrimidines are used. The aforementioned compounds can be used both in free form and in the form of their physiologically tolerable salts, e.g. B. as salts of inorganic acids, such as hydrochloric or sulfuric acid.

The aromatic hydroxy compounds component B are preferably selected from the group consisting of from 2-, 4-, 5-methylresorcinol, 2,5-dimethylresorcinol, resorcinol, 3-methoxyphenol, Pyrocatechol, hydroquinone, pyrogallol, phloroglucin, hydroxyhydroquinone, 2-, 3-, 4-methoxy-, 3-dimethylamino-, 2- (2-hydroxyethyl) -, 3,4-methylenedioxyphenol, 2,4-, 3,4-dihydroxybenzoic acid, phenylacetic acid, Gallic acid, 2,4,6-trihydroxybenzoic acid, acetophenone, 2-, 4-chlororesorcinol, 1-naphthol, 1,5-, 2,3-, 2,7-dihydroxynaphthalene, 6-dimethylamino-4-hydroxy-2-naphthalenesulfonic acid and 3,6-dihydroxy-2,7-naphthalenesulfonic acid.

The above connections of component B are each preferably in an amount of 1 to 60% by weight, in particular 5 to 40% by weight, based on the entire molded body in the molded body incorporated.

It is preferred to contain a molded article Component A and component B, for example as multi-phase moldings to be formulated with 3 separate layers. One contains first phase component A and a second phase component B. Touch these two phases itself in the compressed tablet not, but are replaced by a third phase, the so-called separation phase, Cut. In this way, the components reactive with each other occur A and B not in direct contact and an early color formation, e.g. while the storage of the tablet is prevented. More information about this embodiment are listed below under the heading "Shaped body geometries".

wobeiFurthermore, the molded article according to the invention can contain oxidation dye precursors of the developer and of the coupler type. It may be preferred according to the invention to use a p-phenylenediamine derivative or one of its physiologically tolerable salts as the developer component. P-Phenylenediamine derivatives of the formula (E1) are particularly preferred

in which

• G ¹ represents a hydrogen atom, a C ₁ to C ₄ alkyl radical, a C ₁ to C ₄ monohydroxyalkyl radical, a C ₂ to C ₄ polyhydroxyalkyl radical, a (C ₁ to C ₄ ) alkoxy radical (C ₁ to C ₄ ) alkyl, a 4'-aminophenyl group or a C ₁ to C ₄ alkyl group which is substituted by a nitrogen-containing group, a phenyl or a 4'-aminophenyl group;
• G ² represents a hydrogen atom, a C ₁ to C ₄ alkyl radical, a C ₁ to C ₄ monohydroxyalkyl radical, a C ₂ to C ₄ polyhydroxyalkyl radical, a (C ₁ to C ₄ ) alkoxy radical (C ₁ - to C ₄ ) -alkyl radical or a C ₁ - to C ₄ -alkyl radical which is substituted by a nitrogen-containing group;
• G ³ represents a hydrogen atom, a halogen atom, such as a chlorine, bromine, iodine or fluorine atom, a C ₁ to C ₄ alkyl radical, a C ₁ to C ₄ monohydroxyalkyl radical, a C ₂ to C _4- polyhydroxyalkyl, a C ₁ to C ₄ hydroxyalkoxy, a C ₁ to C ₄ acetylaminoalkoxy, a C ₁ to C ₄ mesylaminoalkoxy or a C ₁ to C ₄ carbamoylaminoalkoxy;
• - G ⁴ represents a hydrogen atom, a halogen atom or a C ₁ - to C ₄ -alkyl radical or
• - If G ³ and G ⁴ are ortho to each other, they can together form a bridging α, ω-alkylenedioxo group, such as an ethylenedioxy group.

Examples of the C ₁ to C ₄ alkyl radicals mentioned as substituents in the compounds according to the invention are the groups methyl, ethyl, propyl, isopropyl and butyl. Ethyl and methyl are preferred alkyl radicals. C ₁ to C ₄ alkoxy radicals preferred according to the invention are, for example, a methoxy or an ethoxy group. Further preferred examples of a C ₁ to C ₄ hydroxyalkyl group are a hydroxymethyl, a 2-hydroxyethyl, a 3-hydroxypropyl or a 4-hydroxybutyl group. A 2-hydroxyethyl group is particularly preferred. A particularly preferred C ₂ - to C ₄ -polyhydroxyalkyl group is the 1,2-dihydroxyethyl group. Examples of halogen atoms according to the invention are F, Cl or Br atoms, Cl atoms are very particularly preferred. According to the invention, the other terms used are derived from the definitions given here. Examples of nitrogen-containing groups of the formula (E1) are in particular the amino groups, C ₁ - to C ₄ -monoalkylamino groups, C ₁ - to C ₄ -dialkylamino groups, C ₁ - to C ₄ -trialkylammonium groups, C ₁ - to C ₄ -monohydroxyalkylamino groups, Imidazolinium and ammonium.

Particularly preferred p-phenylenediamines of the formula (E1) are selected from p-phenylenediamine, p-toluenediamine, 2-chloro-p-phenylenediamine, 2,3-dimethyl-p-phenylenediamine, 2,6-dimethyl-p-phenylenediamine, 2,6-diethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, N, N-dimethyl-p-phenylenediamine, N, N-diethyl-p-phenylenediamine, N, N-dipropyl-p-phenylenediamine, 4-amino-3-methyl- (N, N-diethyl) -aniline, N, N-bis- (β-hydroxyethyl) -p-phenylenediamine, 4-N, N-bis (β-hydroxyethyl) amino-2-methylaniline, 4-N, N-bis (β-hydroxyethyl) amino-2-chloroaniline, 2- (β-hydroxyethyl) -p-phenylenediamine, 2- (α, β-dihydroxyethyl) -p-phenylenediamine, 2-fluoro-p-phenylenediamine, 2-isopropyl-p-phenylenediamine, N- (β-hydroxypropyl) -p-phenylenediamine, 2-hydroxymethyl-p-phenylenediamine, N, N-dimethyl-3-methyl-p-phenylenediamine, N, N- (ethyl, β-hydroxyethyl) -p-phenylenediamine, N- (β, γ-dihydroxypropyl) -p-phenylenediamine, N- (4-aminophenyl) -p-phenylenediamine, N-phenyl-p-phenylenediamine, 2- (β-hydroxyethyloxy) -p-phenylenediamine, 2- (β-Acetylaminoethyloxy) -p-phenylenediamine, N- (β-methoxyethyl) -p-phenylenediamine and 5,8-diaminobenzo-1,4-dioxane as well as their physiologically compatible Salt.

Very particularly preferred according to the invention p-phenylenediamine derivatives of the formula (E1) are p-phenylenediamine, p-toluenediamine, 2- (β-hydroxyethyl) -p-phenylenediamine, 2- (α, β-dihydroxyethyl) -p-phenylenediamine and N, N-bis (β-hydroxyethyl) -p-phenylenediamine.

It can continue according to the invention be preferred to use compounds as developer components, that contain at least two aromatic nuclei that are and / or hydroxyl groups are substituted.

wobei:Among the binuclear developer components which can be used in the coloring compositions according to the invention, one can name in particular the compounds which correspond to the following formula (E2) and their physiologically tolerable salts:

in which:

• - Z ¹ and Z ² each independently represent a hydroxyl or NH ₂ radical, optionally by a C ₁ - to C ₄ -alkyl radical, by a C ₁ - to C ₄ -hydroxyalkyl radical and / or by a bridging Y. is substituted or which is optionally part of a bridging ring system,
• - The bridge Y stands for an alkylene group with 1 to 14 carbon atoms, such as a linear or branched alkylene chain or an alkylene ring which is interrupted or terminated by one or more nitrogen-containing groups and / or one or more heteroatoms such as oxygen, sulfur or nitrogen atoms and may be substituted by one or more hydroxyl or C ₁ to C ₈ alkoxy radicals, or a direct bond,
• G ⁵ and G ⁶ each independently represent a hydrogen or halogen atom, a C ₁ to C ₄ alkyl radical, a C ₁ to C ₄ monohydroxyalkyl radical, a C ₂ to C ₄ polyhydroxyalkyl radical, a C ₁ - to C ₄ -aminoalkyl radical or a direct connection to the bridge Y,
• - G ⁷ , G ⁸ , G ⁹ , G ¹⁰ , G ¹¹ and G ¹² each independently represent a hydrogen atom, a direct bond to the bridge Y or a C ₁ - to C ₄ -alkyl radical, with the provisos that
• - the Compounds of formula (E2) contain only one bridge Y per molecule and
• - the Compounds of the formula (E2) contain at least one amino group, which carries at least one hydrogen atom.

The substituents used in formula (E2) are analog according to the invention to the above statements Are defined.

Preferred dinuclear developer components of the formula (E2) are in particular: N, N'-bis (β-hydroxyethyl) -N, N'-bis (4-aminophenyl) -1,3-diamino-propan-2-ol, N , N'-bis (β-hydroxyethyl) -N, N'-bis (4-aminophenyl) ethylenediamine, N, N'-bis (4-aminophenyl) tetramethylene diamine, N, N'-bis ( β-hydroxye thyl) -N, N'-bis- (4-aminophenyl) tetramethylene diamine, N, N'-bis (4-methyl-aminophenyl) tetramethylene diamine, N, N'-diethyl-N, N'-bis- ( 4-amino-3-methylphenyl) ethylenediamine, bis (2-hydroxy-5-aminophenyl) methane, N, N'-bis (4-aminophenyl) -1,4-diazacycloheptane, N, N'-bis - (2-Hydroxy-5-aminobenzyl) piperazine, N- (4-aminophenyl) -p-phenylenediamine and 1,10-bis (2,5-diaminophenyl) -1,4,7,10-tetraoxadecane and their physiologically acceptable salts.

Very particularly preferred dinuclear Developer components of the formula (E2) are N, N'-bis (β-hydroxyethyl) -N, N'-bis- (4-aminophenyl) -1,3-diamino-propan-2-ol, Bis- (2-hydroxy-5-aminophenyl) methane, N, N'-bis (4-aminophenyl) -1,4-diazacycloheptane and 1,10-bis (2,5-diaminophenyl) -1,4,7,10-tetraoxadecane or one their physiologically tolerable Salts.

wobei:Furthermore, it can be preferred according to the invention to use a p-aminophenol derivative or one of its physiologically tolerable salts as developer component. P-Aminophenol derivatives of the formula (E3) are particularly preferred

in which:

• G ¹³ represents a hydrogen atom, a halogen atom, a C ₁ to C ₄ alkyl radical, a C ₁ to C ₄ monohydroxyalkyl radical, a C ₂ to C ₄ polyhydroxyalkyl radical, a (C ₁ to C ₄ ) Alkoxy- (C ₁ - to C ₄ ) -alkyl radical, a C ₁ - to C ₄ -aminoalkyl radical, a hydroxy- (C ₁ - to C ₄ ) -alkylamino radical, a C ₁ - to C ₄ -hydroxyalkoxy radical, a C ₁ - to C ₄ hydroxyalkyl aminoalkyl (C ₁ to C _4), or (di-C ₁ - to C ₄ -alkylamino) - (C ₁ - to C ₄₎ alkyl, and
• G ¹⁴ represents a hydrogen or halogen atom, a C ₁ to C ₄ alkyl radical, a C ₁ to C ₄ monohydroxyalkyl radical, a C ₂ to C ₄ polyhydroxyalkyl radical, a (C ₁ to C ₄ ) Alkoxy- (C ₁ - to C ₄ ) -alkyl radical, a C ₁ - to C ₄ -aminoalkyl radical or a C ₁ - to C ₄ -cyanoalkyl radical,
• G ¹⁵ represents hydrogen, a C ₁ to C ₄ alkyl radical, a C ₁ to C ₄ monohydroxyalkyl radical, a C ₂ to C ₄ polyhydroxyalkyl radical, a phenyl radical or a benzyl radical, and
• - G ¹⁶ represents hydrogen or a halogen atom.

The substituents used in formula (E3) are analog according to the invention to the above statements Are defined.

Preferred p-aminophenols of the formula (E3) are in particular p-aminophenol, N-methyl-p-aminophenol, 4-amino-3-methyl-phenol, 4-amino-3-fluorophenol, 2-hydroxymethylamino-4-aminophenol, 4-amino-3-hydroxymethylphenol, 4-amino-2- (β-hydroxyethoxy) phenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethylphenol, 4-amino-2-aminomethylphenol, 4-amino-2- (β-hydroxyethyl-aminomethyl) phenol, 4-amino-2- (α, β-dihydroxyethyl) phenol, 4-amino-2-fluorophenol, 4-amino-2-chlorophenol, 4-amino-2,6-dichlorophenol, 4-amino-2- (diethylaminomethyl) phenol as well as their physiologically tolerable Salts.

Very particularly preferred compounds of the formula (E3) are p-aminophenol, 4-amino-3-methylphenol, 4-amino-2-aminomethylphenol, 4-amino-2- (α, β-dihydroxyethyl) phenol and 4-amino-2- (diethylaminomethyl) phenol.

Furthermore, the developer component selected be from o-aminophenol and its derivatives, such as 2-amino-4-methylphenol, 2-amino-5-methylphenol or 2-amino-4-chlorophenol.

Furthermore, the developer component selected be from heterocyclic developer components such as the pyridine, pyrimidine, pyrazole, pyrazole-pyrimidine derivatives and their physiological acceptable Salt.

Preferred pyridine derivatives are especially the compounds described in the patents GB 1 026 978 and GB 1 153 196 are described, such as 2,5-diamino-pyridine, 2- (4-methoxyphenyl) amino-3-amino-pyridine, 2,3-diamino-6-methoxy-pyridine, 2- (β-methoxyethyl) amino- 3-amino-6-methoxy-pyridine and 3,4-diamino-pyridine.

Preferred pyrimidine derivatives are in particular the compounds described in the German patent DE 2 359 399 , the Japanese laid-open patent JP 02019576 A2 or in published patent application WO 96/15765, such as 2,4,5,6-tetraaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2-dimethylamino 4,5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine and 2,5,6-triaminopyrimidine.

Preferred pyrazole derivatives are in particular the compounds described in the patents DE 3 843 892 . DE 4 133 957 and patent applications WO 94/08969, WO 94/08970, EP-740 931 and DE 195 43 988 are described, such as 4,5-diamino-1-methylpyrazole, 4,5-diamino-1- (β-hydroxyethyl) pyrazole, 3,4-diaminopyrazole, 4,5-diamino-1- (4-chlorobenzyl) - pyrazole, 4,5-diamino-1,3-dimethylpyrazole, 4,5-diamino-3-methyl-1-phenylpyrazole, 4,5-diamino-1-methyl-3-phenylpyrazole, 4-amino-1,3- dimethyl-5-hydrazinopyrazole, 1-benzyl-4,5-diamino-3-methylpyrazole, 4,5-diamino-3-tert-butyl-1-methylpyrazole, 4,5-diamino-1-tert-butyl- 3-methylpyrazole, 4,5-diamino-1- (β-hydroxyethyl) -3-methylpyrazole, 4,5-diamino-1-ethyl-3-methylpyrazole, 4,5-diamino-1-ethyl-3- (4th -methoxyphenyl) -pyrazole, 4,5-diamino-1-ethyl-3-hydroxymethylpyrazole, 4,5-diamino-3-hydroxymethyl-1-methylpyrazole, 4,5-diamino-3-hydroxymethyl-1-isopropylpyrazole, 4, 5-diamino-3-methyl-1-isopropylpyrazole, 4-amino-5- (D-aminoethyl) amino-1,3-dimethylpyrazole, 3,4,5-triaminopyrazole, 1-methyl-3,4,5, triaminopyrazole, 3,5-diamino-1-methyl-4-methylaminopyrazole and 3,5-diamino-4- (β-hydroxyethyl) amino-1-methylpyrazole.

wobei:Preferred pyrazole-pyrimidine derivatives are, in particular, the derivatives of pyrazolo [1,5-a] pyrimidine of the following formula (E4) and its tautomeric forms, provided there is a tautomeric equilibrium:

in which:

• - G ¹⁷ , G ¹⁸ , G ¹⁹ and G ²⁰ each independently represent a hydrogen atom, a C ₁ - to C ₄ -alkyl radical, an aryl radical, a C ₁ - to C ₄ -hydroxyalkyl radical, a C ₂ - bis C ₄ -polyhydroxyalkyl radical is a (C ₁ - to C ₄ ) -alkoxy- (C ₁ - to C ₄ ) -alkyl radical, a C ₁ - to C ₄ -aminoalkyl radical which is optionally substituted by an acetyl-ureide or a sulfonyl radical can be protected, a (C ₁ - to C ₄ ) -alkylamino- (C ₁ - to C ₄ ) -alkyl radical, a di - [(C ₁ - to C ₄ ) -alkyl] - (C ₁ - to C ₄ ) aminoalkyl radical, where the dialkyl radicals optionally form a carbon cycle or a heterocycle with 5 or 6 chain links, a C ₁ - to C ₄ -hydroxyalkyl or a di- (C ₁ - to C ₄ ) - [hydroxyalkyl] - ( C ₁ - to C ₄ ) -aminoalkyl radical,
• - the X radicals are each independently a hydrogen atom, a C ₁ - to C ₄ -alkyl radical, an aryl radical, a C ₁ - to C ₄ -hydroxyalkyl group, a C ₂ - to C ₄ - polyhydroxyalkyl radical, a C ₁ - to C ₄ -aminoalkyl, a (C ₁ - to C ₄ ) -alkylamino- (C ₁ - to C ₄ ) -alkyl, a di - [(C ₁ - to C ₄ ) alkyl] - (C ₁ - to C ₄₎ aminoalkyl wherein the dialkyl residues optionally form a carbocycle or a heterocycle with 5 or 6 chain links, a C ₁ - to C ₄ hydroxyalkyl or a di- (C ₁ - to C ₄ hydroxyalkyl) - aminoalkyl residue, an amino residue, a C ₁ to C ₄ alkyl or di (C ₁ to C ₄ hydroxyalkyl) amino residue, a halogen atom, a carboxylic acid group or a sulfonic acid group,
• - i has the value 0, 1, 2 or 3,
• - p has the value 0 or 1,
• - q has the value 0 or 1 and
• - n has the value 0 or 1, with the proviso that
• - the Sum of p + q is not equal to 0,
• - if p + q is 2, n has the value 0, and the groups NG ¹⁷ G ¹⁸ and NG ¹⁹ G ²⁰ occupy positions (2,3); (5,6); (6,7); (3.5) or (3.7);
• - if p + q is 1, n is 1, and the groups NG ¹⁷ G ¹⁸ (or NG ¹⁹ G ²⁰ ) and the group OH occupy positions (2,3); (5,6); (6,7); (3.5) or (3.7);

The substituents used in formula (E4) are analog according to the invention to the above statements Are defined.

If the pyrazolo [1,5-a] pyrimidine of the above formula (E4) contains a hydroxy group at one of the positions 2, 5 or 7 of the ring system, there is a tautomeric equilibrium, which is illustrated, for example, in the following scheme:

• – Pyrazolo[1,5-a]pyrimidin-3,7-diamin;
• – 2,5-Dimethyl-pyrazolo[1,5-a]pyrimidin-3,7-diamin;
• – Pyrazolo[1,5-a]pyrimidin-3,5-diamin;
• – 2,7-Dimethyl-pyrazolo[1,5-a]pyrimidin-3,5-diamin;
• – 3-Aminopyrazolo[1,5-a]pyrimidin-7-ol;
• – 3-Aminopyrazolo[1,5-a]pyrimidin-5-ol;
• – 2-(3-Aminopyrazolo[1,5-a]pyrimidin-7-ylamino)-ethanol;
• – 2-(7-Aminopyrazolo[1,5-a]pyrimidin-3-ylamino)-ethanol;
• – 2-[(3-Aminopyrazolo[1,5-a]pyrimidin-7-yl)-(2-hydroxy-ethyl)-amino]-ethanol;
• – 2-[(7-Aminopyrazolo[1,5-a]pyrimidin-3-yl)-(2-hydroxy-ethyl)-amino]-ethanol;
• – 5,6-Dimethylpyrazolo[1,5-a]pyrimidin-3,7-diamin;
• - 2,6-Dimethylpyrazolo[1,5-a]pyrimidin-3,7-diamin;
• - 3-Amino-7-dimethylamino-2,5-dimethylpyrazolo[1,5-a]pyrimidin;

sowie ihre physiologisch verträglichen Salze und ihre tautomeren Formen, wenn ein tautomers Gleichgewicht vorhanden ist.Among the pyrazolo [1,5-a] pyrimidines of the formula (E4) above, one can in particular mention nen:

• - pyrazolo [1,5-a] pyrimidine-3,7-diamine;
• - 2,5-dimethyl-pyrazolo [1,5-a] pyrimidine-3,7-diamine;
• - pyrazolo [1,5-a] pyrimidine-3,5-diamine;
• - 2,7-dimethyl-pyrazolo [1,5-a] pyrimidine-3,5-diamine;
• - 3-aminopyrazolo [1,5-a] pyrimidin-7-ol;
• - 3-aminopyrazolo [1,5-a] pyrimidin-5-ol;
• - 2- (3-aminopyrazolo [1,5-a] pyrimidin-7-ylamino) ethanol;
• - 2- (7-aminopyrazolo [1,5-a] pyrimidin-3-ylamino) ethanol;
• - 2 - [(3-aminopyrazolo [1,5-a] pyrimidin-7-yl) - (2-hydroxyethyl) amino] ethanol;
• - 2 - [(7-aminopyrazolo [1,5-a] pyrimidin-3-yl) - (2-hydroxyethyl) amino] ethanol;
• - 5,6-dimethylpyrazolo [1,5-a] pyrimidine-3,7-diamine;
• - 2,6-dimethylpyrazolo [1,5-a] pyrimidine-3,7-diamine;
• - 3-amino-7-dimethylamino-2,5-dimethylpyrazolo [1,5-a] pyrimidine;

as well as their physiologically acceptable salts and their tautomeric forms when there is a tautomeric equilibrium.

The Pyrazolo [1,5-a] pyrimidines of formula (E4) above as described in the literature by cyclization from an aminopyrazole or hydrazine.

As oxidation dye precursors m-phenylenediamine derivatives, naphthols, resorcinol are generally of the coupler type and resorcinol derivatives, pyrazolones and m-aminophenol derivatives are used. As coupler substances 1-naphthol are particularly suitable, 1,5-, 2,7- and 1,7-dihydroxynaphthalene, 5-amino-2-methylphenol, m-aminophenol, resorcinol, resorcinol monomethyl ether, m-phenylenediamine, 1-phenyl-3-methyl-5-pyrazolone, 2,4-dichloro-3-aminophenol, 1,3-bis (2,4-diaminophenoxy) propane, 2-chloro-resorcinol, 4-chloro-resorcinol, 2-chloro-6-methyl-3-aminophenol, 2-amino-3-hydroxypyridine, 2-methyl, 5-methylresorcinol and 2-methyl-4-chloro-5-aminophenol.

Coupler components preferred according to the invention are

• M-aminophenol and its derivatives such as 5-amino-2-methylphenol, N-cyclopentyl-3-aminophenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy-4-aminophenoxyethanol, 2,6-dimethyl-3-aminophenol, 3-trifluoroacetylamino-2-chloro-6-methylphenol, 5-amino-4-chloro-2-methylphenol, 5-amino-4-methoxy-2-methylphenol, 5- (2-hydroxyethyl) amino-2-methylphenol, 3- (diethylamino) phenol, N-cyclopentyl-3-aminophenol, 1,3-dihydroxy-5- (methylamino) benzene, 3-ethylamino-4-methylphenol and 2,4-dichloro-3-aminophenol,
• O-aminophenol and its derivatives,
• - m-diamino benzene and its derivatives such as, for example, 2,4-diaminophenoxyethanol, 1,3-bis (2,4-diaminophenoxy) propane, 1-methoxy-2-amino-4- (2-hydroxyethylamino) benzene, 1,3-bis (2,4-diaminophenyl) propane, 2,6-bis (2-hydroxyethylamino) -1-methylbenzene and 1-amino-3-bis- (2-hydroxyethyl) aminobenzene,
• O-diamino benzene and its derivatives such as 3,4-diaminobenzoic acid and 2,3-diamino-1-methylbenzene,
• - Di- or trihydroxybenzene derivatives such as resorcinol, Resorcinol monomethyl ether, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol, 2-chlororesorcinol, 4-chlororesorcinol, pyrogallol and 1,2,4-trihydroxybenzene,
• - pyridine derivatives such as 2,6-dihydroxypyridine, 2-amino-3-hydroxypyridine, 2-amino-5-chloro-3-hydroxypyridine, 3-amino-2-methylamino-6-methoxypyridine, 2,6-dihydroxy-3,4-dimethylpyridine, 2,6-dihydroxy-4-methylpyridine, 2,6-diaminopyridine, 2,3-diamino-6-methoxypyridine and 3,5-diamino-2,6-dimethoxypyridine,
• - naphthalene derivatives such as 1-naphthol, 2-methyl-1-naphthol, 2-hydroxymethyl-1-naphthol, 2-hydroxyethyl-1-naphthol, 1,5-dihydroxynaphthalene, 1,6-dihydroxynaphthalene, 1,7-dihydroxynaphthalene, 1,8-dihydroxynaphthalene, 2,7-dihydroxynaphthalene and 2,3-dihydroxynaphthalene,
• - Morpholine derivatives such as 6-hydroxybenzomorpholine and 6-aminobenzomorpholine,
• - Quinoxaline derivatives such as 6-methyl-1,2,3,4-tetrahydroquinoxaline,
• - pyrazole derivatives such as 1-phenyl-3-methylpyrazol-5-one,
• - Indole derivatives such as 4-hydroxyindole, 6-hydroxyindole and 7-hydroxyindole,
• - pyrimidine derivatives, such as 4,6-diaminopyrimidine, 4-amino-2,6-dihydroxypyrimidine, 2,4-diamino-6-hydroxypyrimidine, 2,4,6-trihydroxypyrimidine, 2-amino-4-methylpyrimidine, 2-amino-4-hydroxy-6-methylpyrimidine and 4,6-dihydroxy-2-methylpyrimidine, or
• - Methylenedioxybenzene derivatives such as 1-hydroxy-3,4-methylenedioxybenzene, 1-amino-3,4-methylenedioxybenzene and 1- (2-hydroxyethyl) amino-3,4-methylenedioxybenzene.

At least is particularly preferred in the molded article according to the invention a coupler type oxidation dye precursor selected from 1-naphthol, 1,5-, 2,7- and 1,7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, 3-amino-2-methylamino-6-methoxy-pyridine, resorcinol, 4-chlororesorcinol, 2,4-diaminophenoxyethanol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, Contain 2,5-dimethylresorcinol and 2,6-dihydroxy-3,4-dimethylpyridine.

With regard to the usable in the moldings according to the invention Coupler components will continue to expressly on the monograph Ch. Zviak, The Science of Hair Care, Chapter 7 (pp. 248-250; direct dyes) and Chapter 8, pages 264-267; Oxidation dye precursors), published as Volume 7 of the series "Dermatology" (Ed .: Ch., Culnan and H. Maibach), Marcel Dekker Inc., New York, Basel, 1986, and the “European inventory of cosmetic raw materials " published by the European Community, available in floppy form from the Federal Association of German Industry and Trade Companies for Medicines, Health food and personal care products e.V., Mannheim, referred to.

The molded body according to the invention contains at least one dissolution accelerator. The term resolution accelerator includes gas-developing components, pre-formed and enclosed gases, Disintegrants and their mixtures.

In one embodiment of the present invention, gas-evolving components are used as the dissolution accelerator. Upon contact with water, these components react with one another to form gases in-situ, which generate a pressure in the tablet which causes the tablet to disintegrate into smaller particles. An example of such a system are special combinations of suitable acids with bases. Mono-, di- or trivalent acids with a pK _a value of 1.0 to 6.9 are preferred. Preferred acids are citric acid, malic acid, maleic acid, malonic acid, itaconic acid, tartaric acid, oxalic acid, glutaric acid, glutamic acid, lactic acid, fumaric acid, glycolic acid and mixtures thereof. Citric acid is particularly preferred. It can be very particularly preferred to use citric acid in particle form, the particles having a diameter below 1000 μm, in particular less than 700 μm, very particularly preferably less than 400 μm. Further alternative suitable acids are the homopolymers or copolymers of acrylic acid, maleic acid, methacrylic acid or itaconic acid with a molecular weight of 2,000 to 200,000. Homopolymers of acrylic acid and copolymers of acrylic acid and maleic acid are particularly preferred. Preferred bases according to the invention are alkali metal silicates, carbonates, hydrogen carbonates and mixtures thereof. Metasilicates, bicarbonates and carbonates are particularly preferred, bicarbonates are very particularly preferred. Particulate hydrogen carbonates with a particle diameter of less than 1000 μm, in particular less than 700 μm, very particularly preferably less than 400 μm are particularly preferred. Sodium or potassium salts of the above bases are particularly preferred. These gas-generating components are preferably present in the colored shaped bodies according to the invention in an amount of at least 10% by weight, in particular at least 20% by weight.

In a further embodiment of the present invention, the gas is pre-formed or enclosed, so that when the dissolution of the shaped body begins, the gas evolution begins and the further dissolution accelerates. Examples of suitable gases are air, carbon dioxide, N ₂ O, oxygen and / or other non-toxic, non-combustible gases.

In a particularly preferred embodiment of the present invention, disintegration aids, so-called molded explosives, into the moldings incorporated to reduce disintegration times. Under molded explosives or decay accelerators are according to Römpp (9th edition, Vol. 6, p. 4440) and Voigt "textbook pharmaceutical technology "(6. Edition, 1987, pp. 182-184) understood auxiliaries for rapid Decay of molded articles in water or gastric juice and for ensure the release of the pharmaceuticals in an absorbable form.

These substances, also because of their Effect called "explosive" medium increase with water ingress their volume (swelling). Swelling disintegration aids are for example synthetic polymers such as polyvinyl pyrrolidone (PVP) or natural Polymers or modified natural substances such as cellulose and starch and their derivatives, alginates or casein derivatives.

Disintegrants based on cellulose are used as preferred disintegrants in the context of the present invention, so that preferred moldings such a disintegrant based on cellulose in amounts of 0.5 to 70% by weight, preferably 3 to 30% by weight, based on the entire molded body contain. Pure cellulose has the formal gross composition (C ₆ H ₁₀ O ₅ ) _n and, viewed formally, is a β-1,4-polyacetal of cellobiose, which in turn is made up of two molecules of glucose. Suitable celluloses consist of approximately 500 to 5000 glucose units and consequently have average molecular weights of 50,000 to 500,000. Cellulose-based disintegrants which can be used in the context of the present invention are also cellulose derivatives which can be obtained from cellulose by polymer-analogous reactions. Such chemically modified celluloses include, for example, products from esterifications or etherifications in which hydroxy hydrogen atoms have been substituted. However, celluloses in which the hydroxyl groups have been replaced by functional groups which are not bound via an oxygen atom can also be used as cellulose derivatives. In the group of Cel Cellulose derivatives include, for example, alkali celluloses, carboxymethyl cellulose (CMC), cellulose esters and ethers and aminocelluloses. The cellulose derivatives mentioned are preferably not used as the only cellulose-based disintegrant, but are used in a mixture with cellulose. The content of cellulose derivatives in these mixtures is preferably below 50% by weight, particularly preferably below 20% by weight, based on the cellulose-based disintegrant. Pure cellulose which is free of cellulose derivatives is particularly preferably used as the cellulose-based disintegrant.

According to the invention, the cellulose used as disintegration aid cannot be used in finely divided form, but can be converted into a coarser form, for example granulated or compacted, before being added to the premixes to be compressed. The particle sizes of such disintegrants are usually above 200 μm, preferably at least 90% by weight between 300 and 1600 μm and in particular at least 90% by weight between 400 and 1200 μm. The disintegration auxiliaries according to the invention are available commercially for example under the name of Arbocel ^® from Rettenmaier. A preferred disintegration aid is, for example, Arbocel ^® TF-30-HG.

Microcrystalline cellulose is used as the preferred cellulose-based disintegrant or as a component of this component. This microcrystalline cellulose is obtained by partial hydrolysis of celluloses under conditions which only attack and completely dissolve the amorphous areas (approx. 30% of the total cellulose mass) of the celluloses, but leave the crystalline areas (approx. 70%) undamaged. Subsequent disaggregation of the microfine celluloses produced by the hydrolysis provides the microcrystalline celluloses, which have primary particle sizes of approximately 5 μm and can be compacted, for example, into granules with an average particle size of 200 μm. Suitable microcrystalline cellulose is available commercially for example under the trade name Avicel ^®.

The accelerated dissolution of the moldings can also according to the invention Pregranulation of the other constituents of the molded body achieved become.

In a preferred embodiment contain the shaped body according to the invention these to accelerate the resolution, in particular in addition to at least one disintegrant based on cellulose, a mixture of starch and at least one saccharide. Disaccharides are preferably used Saccharides of this embodiment. Said mixture is preferably in a weight ratio of Strength and the saccharides used from 10: 1 to 1:10, particularly preferably from 1: 1 to 1:10, very particularly preferably from 1: 4 to 1: 8 in the molded body in front.

The disaccharides used are preferably selected from lactose, maltose, sucrose, trehalose, turanose, gentiobiose, Melibiosis and cellobiose. Lactose and maltose are particularly preferred and sucrose and very particularly preferably lactose in the moldings according to the invention.

The starch-saccharide mixture is in the molded body in an amount of 5 to 70% by weight, preferably 20 to 40% by weight based on the mass of the entire molded body.

Although the moldings of the invention their dissolution Application formulations can result in being slightly acidic, neutral or are also set alkaline, contain the moldings in a preferred embodiment at least one alkalizing agent.

In principle, the alkalizing agents are subject no restrictions. Suitable alkalizing agents are, for example, ammonium salts, Carbonates, hydrogen carbonates, phosphates, amino acids, alkali or alkaline earth hydroxides and organic amines.

In a preferred embodiment Solid alkalizing agents are used in the present invention Commitment.

In another embodiment In the present invention, it may be preferred to use alkalizing agents use, which are characterized by good water solubility. Good water soluble are compounds according to the invention, of which at least 5g dissolve in 100ml water at 15 ° C. Especially Compounds with a water solubility of more than 7.5 are preferred g in 100ml water at 15 ° C.

In a preferred embodiment In the present extension, amino acids or Oligopeptides with at least one amino group and one carboxy or a sulfo group is used, the 2.5% aqueous solution of which pH greater than 9.0.

In the context of this embodiment are aminocarboxylic acids particularly preferred, in particular α-aminocarboxylic acids and ω-aminocarboxylic acids. Under the α-aminocarboxylic acids again lysine and especially arginine are particularly preferred.

The amino acids can be preferred for the shaped articles according to the invention be added in free form. In a number of cases however it is also possible the amino acids use in salt form. The preferred salts are then the compounds with hydrohalic acids, especially the hydrochloride and the hydrobromide.

Furthermore, the amino acids can also be used in the form of oligopeptides and protein hydrolyzates if it is ensured that the required amounts of the amino acids used according to the invention are contained therein. In this context, the revelation of the DE-OS 22 15 303 referred to, to which express reference is made.

A very particularly preferred alkalizing agent is arginine, especially in free form, but also as hydrochloride used, because in addition to its alkaline properties it also penetration capacity of the dyes increased significantly.

The alkalizing agent is in the Shaped bodies according to the invention preferred in amounts of 0.5 to 20% by weight, in particular 5 to 15% by weight, based on the total mean.

According to the invention, it may be desirable to integrate direct dyes in the moldings. As special Nitro dyes have proven suitable. According to the invention are under Nitro dyes the coloring To understand components that have at least one aromatic ring system have at least one nitro group.

Particularly preferred nitro dyes are HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 12, HC Orange 1, HC Red 1, HC Red 3, HC Red 10, HC Red 11, HC Red 13, HC Red BN, HC Blue 2, HC Blue 12, HC Violet 1 and 1,4-diamino-2-nitrobenzene, 2-amino-4-nitrophenol, 1,4-bis (β-hydroxyethyl) -amino-2-nitrobenzene, 3-nitro-4- (β-hydroxyethyl) -aminophenol, 2- (2-hydroxyethyl) amino-4,6-dinitrophenol, 1- (2-hydroxyethyl) amino-4-methyl-2-nitrobenzene, 1-amino-4- (2-hydroxyethyl) amino-5-chloro-2-nitrobenzene, 4-amino-3-nitrophenol, 1- (2-ureidoethyl) amino-4-nitrobenzene, 4-amino-2-nitrodiphenylamine-2-carboxylic acid, 6-nitro-1,2,3,4-tetrahydroquinoxaline, picramic and their salts, 2-amino-6-chloro-4-nitrophenol, 4-ethylamino-3-nitrobenzoic acid and 2-chloro-6-ethylamino-1-hydroxy-4-nitrobenzene.

In addition to the nitro dyes are also preferred the azo dyes, anthraquinones or naphthoquinones according to the invention synthetic direct dyes. Preferred direct Dyes of this type are, for example, Disperse Orange 3 Disperse Blue 3, Disperse Violet 1, Disperse Violet 4, Acid Violet 43, Disperse Black 9 and Acid Black 52 as well as 2-hydroxy-1,4-naphthoquinone.

Furthermore, it can be preferred according to the invention be when the synthetic direct dye is a cationic Group carries. Are particularly preferred

• (i) cationic triphenylmethane dyes,
• (ii) aromatic systems with a quaternary nitrogen group are substituted, and
• (iii) direct dyes containing a heterocycle, the at least one quaternary Has nitrogen atom.

Examples of dyes of class (i) are in particular Basic Blue 7, Basic Blue 26, Basic Violet 2 and Basic Violet 14.

Examples of class (ii) dyes are in particular Basic Yellow 57, Basic Red 76, Basic Blue 99, Basic Brown 16 and Basic Brown 17.

Examples of dyes of class (iii) are particularly in the EP-A2-998 908 , to which reference is expressly made at this point, is disclosed in claims 6 to 11.

Preferred cationic direct dyes of group (iii) are in particular the following compounds:

The compounds of the formulas (DZ1), (DZ3) and (DZ5) are very particularly preferred cationic direct pulls Group (iii) dyes.

The preparations according to the invention can also dyes occurring in nature, such as for example in henna red, henna neutral, henna black, chamomile flower, sandalwood, black tea, rotten tree bark, sage, blue wood, madder root, catechu, Sedre and alkanna root are included.

The moldings according to the invention contain the direct ones Dyes preferably in an amount of 0.01 to 20 wt .-%.

In a particularly preferred embodiment contain the moldings at least one pearlescent pigment. Frequently used pearlescent pigments are natural Pearlescent pigments such as Fish silver (guanine / hypoxanthine mixed crystals from fish scales) or mother-of-pearl (from ground mussel shells), monocrystalline pearlescent pigments such as Bismuth oxychloride, as well Pearlescent pigments based on mica or mica / metal oxide. The latter pearlescent pigments are coated with a metal oxide Mistake. By using the pearlescent pigments, shine and if necessary additionally Color effects achieved in the moldings according to the invention. The coloring through the pearlescent pigments used in the moldings however, affects the color result of the coloring of the keratin fibers Not.

Pearlescent pigments based on mica and on mica / metal oxide are preferred according to the invention. Mica is one of the layered silicates. The most important representatives of these silicates are muscovite, phlogopite, paragonite, biotite, lepidolite and margarite. To produce the pearlescent pigments in conjunction with metal oxides, the mica, predominantly muscovite or phlogopite, is coated with a metal oxide. Suitable metal oxides include TiO ₂ , Cr ₂ O ₃ and Fe ₂ O ₃ . Appropriate coating eliminates interference pigments and color gloss pigments obtained as pearlescent pigments according to the invention. In addition to a glittering optical effect, these types of pearlescent pigment also have color effects. Furthermore, the pearlescent pigments which can be used according to the invention can furthermore contain a color pigment which is not derived from a metal oxide.

The grain size of the preferred ones Pearlescent pigments are preferably between 1.0 and 100 μm, particularly preferably between 5.0 and 60.0 μm.

Particularly preferred pearlescent pigments are marketed by Merck under the trade names Colorona ^®, wherein the pigments Colorona ^® red-brown (47-57 wt.% Muscovite mica (KH ₂ (AlSiO _{4) 3),} 43-50 wt % Fe ₂ O ₃ (INCI: Iron Oxides CI 77491), <3% by weight TiO ₂ (INCI: Titanium Dioxide CI 77891), Colorona ^® Blackstar Blue (39-47% by weight Muscovit Mica (KH ₂ (AlSiO ₄ .) _3), 53-61% by weight of Fe ₃ O ₄ (INCI: Iron oxide CI 77499)), Colorona ^® Fine Siena (35-45% by weight of muscovite mica (KH ₂ (AlSiO _{4) 3),} 55-65. % By weight Fe ₂ O ₃ (INCI: Iron Oxides CI 77491)), Colorona ^® Aboriginal Amber (50-62% by weight Muscovit Mica (KH ₂ (AlSiO ₄ ) ₃ ), 36-44% by weight Fe ₃ O ₄ (INCI: Iron Oxides CI 77499), 2-6% by weight TiO ₂ (INCI: Titanium Dioxide CI 77891)), Colorona ^® Patagonian Purple (42-54% by weight Muscovit Mica (KH ₂ (AlSi0 ₄ ) ₃ ), 26-32% by weight Fe ₂ O ₃ (INCI: Iron Oxides CI 77491), 18-22% by weight TiO ₂ (INCI: Titanium Dioxide CI 77891), 2-4% by weight Prussian Blue (INCI: Ferric Ferrocyanide CI 77510) ), Colorona ^® Chameleon (40-50% by weight Muscovit Mica (KH ₂ (AlSiO ₄ ) ₃ ), 50-60% by weight Fe ₂ O ₃ (INCI: Iron Oxides CI 77491)) and Silk ^® Mica (> 98 % By weight Muscovit Mica (KH ₂ (AlSiO ₄ ) ₃ )) are very particularly preferred.

With regard to the usable in the moldings according to the invention Pearlescent pigments continue to be expressly on the monographs Inorganic Pigments, Chemical technology review No. 166, 1980, pages 161-173 (ISBN 0-8155-0811-5) and Industrial Inorganic Pigments, 2nd edition, Weinheim, VCH, 1998, pages 211-231.

In the molded body according to the invention can also Oxidizing agents may be included. Although the choice of oxidant basically no restrictions subject, it can be preferred according to the invention as an oxidizing agent Addition products of hydrogen peroxide, especially on urea, Melamine or sodium borate. The use of percarbamide is particularly preferred.

It is also possible to use the Perform oxidation with the help of enzymes, the enzymes both be used to produce oxidizing per compounds as well as for reinforcement the effect of a small amount of oxidizing agents present.

The enzymes (enzyme class 1: Oxidoreductases) electrons from suitable developer components (Reducing agent) transferred to atmospheric oxygen. Are preferred Oxidases such as tyrosinase and laccase but also glucose oxidase, uricase or pyruvate oxidase. Furthermore, the procedure, the effect small amounts (e.g. 1% and less, based on the total Medium) to amplify hydrogen peroxide by peroxidases.

The formation of the color can also be supported and increased by adding certain metal ions to the shaped body. Such metal ions are, for example, Zn ²⁺ , Cu ²⁺ , Fe ²⁺ , Fe ³⁺ , Mn ²⁺ , Mn ⁴⁺ , Li ⁺ , Mg ²⁺ , Ca ²⁺ and Al ³⁺ . Zn ²⁺ , Cu ²⁺ and Mn ²⁺ are particularly suitable. In principle, the metal ions can be used in the form of any physiologically acceptable salt. Preferred salts are the acetates, sulfates, halides, lactates and tartrates. By using these metal salts, the formation of the coloring can be accelerated and the color shade can be influenced in a targeted manner. However, it has also proven practical to use the metal ions in the form of their complexes or also attached to zeolites to increase the coloring power.

In a special embodiment the molded body according to the invention is free of oxidizing agents.

The consumer likes perception the molded body, in particular caused by a spherical shape of the shaped body, if appropriate in conjunction with aromatic fragrance notes, the shaped body according to the invention a luxury food such as. Confectionery get in touch. This association can, in particular in children, oral intake or swallowing molding in principle not be excluded. In a preferred embodiment The moldings according to the invention therefore contain a bitter substance to prevent swallowing or accidental ingestion. Bitter substances according to the invention preferred in water at 20 ° C at least 5 g / l soluble are.

Regarding an undesirable Interaction with any fragrance components contained in the shaped body, especially a change of the fragrance perceived by the consumer, have the ionogenic Bitter substances have proven to be superior to the non-ionic ones. ionogenic Bitter substances, preferably consisting of organic cations) and organic anion (s), are therefore for the preparations according to the invention prefers.

Quaternary ammonium compounds which contain an aromatic group both in the cation and in the anion are particularly suitable as bitter substances. One such compound is commercially available for example under the trademark Bitrex ^® and Indigestin ^® available benzyldiethyl ((2,6-Xylylcarbamoyl) methyl) ammonium benzoate. This compound is also known as Denatonium Benzoate known.

The bitter substance is in the moldings according to the invention in Amounts of 0.0005 to 0.1 wt .-%, based on the molded body, contain. Quantities of 0.001 to 0.05% by weight are particularly preferred.

Other components

In addition to the ingredients mentioned can the moldings according to the invention continue all for such preparations contain known active ingredients, additives and auxiliaries. As further components you can both solids and liquids are used. If liquids are selected as a further component of the shaped body according to the invention, the dosage should be chosen that before the tablet is a flowable powder is present. The liquid further components are preferred before tabletting through a suitable device spraying tabletting powder. One more way, liquid Incorporating components into the moldings according to the invention, offers e.g. the previous removal of solvents so that the originally liquid component can be used as a solid.

In many cases the moldings contain at least a surfactant, in principle both anionic and zwitterionic, Ampholytic, nonionic and cationic surfactants are suitable. In many cases However, it has proven advantageous to use anionic, select zwitterionic or nonionic surfactants.

Suitable anionic surfactants are in preparations according to the invention all for use on the human body suitable anionic surface-active Substances. These are characterized by a water-solubilizing, anionic group such as B. a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group of about 10 up to 22 carbon atoms. additionally can in the molecule Glycol or polyglycol ether groups, ester, ether and amide groups as well as hydroxyl groups. Examples of suitable ones Anionic surfactants are in the form of sodium, potassium, Ammonium and magnesium as well as the mono-, di- and trialkanolammonium salts with 2 or 3 carbon atoms in the alkanol group,

• - linear fatty acids with 10 to 22 carbon atoms (soaps),
• Ether carboxylic acids of the formula RO- (CH ₂ -CH ₂ O) _x -CH ₂ -COOH, in which R is a linear alkyl group with 10 to 22 C atoms and x = 0 or 1 to 16,
• - acyl sarcosides with 10 to 18 carbon atoms in the acyl group,
• - acyl taurides with 10 to 18 carbon atoms in the acyl group,
• - acyl isethionates with 10 to 18 carbon atoms in the acyl group,
• - sulfosuccinic acid mono- and dialkyl esters with 8 to 18 carbon atoms in the alkyl group and sulfosuccinic acid mono-alkyl polyoxyethyl ester with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups,
• - linear Alkane sulfonates with 12 to 18 carbon atoms,
• - linear Alpha-olefin sulfonates with 12 to 18 carbon atoms,
• - Alpha-sulfofatty acid methyl ester of fatty acids with 12 to 18 carbon atoms,
• Alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH ₂ -CH ₂ O) _x -SO ₃ H, in which R is a preferably linear alkyl group with 10 to 18 C atoms and x = 0 or 1 to 12,
• - Mixtures of surface-active hydroxysulfonates according to DE-A-37 25 030 .
• - Sulphated hydroxyalkyl polyethylene and / or hydroxyalkylene propylene glycol ether according to DE-A-37 23 354 .
• - Sulfonates of unsaturated fatty acids with 12 to 24 carbon atoms and 1 to 6 double bonds according to DE-A-39 26 344 .
• - esters of tartaric acid and citric acid with alcohols, the addition products of about 2-15 molecules of ethylene oxide and / or propylene oxide on fatty alcohols with 8 to 22 carbon atoms.

Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids with 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule, and in particular salts of saturated and in particular unsaturated C ₈ -C ₂₂ carboxylic acids, such as stearic acid, oleic acid, isostearic acid and palmitic acid ,

Nonionic surfactants contain as hydrophilic group e.g. B. a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether groups. Such Connections are, for example

• - Addition products from 2 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide linear fatty alcohols with 8 to 22 carbon atoms, with fatty acids with 12 to 22 carbon atoms and on alkylphenols with 8 to 15 carbon atoms in the alkyl group,
• C ₁₂ -C ₂₂ fatty acid monoesters and diesters of addition products of 1 to 30 moles of ethylene oxide with glycerol,
• - C ₈ -C ₂₂ alkyl mono- and oligoglycosides and their ethoxylated analogues as well
• - Addition products from 5 to 60 moles of ethylene oxide on castor oil and hardened castor oil.

Preferred nonionic surfactants are alkyl polyglycosides of the general formula R ¹ O- (Z) _x . These compounds are available, for example, from Henkel under the trade name Plantacare ^® and are characterized by the following parameters.

The alkyl radical R ¹ contains 6 to 22 carbon atoms and can be either linear or branched. Primary linear and methyl-branched aliphatic radicals in the 2-position are preferred. Examples of such alkyl radicals are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. 1-Octyl, 1-decyl, 1-lauryl, 1-myristyl are particularly preferred. When using so-called "oxo alcohols" as starting materials, compounds with an odd number of carbon atoms in the alkyl chain predominate.

The alkyl polyglycosides which can be used according to the invention can contain, for example, only a certain alkyl radical R ¹ . Usually, however, these compounds are made from natural fats and oils or mineral oils. In this case, the alkyl radicals R are mixtures corresponding to the starting compounds or corresponding to the respective working up of these compounds.

Alkylpolyglycosides in which R ¹

• Essentially from C ₈ and C ₁₀ alkyl groups,
• Essentially from C ₁₂ and C ₁₄ alkyl groups,
• - essentially from C ₈ - to C ₁₆ alkyl groups or
• - consists essentially of C ₁₂ - to C ₁₆ alkyl groups.

Any sugar block Z can be used Mono- or oligosaccharides can be used. Usually sugar with 5 or 6 carbon atoms and the corresponding oligosaccharides used. Examples of such sugars are glucose, fructose, Galactose, arabinose, ribose, xylose, lyxose, allose, old rose, mannose, Gulose, Idose, Talose and Sucrose. Preferred sugar building blocks are Glucose, fructose, galactose, arabinose and sucrose; Is glucose particularly preferred.

The alkyl polyglycosides which can be used according to the invention contain an average of 1.1 to 5 sugar units. Alkylpolyglykoside with x values from 1.1 to 1.6 are preferred. Very particularly preferred are alkyl glycosides where x is 1.1 to 1.4.

In addition to their surfactant action, the alkyl glycosides can also serve to improve the fixation of fragrance components on the hair. In the event that an effect of the perfume oil on the hair beyond the duration of the hair treatment is desired, the person skilled in the art will preferably resort to this class of substance as a further ingredient of the preparations according to the invention. An inventively particularly preferred alkyl glucoside is the commercial product Plantacare® ^® 1200G.

Even the alkoxylated homologues of the alkyl polyglycosides mentioned can be used according to the invention become. These homologues can on average up to 10 ethylene oxide and / or propylene oxide units included per alkyl glycoside unit.

Furthermore, zwitterionic surfactants can be used, in particular as co-surfactants. Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one -COO ^(-) - or -SO ₃ ^(-) group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines, such as the N-alkyl-N, N-dimethylammonium glycinate, for example the cocoalkyl-dimethylammonium glycinate, N-acyl-aminopropyl-N, N-dimethylammonium glycinate, for example the cocoacylaminopropyl-dimethylammonium glycinate, and 2 -Alkyl-3-carboxylmethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate. A preferred zwitterionic surfactant is the fatty acid amide derivative known under the INCI name Cocamidopropyl Betaine.

Ampholytic surfactants are also particularly suitable as co-surfactants. Ampholytic surfactants are surface-active compounds which, in addition to a C ₈ -C ₁₈ -alkyl or acyl group, contain at least one free amino group and at least one -COOH or -SO ₃ H group in the molecule and are capable of forming internal salts. Examples of suitable ampholytic surfactants are N-alkylglycine, N-alkylpropionic acid, N-alkylaminobutyric acid, N-alkyliminodipropionic acid, N-hydroxyethyl-N-alkylamidopropylglycine, N-alkyltaurine, N-alkyl sarcosine, 2-alkylamino propionic acid and alkylaminoacetic acid each with about 8 to 18 C atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C _12-18 acyl sarcosine.

According to the invention as cationic surfactants in particular those of the quaternary ammonium compound type, the Esterquats and the Amidoamine used.

Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g. B. cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, as well as the imidazolium compounds known under the INCI names Quatemium-27 and Quaternium-83. The long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.

Ester quats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element. Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines. Such products are sold, for example, under the trademarks Stepantex ^® , Dehyquart ^® and Armocare ^® . The products Armocare ^® VGH-70, an N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ^® F-75 and Dehyquart ^® AU-35 are examples of such esterquats.

The alkylamidoamines are usually produced by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines. An inventively particularly suitable compound from this group is that available under the name Tegoamid ^® S 18 commercially stearamidopropyl.

Further usable according to the invention cationic surfactants are the quaternized protein hydrolyzates represents.

Also suitable according to the invention are cationic silicone oils such as, for example, the commercially available products Q2-7224 (manufacturer: Dow Corning; a stabilized trimethylsilylamodimethicone), Dow Corning 929 emulsion (containing a hydroxylamino-modified silicone, which is also referred to as amodimethicone), SM-2059 (Manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ^® -Quat 3270 and 3272 (manufacturer: Th. Goldschmidt; diquaternary polydimethylsiloxanes, Quaternium-80).

An example of a suitable cationic surfactant quaternary Zuckerdenvat represents the commercial product Glucquat ^® 100, according to INCI nomenclature a "lauryl methyl Gluceth-10 Hydroxypropyl Dimonium Chloride".

For the compounds used as surfactants alkyl groups can be uniform substances act. However, it is usually preferred in manufacturing of these substances from native vegetable or animal raw materials going out so that one Mixtures of substances with different raw materials dependent alkyl chain lengths receives.

In the case of surfactants, the add-on products of ethylene and / or propylene oxide to fatty alcohols or derivatives of these addition products can be both products with a "normal" homolog distribution as well as those with a narrow homolog distribution become. Under "normal" homolog distribution are understood as mixtures of homologues that are used in the Reaction of fatty alcohol and alkylene oxide using alkali metals, Alkali metal hydroxides or alkali metal alcoholates as catalysts receives. On the other hand, narrow homolog distributions are obtained if, for example Hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or alcoholates can be used as catalysts. The use of products with a narrow homolog distribution can be preferred.

The moldings according to the invention can furthermore be preferred another conditioning agent selected from the group of cationic surfactants, cationic polymers, alkylamidoamines, paraffin oils, vegetable oils and synthetic oils is formed. Regarding the cationic surfactants on the above statements directed.

Preferred as conditioning agents could be cationic polymers. These are usually polymers that have a quaternary nitrogen atom, for example in the form of an ammonium group.

Preferred are cationic polymers for example

• - Quaternized cellulose derivatives, as are commercially available under the names Celquat ^® and Polymer JR ^® . The compounds Celquat ^® H 100, Celquat ^® L 200 and Polymer JR ^® 400 are preferred quaternized cellulose derivatives.
• - polymeric dimethyldiallylammonium salts and their copolymers with acrylic acid and esters and amides of acrylic acid and methacrylic acid. Under the names Merquat ^® 100 (Poly (dimethyldiallylammonium chloride)), Merquat ^® 550 (dimethyldiallylammonium chloride-acrylamide copolymer) and Merquat ^® 280 (dimethyldiallylammonium chloride-acrylic acid copolymer commercially available products are examples of such cationic polymers.
• - Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoacrylate and methacrylate, such as vinylpyrrolidone-dimethylaminomethacrylate copolymers quaternized with diethyl sulfate. Such compounds are commercially available under the names Gafquat ^® 734 and Gafquat ^® 755.
• - Vinylpyrrolidone-methoimidazolinium chloride copolymers, as are offered under the name Luviquat ^® .
• - quaternized polyvinyl alcohol as well as those under the designations
• - Polyquaternium 2,
• - Polyquaternium 17
• - Polyquaternium 18 and
• - Polyquaternium 27 known polymers with quaternary Nitrogen atoms in the main polymer chain.

Cationic ones are particularly preferred Polymers of the first four groups, very particularly preferred are Polyquaternium-2, Polyquaternium-10 and Polyquaternium-22.

Also suitable as conditioning agents are silicone oils, in particular dialkyl and alkylarylsiloxanes, such as dimethylpolysiloxane and methylphenylpolysiloxane, and their alkoxylated and quaternized analogs. Examples of such silicones are the products sold by Dow Corning under the names DC 190, DC 200, DC 344, DC 345 and DC 1401 as well as the commercial products Q2-7224 (manufacturer: Dow Corning; a stabilized trimethylsilylamodimethicone), Dow ^Corning® 929 emulsion (containing a hydroxyl-amino-modified silicone, which is also referred to as amodimethicone), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ^® -Quat 3270 and 3272 (manufacturer: Th. Goldschmidt ; diquaternary polydimethylsiloxanes, Quaternium-80).

Can also be used as conditioning Active ingredients are paraffin oils, synthetically produced oligomeric alkenes as well as vegetable oils such as jojoba oil, sunflower oil, orange oil, almond oil, wheat germ oil and peach seed oil.

Also suitable hair conditioning Compounds are phospholipids, for example soy lecithin, egg lecithin and cephaline.

Furthermore, the used according to the invention Preparations preferably have at least one oil component.

Oil components suitable according to the invention are basically all water-insoluble oils and fats as well their mixtures with solid paraffins and waxes. As become water insoluble according to the invention such Substances defined, their solubility in water at 20 ° C is less than 0.1% by weight.

A preferred group of oil components are vegetable oils. examples for such oils are sunflower oil, Olive oil, Soybean oil, Rapeseed oil, Almond oil, jojoba oil, Orange oil, Wheat germ oil, Pfirsichkemöl and the liquid Proportions of coconut oil.

However, other triglyceride oils such as that are also suitable liquid Shares of beef tallow and synthetic triglyceride oils.

A further, particularly preferred group of compounds which can be used according to the invention as an oil component are liquid paraffin oils and synthetic hydrocarbons and di-n-alkyl ethers with a total of between 12 to 36 C atoms, in particular 12 to 24 C atoms, such as, for example, di-n-octyl ether, Di -n-decyl ether, di-n-nonyl ether, di-n-undecyl ether, di-n-dodecyl ether, n-hexyl-n-octyl ether, n-octyl-n-decyl ether, n-decyl-n-undecyl ether, n-undecyl -n-dodecyl ether and n-hexyl-n-undecyl ether and di-tert-butyl ether, di-iso-pentyl ether, di-3-ethyl decyl ether, tert-butyl-n-octyl ether, iso-pentyl-n-octyl ether and 2-methyl-pentyl-n-octyl ether. The compounds are available as commercial products 1,3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ^® S), and di-n-octyl ether (Cetiol ^® OE) may be preferred.

Oil components which can likewise be used according to the invention are fatty acid and fatty alcohol esters. The monoesters of the fatty acids with alcohols having 3 to 24 carbon atoms are preferred. This group of substances concerns the products of the esterification of fatty acids with 6 to 24 carbon atoms such as, for example, caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, Petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures, the z. B. in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxosynthesis or the dimerization of unsaturated fatty acids, with alcohols such as isopropyl alcohol, capronic alcohol, caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, Myristyl alcohol, cetyl alcohol, palmitoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, and technical mixtures, and alcohol mixtures thereof, and brassidyl. B. in the high pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from Roelen's oxosynthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols. According to the invention particularly preferably isopropyl myristate, isononanoic acid C16-18 alkyl ester (Cetiol ^® SN), stearic acid-2-ethylhexyl ester (Cetiol ^® 868), cetyl oleate, glycerol tricaprylate, cocofatty alcohol caprate / caprylate and n-butyl stearate.

Furthermore, dicarboxylic acid esters are also available such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecylacelaate and diol esters such as ethylene glycol dioleate, Ethylene glycol di-isotridecanoate, propylene glycol di (2-ethylhexanoate), Propylene glycol di-isostearate, propylene glycol di-pelargonate, butanediol di-isostearate and neopentyl glycol di-caprylate oil components which can be used according to the invention are just as complex esters such. B. the diacetyl glycerol monostearate.

Finally, fatty alcohols with 8 to 22 carbon atoms can also be used as oil components acting according to the invention. The fatty alcohols can be saturated or unsaturated and linear or branched his. For example, decanol, octanol, octenol, dodecenol, decenol, octadienol, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinol alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, capryl alcohol, arachidyl alcohol, arachidyl alcohol, arachidyl alcohol, arachidyl alcohol, arachidyl alcohol, arachidyl alcohol , as well as their Guerbet alcohols, this list is intended to be exemplary and not limiting. The fatty alcohols, however, derive from preferably natural fatty acids, and it can usually be assumed that they are obtained from the esters of the fatty acids by reduction. Also suitable according to the invention are those fatty alcohol cuts which are produced by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols.

The oil components are preferred in amounts of 0.05 to 10% by weight, in particular 0.1 to 2% by weight used in the moldings according to the invention.

In a preferred embodiment of the present extension, a gel forms when the shaped bodies are dissolved in water. For this purpose, the shaped body thickeners such as agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, for. B. methyl cellulose, hydroxyalkyl cellulose and carboxymethyl cellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such. B. bentonite, silicates, such as those sold under the trade names Optigel ^® (Süd-Chemie) or Laponite ^® (Solvay), or fully synthetic hydrocolloids such as polyvinyl alcohol are added. Particularly preferred thickeners are xanthans, alginates and highly substituted carboxymethyl celluloses.

Other active ingredients, auxiliaries and additives are for example

• - zwitterionic and amphoteric polymers such as acrylamidopropyltrimethylammonium chloride / acrylate copolymers and octylacrylamide / methyl methacrylate-butylaminoethyl methacrylate / 2-hydroxypropyl methacrylate copolymers,
• - anionic polymers such as polyacrylic acids, crosslinked polyacrylic acids, vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobornyl acrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and acrylic acid / ethyl acrylate / N-tert.butyl acrylamide terpolymers,

  - structurants such as maleic acid and lactic acid,

  Protein hydrolyzates, in particular elastin, collagen, keratin, milk protein, soy protein and wheat protein hydrolyzates, their condensation products with fatty acids and quaternized protein hydrolyzates,

  - perfume oils, dimethyl isosorbide and cyclodextrins,

  Solvents and mediators such as ethylene glycol, propylene glycol, glycerol and diethylene glycol,

  Active ingredients that improve fiber structure, in particular mono-, di- and oligosaccharides such as, for example, glucose, galactose, fructose, fruit truck and lactose,

  - Quaternized amines such as methyl 1-alkylamidoethyl-2-alkylimidazolinium methosulfate

  - defoamers like silicones,

  Dyes for coloring the agent,

  - anti-dandruff agents such as piroctone olamine, zinc omadine and climbazol,

  Light stabilizers, in particular derivatized benzophenones, cinnamic acid derivatives and triazines,

  Substances for adjusting the pH, such as, for example, customary acids, in particular edible acids and bases,

  Active ingredients such as allantoin, pyrrolidone carboxylic acids and their salts and bisabolol,

  Vitamins, provitamins and vitamin precursors, in particular those of groups A, B ₃ , B ₅ , B ₆ , C, E, F and H,

  - Plant extracts such as the extracts from green tea, oak bark, nettle, witch hazel, hops, chamomile, burdock root, horsetail, hawthorn, linden flowers, almond, aloe vera, spruce needle, horse chestnut, sandalwood, juniper, coconut, mango, apricot, lime, wheat, Kiwi, melon, orange, grapefruit, sage, rosemary, birch, mallow, cuckoo flower, quendel, yarrow, thyme, lemon balm, hake, coltsfoot, marshmallow, meristem, ginseng and ginger root,

  - cholesterol,

  - consistency enhancers such as sugar esters, polyol esters or polyol alkyl ethers,

  - fats and waxes such as walrus, beeswax, montan wax and paraffins,

  - fatty acid alkanolamides,

  Complexing agents such as EDTA, NTA, β-alaninediacetic acid and phosphonic acids,

  Swelling and penetration substances such as glycerol, propylene glycol monoethyl ether, carbonates, hydrogen carbonates, guanidines, ureas and primary, secondary and tertiary phosphates,

  - opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers

  Pearlescent agents such as ethylene glycol mono- and distearate and PEG-3 distearate,

  Stabilizing agent for the oxidizing agent,

  - antioxidants.

Shaped body geometries

The moldings according to the invention can have any geometric shape have, such as concave, convex, biconcave, biconvex, cubic, tetragonal, orthorhombic, cylindrical, spherical, cylindrical segment-like, disc-shaped, tetrahedral, dodecahedral, octahedral, conical, pyramidal, ellipsoid, five, seven- and octagonal-prismatic as well as rhombohedral shapes. Completely irregular areas like Arrow or animal shapes, trees, Clouds etc. will be realized. The training as a board, the rod or bar shape, Cube, Cuboid and corresponding room elements with flat side surfaces as well especially cylindrical Circular designs or oval cross-section and shaped body with spherical Geometry is preferred according to the invention. Shaped bodies are particularly preferred in the shape of spherical Geometry.

The cylindrical design detects the presentation form from tablets to compact cylinder pieces a relationship of height to diameter larger than 1. Knows the base molding corners and edges, they are preferably rounded. As an additional optical differentiation is an embodiment with rounded Corners and beveled ("Chamfered") edges preferred.

The spherical design includes a spherical one Build a hybrid of spherical and cylindrical shapes, each Floor space the cylinder is capped with a hemisphere. The hemispheres preferably have a radius of about 4 mm and the entire molded body Design a length from 12 - 14 mm.

A shaped body according to the invention with spherical Design can be produced by the known methods. It is possible the moldings by extrusion of a premix followed by shaping to produce, as detailed in WO-A-91/02047, for example, to which express reference is made in the context of this application.

In a further preferred embodiment are therefore almost spherical Moldings, especially by extrusion and subsequent rounding to shape, manufactured.

In another embodiment can the portioned compacts each formed as separate individual elements be that of the predetermined dosage of the oxidation dye precursors corresponds to the type of coupler. But it is also possible to form compacts, the one Connect a plurality of such mass units in one compact, in particular easy separation of portions by predetermined predetermined breaking points smaller units is provided. The formation of the portioned compacts as Tablets in cylindrical or cuboid shape can be useful with a diameter / height ratio in Range of about 0.5: 2 to 2: 0.5 is preferred. Commercial hydraulic presses, Eccentric presses or rotary presses are suitable devices especially for the production of such compacts.

A further possible space of the molded body according to the invention has a rectangular base on, the height the molded body is smaller than the smaller rectangle side of the base area. rounded Corners are preferred with this type of offer.

Another molded body, the can be produced has a plate or plate-like structure with alternating thick long and thin short segments, so that individual Segments of this "bolt" at the predetermined breaking points, the short thin ones Display segments, broken off and used in such portions can come. This principle of the "bar-shaped" shaped body can also in other geometric shapes, for example vertical ones Triangles that are connected to each other only on one of their sides are to be realized.

Contain the moldings according to the invention in addition the reactive carbonyl compound at least one further component, can be in another embodiment be advantageous not only to the various components a single tablet. When tableting are in this embodiment moldings get multiple layers, i.e. at least two layers, exhibit. It is also possible that these different layers have different dissolving speeds. From this you can advantageous application properties of the molded articles result. If For example, components are contained in the shaped bodies affect each other negatively, so it is possible to use one component in the faster soluble Integrate layer and the other component in a slower soluble Incorporate layer so that the Components not already during the release operation react with each other.

The layer structure of the shaped bodies can take place in a stack-like manner, with the inner layers) already loosening at the edges of the shaped body when the outer layers have not yet been completely detached. With the stack-like arrangement, the stacking axis can be used for tablets axis arranged. In the case of a cylindrical tablet, for example, the stacking axis can be parallel or perpendicular to the height of the cylinder.

But it can also be according to one another embodiment be preferred if a complete wrapping of the inner layers) by the respective outer layers) is achieved, which prevents the premature release of components of the inner layers). Shaped bodies are preferred, in which the layers with the different active ingredients envelop each other. For example be a layer (A) complete of layer (B) and this in turn completely encased by layer (C). As well can moldings be preferred in which e.g. the layer (C) completely of the layer (B) and this in turn is completely enveloped by the layer (A).

Similar Effects can also be achieved by coating individual components of the parts to be pressed Reach composition or the entire molded body. For this, the body to be coated for example with aqueous solutions or Emulsions become, or about the process of melt coating received a coating. As suitable according to the invention shows the use of a coating, for example Hydroxypropy-methyl cellulose, cellulose, PEG stearates and color pigments.

The (trough) moldings produced according to the invention can - as above described - completely or be partially coated. Method, in which a post-treatment in the application of a coating layer on the molding surface (s), in which the filled (n) Trough (s), or in the application of a coating layer on the entire molded body there are preferred according to the invention.

The shaped body according to the invention has a preferred one fracture toughness from 30 - 100 N, particularly preferably from 40 to 80 N, very particularly preferably from 50-60 N (measured according to the European Pharmacopoeia 1997, 3rd edition, ISBN 3-7692-2186-9, "2.9.8 Breaking strength of tablets "; Page 143-144 with a Schleuniger 6D tablet hardness tester).

Furthermore, the moldings according to the invention can be made from one described with the term "base molding" molded articles produced by known tabletting processes, which has a trough. It is preferred in this embodiment the basic molded body manufactured first and the further pressed part in another Work step applied to or introduced into this base molding. The resulting product is referred to below with the generic term “trough shaped body” or “trough tablet”.

The basic molded body can, in principle, according to the invention accept all feasible forms of space. Are particularly preferred the spatial shapes already mentioned above. The shape of the trough can be free to get voted, molded articles preferred according to the invention are in which at least one trough is a concave, convex, cubic, tetragonal, orthorhombic, cylindrical, spherical, segment-like, disc-shaped, tetrahedral, dodecahedral, octahedral, conical, pyramidal, ellipsoid, five, seven- and octagonal-prismatic as well as rhombohedral shape. Completely irregular trough shapes like arrow or animal shapes, trees, Clouds etc. will be realized. As with the basic shaped bodies, the troughs are rounded Corners and edges or with rounded corners and chamfered edges prefers.

The size of the trough compared to entire molded body depends on the desired Intended use of the molded body. Depending on whether in the second pressed part a lower or bigger amount the size of the trough can be contained in active substance vary. Independently molded articles are of use preferred, in which the weight ratio of the base molding to depression filling in the range from 1: 1 to 100: 1, preferably from 2: 1 to 80: 1, particularly is preferably from 3: 1 to 50: 1 and in particular from 4: 1 to 30: 1.

Similar Statements can be made about the surface proportions that the Basic tablet or the trough filling on the total surface of the shaped body turn off. Here are moldings preferred where the surface the pressed depression filling 1 to 25%, preferably 2 to 20%, particularly preferably 3 to 15 % and in particular 4 to 10% of the total surface area of the filled base molding.

If, for example, the overall shaped body has dimensions of 20 × 20 × 40 mm and thus a total surface area of 40 cm ² , trough fillings are preferred which have a surface area of 0.4 to 10 cm ² , preferably 0.8 to 8 cm ² , particularly preferably of Have 1.2 to 6 cm ² and in particular from 1.6 to 4 cm ² .

The trough filling and the basic molded body are preferably colored visually distinguishable. In addition to the optical differentiation have tablets on the one hand application technology advantages through different solubilities of the different areas on the other hand, but also by the separate Storage of the active ingredients in the different shaped body areas on.

Shaped bodies in which the pressed-in trough filling dissolves more slowly than the basic shaped body are preferred according to the invention. By incorporating certain constituents, on the one hand the solubility of the well filling can be specifically varied, on the other hand the release of certain ingredients from the well filling can lead to advantages in the dyeing process. Ingredients that are preferably located at least partially in the trough filling are, for example, the condition described in the paragraph "further components" active substances, oil bodies, vitamins and plant substances.

tableting

It can be preferred according to the invention be, individual active ingredients separately before their incorporation into the molded body to encapsulate; for example, it is conceivable, especially reactive To use components or the fragrances in encapsulated form.

The moldings according to the invention are produced first by dry mixing the ingredients, all or part can be pre-granulated and then Inform, in particular compression to tablets, with known ones Procedure can be. The premix is prepared in a so-called die between two stamps into a fixed one Compressed compressed. This process, briefly referred to below as Tabletting is divided into four sections: Dosage, compression (elastic deformation), plastic deformation and expelling.

First, the premix is in introduced the die, the filling quantity and thus the weight and the shape of the resulting shaped body by the position of the lower punch and the shape of the press tool be determined. The constant dosage even with high molding throughputs preferably about volumetric dosing of the premix is achieved. In the further Touches the course of the tableting the upper stamp pre-mixes and descends further of the lower stamp. With this compression, the particles of the premix pressed together the void volume within the filling between the punches decreases continuously. From a certain position of the upper stamp (and thus from a certain pressure on the premix) begins the plastic deformation in which the particles flow together and it to form the molded body comes. Depending on the physical properties of the premix some of the premixed particles are also crushed, and this occurs at even higher pressures a sintering of the premix. With increasing press speed, So high throughput, the phase of elastic deformation always shortened, So that the resulting molded body more or less large cavities can have. In the last step of tableting, the finished molded body is finished the lower punch is pressed out of the die and by subsequent transport devices carried away. At this point in time, only the weight of the molded body has been finally determined, there the compacts due to physical processes (stretching, crystallographic Effects, cooling etc.) can still change their shape and size.

Tableting takes place in standard commercial form Tablet presses, which are basically equipped with single or double stamps can. In the latter case, it is not only the upper stamp that builds up pressure used, the lower punch also moves during the pressing process towards the upper stamp during the Upper stamp presses down. For little ones Production quantities are preferably eccentric tablet presses, where the stamp or stamps are attached to an eccentric disc are, in turn, on an axis with a certain rotational speed is mounted. The movement of this ram is with the way of working of a usual Four-stroke engine comparable. The pressing can be done with an upper and lower stamps can be made but also several stamps can be attached to an eccentric disc, the number of die holes is expanded accordingly. The throughputs of eccentric presses vary from a few hundred to depending on the type maximum 3000 tablets per hour.

For one chooses larger throughputs Rotary tablet presses on a so-called die table A larger number of matrices circular is arranged. The number of matrices varies depending on the model 6 and 55, including larger matrices available in the stores are. Each die on the die table is an upper and lower stamp assigned, again the pressure is active only by the Upper or lower stamp, but also built up by both stamps can be. The matrix table and the stamps move by one common vertical axis, using the stamp rail-like curves during of circulation in the positions for filling, Compression, plastic deformation and discharge are brought. In the places where a particularly serious increase or decrease in Stamp is required (filling, Compression, ejection), these curved tracks are created by additional low-pressure pieces, pull-down rails and lift tracks supported. The filling the die is made over a rigidly arranged feed device, the so-called filling shoe, the one with a storage container for the Premix is connected. The pressure on the premix is above that compression paths for top and Lower stamp individually adjustable, whereby the pressure build-up by the rolling of the stamp shaft heads on adjustable pressure rollers happens.

Rotary presses can also be provided with two filling shoes to increase the throughput, only a semicircle having to be run through to produce a tablet. For the production of two- and multi-layer molded articles, several filling shoes are arranged one behind the other without the slightly pressed first layer being ejected before further filling. With suitable process control, jacket and dot tablets can also be produced in this way, which have an onion-shell-like structure, in the case of the point tablets, the top of the core or the core layers is not covered and thus remains visible. Rotary tablet presses can also be equipped with single or multiple tools, so that, for example, an outer circle with 50 and an inner circle with 35 holes can be used simultaneously for pressing. The throughputs of modern rotary tablet presses are over one million tablets per hour.

When tableting with rotary presses it has proven to be advantageous to use the tableting as possible small fluctuations in weight of the tablet. On this way the fluctuations in hardness of the tablet can also be controlled to reduce. Slight weight fluctuations can be achieved in the following way become:

• - Use of plastic inserts with small thickness tolerances
• - Little Number of revolutions of the rotor
• - Big filling shoes
• - Poll of the filler wing speed on the speed of the rotor
• - filling shoe with constant powder height
• - Decoupling of the filling shoe and powder template

To reduce the build-up of stamps they all offer themselves non-stick coatings known from the art. Particularly advantageous are plastic coatings, plastic inserts or plastic stamps. Rotating punches have also proven to be advantageous, whereby if possible The upper and lower stamps should be rotatable. With rotating Stamping can usually be done without a plastic insert become. The stamp surfaces should be electropolished here.

It continued to show that long pressing times are advantageous. these can with pressure rails, several pressure rollers or low rotor speeds can be set.

Because the hardness fluctuations of the tablet caused by the fluctuations of the pressing forces systems should be used that limit the pressing force. Here you can elastic stamps, pneumatic compensators or spring elements be used in the force path. The pressure roller can also be resilient accomplished become.

Within the scope of the present invention Suitable tablet machines are available from, for example the companies Apparatebau Holzwarth GbR, Asperg, Wilhelm Fette GmbH, Schwarzenbek, Fann Instruments Company, Houston, Texas (USA), Hofer GmbH, Weil, Horn & Noack Pharmatechnik GmbH, Worms, IMA Verpackungssysteme GmbH Viersen, KILIAN, Cologne, KOMAGE, Kell am See, KORSCH Pressen AG, Berlin, and Romaco GmbH, Worms. Other providers include Dr. Herbert Pete, Vienna (AT), Mapag Maschinenbau AG, Bern (CH), BWI Manesty, Liverpool (GB), I. Holand Ltd., Nottingham (GB), Courtoy N.V., Halle (BE / LU) and Mediopharm Kamnik (SI). For example, the Hydraulic double printing press HPF 630 from LAEIS, D. tableting tools are, for example, from Adams Tablettierwerkzeuge, Dresden, Wilhelm Fett GmbH, Schwarzenbek, Klaus Hammer, Solingen, Herber % Sons GmbH, Hamburg, Hofer GmbH, Weil, Horn & Noack, Pharmatechnik GmbH, Worms, Ritter Pharamatechnik GmbH, Hamburg, Romaco, GmbH, Worms and Notter Toolmaking, Tamm available. Other providers are e.g. Senss AG, Reinach (CH) and Medicopharm, Kamnik (SI).

The process of making the moldings but is not limited to that only a particulate Premix to a shaped body pressed becomes. Rather, extend the process to the extent that it is known in itself Wise multi-layer moldings prepared by preparing two or more premixes which pressed together become. Here, the premix, which is filled in first, is slightly pre-compressed to form a smooth and parallel to the molded body floor to get the running top, and after filling the second premix to the finished molded body final compression. In the case of three-layer or multi-layer molded articles, each premix is added a further pre-compression before adding the last premix the molded body undergoes final becomes.

The compression of the particulate composition in the trough can be made in the same way as for the production of the base moldings Tablet presses take place. A procedure is preferred for which is only the basic shaped body made with trough, then filled and subsequently pressed again become. This can be done by ejecting the Basic tablet from a first tablet press, filling and transport into one second tablet press in which the final compression takes place. Alternatively, the final compression can also be carried out by pressure rollers that run over the Roll molded articles on a conveyor belt. It is but also possible a rotary tablet press with different stamp sets to be provided so that a first set of stamps presses depressions into the moldings and the second set of stamps after filling by repressing for a flat molded body surface ensures.

A second object of the invention is a dyeing process of keratin fibers in which

• (I) one or more shaped articles according to the invention in solved a medium M. become,
• (II) the resulting preparation, optionally with a Oxidant preparation is mixed,
• (III) the resulting ready-to-use dye F on the fibers applied and
• (IV) is rinsed off again after a contact time.

This dyeing process according to the invention is in several embodiments feasible. The use of the molded body according to the invention can doing for example

• 1) Both in a process of pure oxo staining, however also
• 2) as part of a combination of oxo staining and oxidative staining. In these two exemplary process types 1) and 2) can at the same time direct dyes are used, which in the molded body according to the invention and / or can be contained in the medium M.

If the molded body according to the invention is free of compounds of component B, it is preferred to use a To use medium M, which the component B, in particular its the aforementioned representatives. A combination in which both the shaped body according to the invention and the medium M also contain at least one compound of component B, is also according to the invention. moreover it can be preferred according to the invention his,

• i) a molded body according to the invention, the at least one compound of component A contains and is free of compounds of component B in combination with
• ii) a second molded body, which contains at least one compound of component B and free is of compounds of component A, for the manufacture of the ready-to-use colorant F dissolve in medium M.

The medium M preferably contains an organic one and / or inorganic solvent. In another embodiment the medium M is preferably a gel or an O / W or W / O emulsion. Contains the molded body according to the invention, for example one or more thickeners, then it may be preferred to use as medium M water.

If the medium M is an emulsion, the medium M has, for example, a viscosity of 500-100000 mPas, preferably 3000-70000 mPas, particularly preferably 6000-50,000 mPas and very particularly preferably 10,000 -30000 mPas. The viscosities are measured with a Brookfield RVT viscometer at a temperature of 20 ° C at 4 rpm with spindle No. 4. However, the choice of the spindle for measuring the above-mentioned viscosities is preferably carried out according to the viscosity range (measured under the above-mentioned test conditions) according to Table 1. Table 1 Spindle number Viscosity range [mPa · s] 1 - 2500 2 > 2500 - 10000 3 > 10000 - 25000 4 > 25000 - 50000 5 > 50000 - 100000

In a special embodiment the medium M has a viscosity from 500 - 50000 mPa.s, particularly preferably from 500 to 25,000 mPa.s, very particularly preferably from 500 to 15,000 mPa · s. Measuring the viscosities of these special embodiment using a Brookfield RVT viscometer at 20 ° C with the Spindle 4 and 20 rpm performed.

In a preferred embodiment of the method according to the invention, contains the medium M at least one oxidation dye intermediate of the developer type. According to the invention, the developers preferably selected from the compounds already mentioned.

The medium M can in addition to the developer components at least one coupler component and / or at least one direct component Contain dye. The preferred used in this embodiment Coupler components or direct dyes correspond to those that have already been mentioned above. This applies in the corresponding Sections said.

It is not necessary that the im Medium M used oxidation dye precursors or the direct dyes each have uniform compounds represent. Rather you can in the moldings according to the invention through the manufacturing process for the individual dyes, in subordinate quantities may contain other components, insofar as this does not adversely affect the coloring result influence or for any other reason z. B. toxicological, must be excluded.

The oxidation dye precursors are in the colorant F preferably in amounts of 0.01 to 20 wt .-%, preferably 0.5 to 5 wt .-%, each based on the total colorant F, contain.

Those indoles and indolines which are preferably used as precursors of nature-analogous dyes have at least one hydroxyl or amino group, preferably as a substituent on the six-membered ring. These groups can carry further substituents, e.g. B. in the form of etherification or esterification of the hydroxy group or an alkylation of the amino group.

in der jeweils unabhängig voneinander
R¹ steht für Wasserstoff, eine C₁-C₄-Alkylgruppe oder eine C₁-C₄-Hydroxy-alkyl-gruppe,
R² steht für Wasserstoff oder eine -COOH-Gruppe, wobei die -COOH-Gruppe auch als Salz mit einem physiologisch verträglichen Kation vorliegen kann,
R³ steht für Wasserstoff oder eine C₁-C₄-Alkylgruppe,
R⁴ steht für Wasserstoff, eine C₁-C₄-Alkylgruppe oder eine Gruppe -CO-R⁶, in der
R⁶ steht für eine C₁-C₄-Alkylgruppe, und
R⁵ steht für eine der unter R⁴ genannten Gruppen, sowie physiologisch verträgliche Salze dieser Verbindungen mit einer organischen oder anorganischen Säure.Derivatives of 5,6-dihydroxyindoline of the formula XIa are particularly suitable as precursors of naturally analogous hair dyes,

each independently
R ¹ represents hydrogen, a C ₁ -C ₄ -alkyl group or a C ₁ -C ₄ -hydroxy-alkyl group,
R ² stands for hydrogen or a -COOH group, where the -COOH group can also be present as a salt with a physiologically compatible cation,
R ³ represents hydrogen or a C ₁ -C ₄ alkyl group,
R ⁴ represents hydrogen, a C ₁ -C ₄ alkyl group or a group -CO-R ⁶ , in which
R ⁶ represents a C ₁ -C ₄ alkyl group, and
R ⁵ stands for one of the groups mentioned under R ⁴ , as well as physiologically tolerable salts of these compounds with an organic or inorganic acid.

Particularly preferred derivatives of Indolins are 5,6-dihydroxyindoline, N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline, 5,6-dihydroxyindoline-2-carboxylic acid as well as the 6-hydroxyindoline, the 6-aminoindoline and the 4-aminoindoline.

Of particular note are within this group N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline and especially 5,6-dihydroxyindoline.

in der jeweils unabhängig voneinander
R¹ steht für Wasserstoff, eine C₁-C₄-Alkylgruppe oder eine C₁-C₄-Hydroxyalkylgruppe,
R² steht für Wasserstoff oder eine -COOH-Gruppe, wobei die -COOH-Gruppe auch als Salz mit einem physiologisch verträglichen Kation vorliegen kann,
R³ steht für Wasserstoff oder eine C₁-C₄-Alkylgruppe,
R⁴ steht für Wasserstoff, eine C₁-C₄-Alkylgruppe oder eine Gruppe -CO-R⁶, in der
R⁶ steht für eine C₁-C₄-Alkylgruppe, und
R⁵ steht für eine der unter R⁴ genannten Gruppen, sowie physiologisch verträgliche Salze dieser Verbindungen mit einer organischen oder anorganischen Säure.Derivatives of 5,6-dihydroxyindole of the formula XIb are also particularly suitable as precursors of nature-analogous hair dyes,

each independently
R ¹ represents hydrogen, a C ₁ -C ₄ -alkyl group or a C ₁ -C ₄ -hydroxyalkyl group,
R ² stands for hydrogen or a -COOH group, where the -COOH group can also be present as a salt with a physiologically compatible cation,
R ³ represents hydrogen or a C ₁ -C ₄ alkyl group,
R ⁴ represents hydrogen, a C ₁ -C ₄ alkyl group or a group -CO-R ⁶ , in which
R ⁶ represents a C ₁ -C ₄ alkyl group, and
R ⁵ stands for one of the groups mentioned under R ⁴ , as well as physiologically tolerable salts of these compounds with an organic or inorganic acid.

Particularly preferred derivatives of Indoles are 5,6-dihydroxyindole, N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole, 5,6-dihydroxyindole-2-carboxylic acid, 6-hydroxyindole, 6-aminoindole and 4-aminoindole.

To be highlighted within this group are N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole and in particular 5,6-dihydroxyindole.

The indoline and indole derivatives can be used in the colorants used in the process according to the invention both as free bases and in the form of their physiologically tolerable salts with inorganic or organic acids, for. B. the hydrochloride, sulfates and hydrobromides, are used. The indole or indoline derivatives are usually present in these in amounts of 0.05-10% by weight, preferably two se contain 0.2-5 wt .-%.

Especially when using Dye precursors of the indoline or indole type have been found to be advantageous proven as an alkalizing agent, an amino acid and / or an oligopeptide use.

If an oxidizer preparation When used, the mixture will result from step I) of the method and the oxidizing agent preparation are preferred in weight ratio from about 2: 1 to 1: 2, particularly preferably in the weight ratio of mixed about 1: 1. The use of an oxidizer preparation in the method according to the invention does not hang depend on whether a coloring according to the oxidative coloring principle is sought. On the one hand, the oxidizing agent can be used for lightening the fibers to be treated. The addition of an oxidizing agent on the other hand can also develop the actual dye serve from the oxidation dye precursors.

The oxidizing agent preparation contains at least an oxidizer. The actual oxidative coloring of the Fibers can basically done with atmospheric oxygen. However, a chemical one is preferred Oxidizing agents are used, especially if in addition to the coloring Whitening effect on human hair is desired. As an oxidizing agent come persulfates, chlorites and preferably hydrogen peroxide or its adducts with urea, melamine and sodium borate in question. According to the invention, however An oxidation can also be applied to the hair together with a catalyst, which the oxidation of the dye precursors, e.g. through atmospheric oxygen, activated. Such catalysts are e.g. Metal ions, iodides, quinones or certain enzymes.

The formation of the color can also be supported and increased by adding certain metal ions to the shaped body. Such metal ions are, for example, Zn ²⁺ , Cu ²⁺ , Fe ²⁺ , Fe ³⁺ , Mn ²⁺ , Mn ⁴⁺ , Li ⁺ , Mg ²⁺ , Ca ²⁺ and Al ³⁺ . Zn ²⁺ , Cu ²⁺ and Mn ²⁺ are particularly suitable. In principle, the metal ions can be used in the form of any physiologically acceptable salt. Preferred salts are the acetates, sulfates, halides, lactates and tartrates. By using these metal salts, the formation of the coloring can be accelerated and the color shade can be influenced in a targeted manner. However, it has also proven practical to use the metal ions in the form of their complexes or also attached to zeolites to increase the coloring power.

Suitable enzymes are e.g. peroxidases, which can significantly increase the effect of small amounts of hydrogen peroxide. Farther are such enzymes suitable according to the invention, with the help of atmospheric oxygen the oxidation dye precursors oxidize directly, such as laccases, or in situ generate small amounts of hydrogen peroxide and in this way the Activate oxidation of the dye precursors biocatalytically. Especially suitable catalysts for the oxidation of the dye precursors are the so-called 2-electron oxidoreductases in combination with those for it specific substrates, e.g.

• - pyranose oxidase and e.g. D-glucose or galactose,
• - glucose oxidase and D-glucose,
• - glycerin oxidase and glycerin,
• - pyruvate oxidase and pyruvic acid or their salts,
• - alcohol oxidase and alcohol (MeOH, EtOH),
• - lactate oxidase and lactic acid and their salts,
• Tyrosinase oxidase and tyrosine,
• - uricase and uric acid or their salts,
• - choline oxidase and choline,
• - amino acid oxidase and amino acids.

Regarding other optional Components as well as the amounts of these components used expressly to the relevant manuals known to those skilled in the art, e.g. B. Kh. Schrader, Basics and formulations of cosmetics, 2nd edition, Hüthig Buch Verlag, Heidelberg, 1989.

The ready-to-use colorant F should preferably have a pH in the range of 2 to 12, in particular from 4 to 10. The application temperatures can be in a range between 15 and 40 ° C, preferred at the temperature of the scalp. The exposure time is usually about 5 to 45, especially 15 to 30, minutes. Unless strong carrier containing surfactant used, it may be preferred to treat those treated in this way Hair afterwards to clean with a shampoo.

A third subject of the present Invention is the use of the moldings described above for Preparation of a coloring agent fibers containing keratin.

A fourth subject of the present Invention is a kit for use in the method of the invention characterized in that it three separately assembled components in the containers K1, K2 and contains K3, where container K1 is the medium M, container K2 one or more Shaped body according to the invention and Container K3 containing the oxidizing agent preparation.

Packaging of the shaped bodies

The moldings according to the invention can be packaged after production be, with the use of certain packaging systems particularly proven has because the packaging systems on the one hand the storage stability of the ingredients increase, on the other hand, however, the long-term liability of a trough filling may also be significant improve. Further increase Protection against the destruction of the molded body by packaging systems mechanical influences. The term "packaging system" denotes always the primary packaging in the context of the present invention the molded body in container K2, i.e. the packaging that is directly on the inside in contact with the molded body surface is. An optional secondary packaging become the usual Requirements, so here all known materials and systems can be used. It is preferred according to the invention, the molded body to be assembled in a transparent packaging system or this packaging system, if necessary, in a transparent secondary packaging to wrap.

berechnen, wobei A die Fläche des zu testenden Materials in cm², x die Gewichtszunahme des Calciumchlorids in g und y die Expositionszeit in h bedeutet.Packaging systems which have only a low moisture permeability are preferred according to the invention. In this way, the coloring capacity of the shaped bodies according to the invention can be maintained over a longer period of time, even if, for example, hygroscopic components are used in the shaped bodies. Packaging systems which have a moisture vapor permeability rate of 0.1 g / m ² / day to less than 20 g / m ² / day are particularly preferred if the packaging system is stored at 23 ° C. and a relative equilibrium moisture content of 85%. The specified temperature and humidity conditions are the test conditions that are mentioned in DIN standard 53122, whereby according to DIN 53122 minimal deviations are permitted (23 ± 1 ° C, 85 ± 2% relative humidity). The moisture vapor permeability rate of a given packaging system or material can be determined by further standard methods and is, for example, also in the ASTM standard E-96-53T ("Test for measuring Water Vapor transmission of Materials in Sheet form") and in the TAPPI standard T464 m-45 ("Water Vapor Permeability of Sheet Materials at high temperature an Humidity"). The measuring principle of current methods is based on the water absorption of anhydrous calcium chloride, which is stored in a container in the appropriate atmosphere, the container being closed at the top with the material to be tested. The moisture vapor permeability rate can be determined from the surface of the container which is closed with the material to be tested (permeation surface), the weight gain of the calcium chloride and the exposure time

calculate, where A is the area of the material to be tested in cm ² , x is the weight gain of calcium chloride in g and y is the exposure time in h.

The relative equilibrium humidity, often referred to as "relative humidity", is 85% at 23 ° C. when measuring the moisture vapor transmission rate in the context of the present invention. The absorption capacity of air for water vapor increases with the temperature up to a respective maximum content, the so-called saturation content, and is given in g / m ³ . For example, 1 m ^{3 of} air at 17 ° is saturated with 14.4 g of water vapor; at a temperature of 11 ° there is saturation with just 10 g of water vapor. The relative humidity is the ratio of the actual water vapor content to the saturation content corresponding to the prevailing temperature. For example, if air contains 17 ° 12 g / m ³ water vapor, then the relative humidity = (12 / 14.4) 100 = 83%. If this air is cooled, then the saturation (100% r.L.) is reached at the so-called dew point (in the example: 14 °), ie, if it cools further, a precipitate is formed in the form of fog (dew). Hygrometers and psychrometers are used for the quantitative determination of moisture.

The relative equilibrium moisture of 85% at 23 ° C let yourself for example in laboratory chambers with moisture control depending on device type to +/- 2% RH adjust exactly. Also about saturated Solutions of certain Salts form in closed systems at a given temperature constant and well-defined relative humidity levels that on the phase equilibrium between partial pressure of water, more saturated solution and soil body based.

The combinations of molded body and Packaging system can Of course in turn in secondary packaging, for example, cardboard boxes or trays, are packed, whereby the secondary packaging the usual Requirements must be made. The secondary packaging is possible, however unnecessary.

Depending on the embodiment of the invention, the packaging system encloses one or more shaped bodies. It is preferred according to the invention either to design a shaped body in such a way that it comprises an application unit of the colorant, and to pack this shaped body individually, or to pack the number of shaped bodies in a packaging unit which in total comprises one application unit. This principle can of course be expanded, so that combinations according to the invention also three, four, five or can contain even more molded articles in a packaging unit. Of course, two or more molded articles in a package can have different compositions. In this way it is possible to spatially separate certain components from one another, for example in order to avoid stability problems.

The packaging system of the combination according to the invention can consist of different materials and any external shapes accept. For economic reasons establish and for the sake of However, packaging systems are preferred for easier processability, where the packaging material is light, light to process and inexpensive as well as ecological compatible is.

In a first preferred according to the invention The packaging system consists of combinations that are not dimensionally stable Packaging such as a sack or pouch made of one layer or laminated paper and / or plastic film and / or metal foil. You can the moldings unsorted, i.e. as a loose fill, be filled into a bag made of the materials mentioned. But it is for aesthetic reasons and preferred for sorting the combinations in secondary packaging, the moldings to be filled individually or in groups in sacks or bags. This Packaging systems can then - again preferably sorted - optional be packed in outer packaging, what the compact offer form of the shaped body underlines.

The preferred as a packaging system sacks to be used or bags made of single-layer or laminated paper or plastic film or metal foil can can be designed in a wide variety of ways, for example than bloated Bags without a central seam or as a bag with a central seam, which through Heat (hot fusion), Adhesives or tapes be closed. Single-layer bag or sack materials are the known papers that may be impregnated can, as well as plastic films, which can optionally be coextruded. plastic, used in the context of the present invention as a packaging system can be are, for example, in Hans Domininghaus "The plastics and their Characteristics", 3rd edition, VDI Verlag, Düsseldorf; 1988, page 193.

The one shown there 111 at the same time gives information on the water vapor permeability of the materials mentioned.

Although it is possible in addition to the above Films or papers also wax coated papers in the form of To use cardboard as a packaging system for the moldings, it is im Preferred within the scope of the present invention if the packaging system does not include boxes made of wax coated paper.

In another embodiment becomes the molded body in dimensionally stable packaging, such as a blister, stored. In this embodiment, the blister can be made with a metal foil or be sealed with appropriate film laminates.

To the optional secondary packaging become common Requirements, so here all known materials and systems can be used.

In another embodiment, the packaging system is resealable. It has, for example proven to be practical, a reclosable tube as a packaging system Use glass, plastic or metal. In this way Is it possible, the dosability of hair dye products to optimize so that the For example, consumers can be guided per defined Hair length unit one shaped body each to use. Even packaging systems that have a microperforation can be realized with preference according to the invention.

In a particularly preferred embodiment container K2 becomes on the packaging unit of container K1 attached. The container K2 can be mechanically connected to the container K1, for example by appending or plug on, be connected. A connection between the two containers using an adhesive is also possible.

If the molded body is assembled in a blister, it is preferred to attach the blister to the packaging unit of the To fasten containers K1 that the Sealing the blister is also a wall of the container K1 represents. Now the blister is sealed by mechanical The pressure has broken through on the blister or on the molded body moldings Access to the medium M located in container K1. This type of Attachment allows it the consumer in the context of the inventive method, the molded body convenient dosed into the medium M without directly contacting it.

I. Coloring tablets per component

1. Production of the coloring tablets

First the following basic recipe was mixed in a mortar: basic formulation

The following color formulations were then produced based on the basic formulation: Color formulations:

Every single color formulation was pressed as a tablet. The tablets were pressed with a Tablet press of the brand Faun Linear Swall Meter (Faun Instruments, Houston, USA) at a pressure of 2000 psi. Thereby were tablets obtained with a diameter of 3.0 cm.

2. Coloring

One tablet from series A was dissolved with one tablet from series B in 80 ml of water at room temperature with gentle shaking. Each 4 g of the gel formed was placed on a strand of hair of approx. 1 g weight (Kerling natural white) and left there at 32 ° C. for 30 minutes. After rinsing and drying, the following color results (evaluation according to the German Color Atlas) were achieved:

II. 3-phase coloring tablets

1. Production of the coloring tablets

For each phase of the 3-phase tablet, a separate mixture according to Table 2 was produced for each tablet. Table 2

The corresponding solid mixtures The individual phases were stacked in the chamber of the tablet press layered that itself phase 2 is between phases 1 and 3. The pressing the tablets were made with a Faun Linear Swall tablet press Meters (Faun Instruments, Houston, USA) at a pressure of 2000 psi.

The 2nd phase serves as a separation phase, prevents the reactive components A from coming into direct contact and B in phases 1 and 3, thus preventing the premature one Formation of the dye in the tablet. The storage stability of the tablets is increased.

2. Colorings:

One tablet each was dissolved in 95 ml water with gentle shaking. The hair strand was colored as above under I.2. described. The color results were as follows:

Claims (36)

Shaped body for dyeing fibers containing keratin, characterized in that the shaped body contains, in addition to a cosmetically acceptable carrier, at least one compound with a reactive carbonyl group as a dye precursor. Shaped body according to claim 1, characterized in that the compound having a reactive carbonyl group is selected from a group which is formed from compounds according to formulas I, IV, V, VIa and VIb,

where - AR stands for benzene, naphthalene, pyridine, pyrimidine, pyrazine, pyridazine, carbazole, pyrrole, pyrazole, furan, thiophene, 1,2,3-triazine, 1,3,5-triazine, quinoline, isoquinoline, indole, indoline , Indolizine, indan, imidazole, 1,2,4-triazole, 1,2,3-triazole, tetrazole, benzimidazole, 1,3-thiazole, benzothiazole, indazole, benzoxazole, quinoxaline, quinazoline, Quinolizine, cinnoline, acridine, julolidine, acenaphthene, fluorene, biphenyl, diphenylmethane, benzophenone, diphenyl ether, azobenzene, chromone, coumarin, diphenylamine, stilbene, where the N-heteroaromatics can also be quaternized, - R ³ represents a hydrogen atom, a C. ₁ -C ₆ alkyl, C ₂ -C ₆ acyl, C ₂ -C ₄ alkenyl, C ₁ -C ₄ perfluoroalkyl, an optionally substituted aryl or heteroaryl group, - R ⁴ , R ⁵ and R ⁶ each independently represent a hydrogen atom, a halogen atom, a C ₁ -C ₆ alkyl, C ₁ -C ₆ alkoxy, C ₁ -C ₆ aminoalkyl, C ₁ -C ₆ hydroxyalkyl group, a C ₁ -C ₆ alkoxy-C ₁ -C ₆ alkyloxy group, a C ₂ -C ₆ acyl group, an acetyl, carboxyl, carboxylato, carbamoyl, sulfo, sulfato, sulfonamide, Sulfonamido, C ₂ -C ₆ alkenyl, an aryl, an aryl C ₁ -C ₆ alkyl group, a hydroxy, a nitro, a pyrrolidino, a morpholino, a piperidino, an amino or ammonio or a 1-imidazole (in) io group, the last ten three groups with one or more C ₁ -C ₆ alkyl, C ₁ -C ₆ carboxyalkyl, C ₁ -C ₆ hydroxyalkyl, C ₂ -C ₆ alkenyl, C ₁ -C ₆ alkoxy -C ₁ -C ₆ -alkyl-, with optionally substituted benzyl groups, with sulfo (C ₁ -C ₄ ) alkyl or heterocycle (C ₁ -C ₄ ) alkyl groups, two of the radicals also being substituted from R ⁴ , R ⁵ , R ⁶ and -ZYR ³ together with the rest of the molecule can form a fused, optionally substituted 5-, 6- or 7-ring, which can also carry a fused-on aromatic ring, the system AR depending on its size can carry further substituents which can each independently represent the same groups as R ⁴ , R ⁵ and R ⁶ , - Z stands for a direct bond, a carbonyl, a carboxy (C ₁ -C ₄ ) - alkylene, an optionally substituted C ₂ -C ₆ alkenylene, C ₄ -C ₆ alkadienylene, furylene, thienylene, arylene, vinylene arylene, vinylene furylene, vinyl thienylene group, wobe i Z together with the -YR ³ group can also form an optionally substituted 5-, 6- or 7-ring, - Y represents a group which is selected from carbonyl, a group according to formula II and a group according to formula III .

where - R ⁷ represents a hydrogen atom, a hydroxy group, a C ₁ -C ₄ alkoxy group, a C ₁ -C ₆ alkyl group, a C ₁ -C ₆ hydroxyalkyl group, a C ₂ -C ₆ polyhydroxyalkyl group, a C ₁ -C ₆ alkoxy-C ₁ -C ₆ alkyl group, - R ⁸ and R ⁹ independently of one another represent a C ₁ -C ₆ alkyl group, an aryl group or together with the structural element OCO of the formula III form a 5- or 6-link ring. Aldehydes of the formula (IV)

wherein - R ¹⁰ and R ¹¹ each independently represent a hydrogen atom, a C ₁ -C ₆ alkyl group, a C ₁ -C ₄ hydroxyalkyl group, a C ₂ -C ₈ polyhydroxyalkyl group, a C ₁ -C ₄ alkoxy -C ₁ -C ₄ alkyl group, a C ₁ -C ₄ alkoxy group, a group -OCF ₃ or a group -CF ₃ , where the radicals R ¹⁰ and R ¹¹ together with the vinylene unit in the bracket a 5- or 6 -linked, aromatic or aliphatic, carbocyclic or heterocyclic ring, - n is 0, 1, 2 or 3 - R ¹² represents a hydrogen atom, a C ₁ -C ₆ alkyl group, a hydroxy group, a C ₁ -C _4- hydroxyalkyl group, a C ₂ -C ₈ polyhydroxyalkyl group, a C ₁ -C ₄ alkoxy-C ₁ -C ₄ alkyl group, a C ₁ -C ₄ alkoxy group, a formyl group, a group -OCF ₃ or a group -CF ₃ , ketones with the formula (V)

wherein - R ¹³ represents a hydrogen atom, a C ₁ -C ₆ alkyl group, a C ₁ -C ₄ hydroxyalkyl group, a C ₂ -C ₈ polyhydroxyalkyl group, a C ₁ -C ₄ alkoxy-C ₁ -C ₄ - alkyl group, a C ₁ -C ₄ alkoxy group, a group -OCF ₃ or a group -CF ₃ - R ¹⁴ stands for a C ₁ -C ₆ alkyl group, a C ₁ -C ₄ monohydroxyalkyl group, a C ₂ -C ₈ -polyhydroxyalkyl group, - m is equal to 1 or 2, where R ¹³ and R ¹⁴ together with the carbonyl unit form a 5- or 6-membered, aliphatic or aromatic, carbocyclic or heterocyclic ring which, in turn, may in turn form a fused-on 5- 6-membered ring , aliphatic or aromatic, carbocyclic or heterocyclic ring, with the proviso that each heterocyclic ring contains nitrogen or sulfur atoms as heteroatoms, diimino-isoindoline or 3-amino-isoindolone derivatives according to formulas VIa and VIb,

wherein - A represents an oxygen atom or a NH group, - R ¹⁵ and R ¹⁶ each independently represent a hydrogen atom, a C ₁ -C ₄ alkyl group, a C ₁ -C ₄ hydroxyalkyl group, a C ₂ -C ₆ -Polyhydroxyalkylgruppe, a group R ^I R ^II N- (CH ₂ ) _q -, wherein R ^I and R ^II each independently represent a C ₁ -C ₆ alkyl group or an aryl-C ₁ -C ₆ alkyl group and q stands for a number 1, 2, 3, 4, 5 or 6, where R ^I and R ^II together with the nitrogen atom can form an aromatic or aliphatic 5-, 6- or 7-membered heterocycle, - form R ¹⁷ and R ¹⁸ together with the rest of the molecule, a 5- or 6-membered aromatic or heteroaromatic ring, which may optionally be substituted. Shaped body according to one of claims 1 or 2, characterized in that the compound having a reactive carbonyl group is selected from compounds of the formula VII,

wherein - R ^16a , R ^17a and R ^18a each independently represent a hydrogen atom, a halogen atom, a sulfo group, a carboxyl group, a nitro group, a C ₁ -C ₆ alkyl, a C ₁ -C ₆ alkoxy, a C ₁ -C ₆ carboxyalkyl, a C ₁ -C ₆ hydroxyalkyl, a C ₂ -C ₆ alkenyl, and a C ₁ -C ₆ alkoxy-C ₁ -C ₆ alkyl group, R ^15a represents one of the groups defined under R ¹⁵ according to claim 2, a C ₂ -C ₆ alkenyl group, a carboxy-C ₁ -C ₆ alkyl group, a sulfo-C ₁ -C ₆ alkyl group, a sulfo-C ₁ -C ₆ -alkylaminomethyl group, a monohydroxy-C ₁ -C ₆ -alkyl group, a carboxy-C ₁ -C ₆ -alkylaminomethyl group, an optionally substituted benzyl group and a heterocycle-C ₁ -C ₆ -alkyl group. Shaped body according to claim 3, characterized in that the compound having a reactive carbonyl group is selected from the group which is formed from isatin, 5-chloroisatin, 5-nitroisatin, 5,7-dichloroisatin, isatin-5-sulfonic acid, isatin-4 -carboxylic acid and isatin-5-carboxylic acid, N-hydroxymethyl-isatin, N-hydroxyethyl-isatin N- (2-hydroxypropyl) -isatin, N- (3-hydroxypropyl) -isatin, N- (2,3-dihydroxypropyl) - isatin, N- (2-sulfoethyl) -isatin, N- (3-sulfopropyl) -isatin, N-allylisatin, N-vinylisatin, N-benzylisatin, N- (4-methoxybenzyl) -isatin, N- (4-carboxybenzyl ) -isatin, N- (4-sulfobenzyl) -isatin, N- (2-dimethylaminoethyl) -isatin, N- (2-pyrrolidinoethyl) -isatin, N- (2-piperidinoethyl) -isatin, N- (2-furylmethyl ) -isatin, N- (2-thienylmethyl) -isatin, N- (2-pyridylmethyl) -isatin, N- (3-pyridylmethyl) -isatin, N- (4-pyridylmethyl) -isatin, N-allylisatin-5- sulfonic acid, 5-chloro-N- (2-hydroxyethyl) -isatin, 5-methyl-N- (2-hydroxyethyl) -isatin, 5,7-dichloro-N-allylisatin, 5-nitro-N-allylisatin, N- hydroxymethyl 1- 5-methylisatin, N-hydroxymethyl-5-chloroisatin, N-hydroxymethyl-5-sulfoisatin, N-hydroxymethyl-5-carboxyisatin, N-hydroxymethyl-5-nitroisatin, N-hydroxymethyl-5-bromisatin, N-hydroxymethyl 5-me thoxyisatin, N-hydroxymethyl-5,7-dichloroisatin, N-dimethylaminomethylisatin, N-diethylaminomethylisatin, N- (bis- (2-hydroxyethyl) -aminomethyl) -isatin, N- (2-hydroxyethylaminomethyl) -isatin, N- (bis - (2-hydroxypropyl) aminomethyl) isatin, N- (2-pyrrolidino) isatin, N- (2-piperidino) isatin, N-pyrrolidinomethylisatin, N-piperidinomethylisatin, N-morpholinomethylisatin, N- (2-morpholinoethyl ) -isatin, N- (1,2,4-triazol-l-yl-methyl) -isatin, N- (1-imidazolyl) -methylisatin, N-carboxymethylaminomethylisatin, N- (2-carboxyethylaminomethyl) -isatin, N- (3-carboxypropylaminomethyl) isatin, N- (bis (2-hydroxyethyl) aminomethyl) -5-methylisatin, N-piperidinomethyl-5-chloroisatin, N- (2-sulfoethylaminomethyl) isatin, and the alkali and, if appropriate Ammonium salts of the acidic compounds. Shaped body according to one of claims 1 or 2, characterized in that the compound having a reactive carbonyl group is selected from compounds according to formula VIII,

wherein - R ¹⁹ stands for the groups defined under R ³ according to formula I in claim 2, - R ²⁰ , R ²¹ and R ²² each independently represent the groups defined under R ⁴ according to formula I in claim 2 or two of the radicals R ²⁰ , R ²¹ and R ²² together with the residual molecule form a 5-, 6- or 7-membered carbocyclic or heterocyclic, aromatic or aliphatic ring, - R ²³ represents a hydrogen atom, a C ₁ - C ₆ alkyl group, an aryl group or a heteroaryl group, - X stands for a direct bond, an arylene group, an optionally substituted C ₂ -C ₆ alkenylene group and a C ₄ -C ₆ alkadienylene group, - Y - stands for halide, benzenesulfonate , p-toluenesulfonate, methanesulfonate, trifluoromethanesulfonate, perchlorate, 0.5 sulfate, hydrogen sulfate, methyl sulfate, hexafluorophosphate, tetrachlorozincate or tetrafluoroborate. moldings according to claim 5, characterized in that X stands for a direct bond. Moldings, according to claim 5 or 6, characterized in that X is either at position 2, 4 or 6 according to the formula VIII binds. moldings according to one of the claims 5 to 7, characterized in that it is a compound of the formula VIII contains at least one pyridinium and / or quinolinium derivative. Shaped body according to one of claims 5 to 8, characterized in that R ^{19 represents} a hydrogen atom. moldings according to one of the claims 5 to 9, characterized in that the compounds of formula VIII selected is from the group that is formed from benzenesulfonates, p-toluenesulfonates, Methanesulfonates, perchlorates, 0.5 sulfates, chlorides, bromides, Iodides and / or tetrachlorozincates of 4-formyl-1-methylpyridinium, 3-formyl-1-methylpyridinium, 2-formyl-1-methylpyridinium, 4-formyl-1-ethylpyridinium, 2-formyl-1-ethylpyridinium, 4-formyl-1-benzylpyridinium, 2-formyl-1-benzylpyridinium, 4-formyl-1,2-dimethylpyridinium, 4-formyl-1,3-dimethylpyridinium, 4-formyl-1-methylquinolinium, 2-formyl-1-methylquinolinium, 4- (2-formylvinyl) -1-methylquinolium, 4-acetyl-1-methylpyridinium, 2-acetyl-1-methylpyridinium, 4-acetyl-1-methylquinolinium and 4- (2-formylvinyl) -1-methylpyridinium, 2,6-dichloro-4-formyl-1-methylpryridinium, 2,6-diphenyl-4-formyl-1-methylpyridinium, 4-benzoyl-1-methylpyridinium, 4-propionyl-1-methylpyridinium, 4-pyridinaldehyde-N-oxide and N-methylpyridoxal as well as any mixtures of the above compounds. Shaped body according to one of claims 1 or 2, characterized in that the compounds having a reactive carbonyl group are selected from the group consisting of 2-pentendial, acetophenone, propiophenone, 2-hydroxyacetophenone, 3-hydroxyacetophenone, 4-hydroxyacetophenone, 2-hydroxypropiophenone , 3-hydroxypropiophenone, 4-hydroxypropiophenone, 2-hydroxybutyrophenone, 3-hydroxybutyrophenone, 4-hydroxybutyrophenone, 2,4-dihydroxyacetophenone, 2,5-dihydroxyacetophenone, 2,6-dihydroxyaceto phenone, 2,3,4-trihydroxyacetophenone, 3,4,5-trihydroxyacetophenone, 2,4,6-trihydroxyacetophenone, 2,4,6-trimethoxyacetophenone, 3,4,5-trimethoxyacetophenone, 3,4,5-trimethoxy acetophenone diethyl ketal, 4-hydroxy-3-methoxy-acetophenone, 3,5-dimethoxy-4-hydroxyacetophenone, 4-aminoacetophenone, 4-dimethylaminoacetophenone, 4-morpholinoacetophenone, 4-piperidinoacetophenone, 4-imidazolinoacetophenone bromo-acetophenone, 4-hydroxy-3-nitroacetophenone, acetophenone-2-carboxylic acid, acetophenone-4-carboxylic acid, benzophenone, 4-hydroxybenzophenone, 2-aminobenzophenone, 4,4'-dihydroxybenzophenone, 2,4-dihydroxy-benzophenone, 2 , 4,4'-trihydroxybenzophenone, 2,3,4-trihydroxybenzophenone, 2-hydroxy-1-acetonaphthone, 1-hydroxy-2-acetonaphthone, chromone, chromon-2-carboxylic acid, flavone, 3-hydroxyflavone, 3.5, 7-trihydroxyflavon, 4 ', 5,7-trihydroxyflavon, 5,6,7-trihydroxyflavon, quercetin, 1-indanone, 9-fluorenone, 3-hydroxyfluorenone, anthrone, 1,8-dihydroxyanthrone, salicylaldehyde, vanillin, coniferylaldehyde, 2 -Methoxyben zaldehyde, 3-methoxybenzaldehyde, 4-methoxybenzaldehyde, 2-ethoxybenzaldehyde, 3-ethoxybenzaldehyde, 4-ethoxybenzaldehyde, 4-hydroxy-2,3-dimethoxy-benzaldehyde, 4-hydroxy-2,5-dimethoxy-benzaldehyde, 4-hydroxy- 2,6-dimethoxy-benzaldehyde, 4-hydroxy-2-methyl-benzaldehyde, 4-hydroxy-3-methyl-benzaldehyde, 4-hydroxy-2,3-dimethyl-benzaldehyde, 4-hydroxy-2,5-dimethyl- benzaldehyde, 4-hydroxy-2,6-dimethyl-benzaldehyde, 4-hydroxy-3,5-dimethoxy-benzaldehyde, 4-hydroxy-3,5-dimethyl-benzaldehyde, 3,5-diethoxy-4-hydroxy-benzaldehyde, 2,6-diethoxy-4-hydroxy-benzaldehyde, 3-hydroxy-4-methoxy-benzaldehyde, 2-hydroxy-4-methoxy-benzaldehyde, 2-ethoxy-4-hydroxy-benzaldehyde, 3-ethoxy-4-hydroxy- benzaldehyde, 4-ethoxy-2-hydroxy-benzaldehyde, 4-ethoxy-3-hydroxy-benzaldehyde, 2,3-dimethoxybenzaldehyde, 2,4-dimethoxybenzaldehyde, 2,5-dimethoxybenzaldehyde, 2,6-dimethoxybenzaldehyde, 3,4- Dimethoxybenzaldehyde, 3,5-dimethoxybenzaldehyde, 2,3,4-trimethoxybenzaldehyde, 2,3,5-trimethoxybenzaldehyde, 2,3,6-trimethoxybenzaldehyde, 2,4,6-trimethoxybe azaldehyde, 2,4,5-trimethoxybenzaldehyde, 2,5,6-trimethoxybenzaldehyde, 2-hydroxybenzaldehyde, 3-hydroxybenzaldehyde, 4-hydroxybenzaldehyde, 2,3-dihydroxybenzaldehyde, 2,4-dihydroxybenzaldehyde, 2,5-dihydroxybenzaldehyde, 2, 6-dihydroxybenzaldehyde, 3,4-dihydroxybenzaldehyde, 3,5-dihydroxybenzaldehyde, 2,3,4-trihydroxybenzaldehyde, 2,3,5-trihydroxybenzaldehyde, 2,3,6-trihydroxybenzaldehyde, 2,4,6-trihydroxybenzaldehyde, 2, 4,5-trihydroxybenzaldehyde, 2,5,6-trihydroxybenzaldehyde, 4-hydroxy-2-methoxybenzaldehyde, 4-dimethylaminobenzaldehyde, 4-diethylaminobenzaldehyde, 4-dimethylamino-2-hydroxybenzaldehyde, 4-diethylamino-2-hydroxybenzaldehyde, 4-pyrrolidinobaldehyde 4-morpholinobenzaldehyde, 2-morpholinobenzaldehyde, 4-piperidinobenzaldehyde, 2-methoxy-1-naphthaldehyde, 4-methoxy-1-naphthaldehyde, 2-hydroxy-1-naphthaldehyde, 2,4-dihydroxy-1-naphthaldehyde, 4-hydroxy- 3-methoxy-1-naphthaldehyde, 2-hydroxy-4-methoxy-1-naphthaldehyde, 3-hydroxy-4-methoxy-1-naphthaldehyde, 2,4-dimethoxy-1-naphthaldehyde, 3,4-dimethoxy-1- nap hthaldehyde, 4-hydroxy-1-naphthaldehyde, 4-dimethylamino-1-naphthaldehyde, 4-dimethylaminocinnamaldehyde, 2-dimethylaminobenzaldehyde, 2-chloro-4-dimethylaminobenzaldehyde, 4-dimethylamino-2-methylbenzaldehyde, 4-diethylamino-4-cinnamaldehyde Dibutylamino-benzaldehyde, 4-D'iphenylamino-benzaldehyde, 4-dimethylamino-2-methoxybenzaldehyde, 4- (1-imidazolyl) benzaldehyde, piperonal, 2,3,6,7-tetrahydro-1H, 5H-benzo [ij] quinolizine-9-carboxaldehyde, 2,3,6,7-tetrahydro-8-hydroxy-1H, 5H-benzo [ij] quinolizine-9-carboxaldehyde, N-ethylcarbazole-3-aldehyde, 2-formylmethylene-1,3, 3-trimethylindoline (Fischer's aldehyde or tribase aldehyde), 2-indolaldehyde, 3-indolaldehyde, 1-methylindol-3-aldehyde, 2-methylindol-3-aldehyde, 1-acetylindol-3-aldehyde, 3-acetylindole, 1-methyl -3-acetylindole, 2- (1,3,3-trimethyl-2-indolinylidene) acetaldehyde, 1-methylpyrrole-2-aldehyde, 1-methyl-2-acetylpyrrole, 4-pyridine aldehyde, 2-pyridine aldehyde, 3-pyridine aldehyde , 4-acetylpyridine, 2-acetylpyridine, 3-acetylpyridine, pyridoxal, quinoline-3-aldehyde, quinoline 4-aldehyde, antipyrin-4-aldehyde, furfural, 5-nitrofurfural, 2-thenoyl-trifluoroacetone, chromon-3-aldehyde, 3- (5-nitro-2-furyl) acrolein, 3- (2-furyl ) -acrolein and imidazole-2-aldehyde, 1,3-diacetylbenzene, 1,4-diacetylbenzene, 1,3,5-triacetylbenzene, 2-benzoyl-acetophenone, 2- (4-methoxybenzoyl) -acetophenone, 2- (2nd Furoyl) acetophenone, 2- (2-pyridoyl) acetophenone and 2- (3-pyridoyl) acetophenone, benzylidene acetone, 4-hydroxybenzylidene acetone, 2-hydroxybenzylidene acetone, 4-methoxybenzylidene acetone, 4-hydroxy-3-methoxybenzylidene acetone Dimethylaminobenzylidene acetone, 3,4-methylenedioxybenzylidene acetone, 4-pyrrolidinobenzylidene acetone, 4-piperidinobenzylidene acetone, 4-morpholinobenzylidene acetone, 4-diethylaminobenzylidene acetone, 3-benzylidene-2,4-pentanedione, 3- (4-hydroxybenzylidene) -2- (4-dimethylaminobenzylidene) -2,4-pentanedione, 2-benzylidene cyclohexanone, 2- (4-hydroxybenzylidene) cyclohexanone, 2- (4-dimethylaminobenzylidene) cyclohexanone, 2-benzylidene-1,3-cyclohexanedione, 2- (4th -Hydroxybenzyliden) -1,3-cycl ohexanedione, 3- (4-dimethylaminobenzylidene) -1,3-cyclohexanedione, 2-benzylidene-5,5-dimethyl-1,3-cyclohexanedione, 2- (4-hydroxybenzylidene) -5,5-dimethyl-1,3- cyclohexanedione, 2- (4-hydroxy-3-methoxybenzylidene) -5,5-dimethyl-1,3-cyclohexanedione, 2- (4-dimethylaminobenzylidene) -5,5-dimethyl-1,3-cyclohexanedione, 2-benzylidene cyclopentanone, 2- (4-hydroxybenzylidene) cyclopentanone, 2- (4-dimethylaminobenzylidene) cyclopentanone, 5- (4-dimethylaminophenyl) penta-2,4-dienal, 5- (4-diethylaminophenyl) penta-2,4-dienal, 5- (4-methoxyphenyl) penta-2,4-dienal, 5- (3,4-dimethoxyphenyl) penta-2,4-dienal, 5- (2,4-dimethoxyphenyl) penta-2,4-dienal, 5 - [4- (1-piperidinyl) phenyl] -2,4-pentadienal, 5- [4- (1-morpholinyl) phenyl] -2,4-pentadienal, 5- [4- (1-pyrrolidinyl) phenyl] - 2,4-pentadienal, 6- (4-dimethylaminophenyl) hexa-3,5-dien-2-one, 6- (4-diethylaminophenyl) hexa-3,5-dien-2-one, 6- (4-methoxyphenyl ) hexa-3,5-dien-2-one, 6- (3,4-dimethoxyphenyl) hexa-3,5-dien-2-one, 6- (2,4-dimethoxyphenyl) hexa-3,5-diene -2-one, 6- [4- (1-piperidinyl) phenyl] hexa-3,5-die n-2-one, 6- [4- (1-morpholinyl) phenyl] hexa-3,5-dien-2-one, 6- [4- (1-pyrrolidinyl) phe nyl] -hexa-3,5-dien-2-one, 5- (4-dimethylamino-1-naphthyl) penta-2,4-dienal, 2-nitrobenzaldehyde, 3-nitrobenzaldehyde, 4-nitrobenzaldehyde, 4-methyl- 3-nitrobenzaldehyde, 3-hydroxy-4-nitrobenzaldehyde, 4-hydroxy-3-nitrobenzaldehyde, 5-hydroxy-2-nitrobenzaldehyde, 2-hydroxy-5-nitrobenzaldehyde, 2-hydroxy-3-nitrobenzaldehyde, 2-fluoro-3- nitrobenzaldehyde, 3-methoxy-2-nitrobenzaldehyde, 4-chloro-3-nitrobenzaldehyde, 2-chloro-6-nitrobenzaldehyde, 5-chloro-2-nitrobenzaldehyde, 4-chloro-2-nitrobenzaldehyde, 2,4-dinitrobenzaldehyde, 2, 6-dinitrobenzaldehyde, 2-hydroxy-3-methoxy-5-nitrobenzaldehyde, 4,5-dimethoxy-2-nitrobenzaldehyde, 6-nitropiperonal, 2-nitropiperonal, 5-nitrovanillin, 2,5-dinitrosalicylaldehyde, 5-bromo-3- nitrosalicylaldehyde, 3-nitro-4-formylbenzenesulfonic acid, 4-nitro-1-naphthaldehyde, 2-nitrocinnamaldehyde, 3-nitrocinnamaldehyde, 4-nitrocinnamaldehyde, 9-methyl-3-carbazolaldehyde, 9-ethyl-3-carbazolaldehyde, 3-acetylcarb 3,6-diacetyl-9-ethylcarbazole, 3-acetyl-9-methylcarbazole, 1,4-dimethyl-3-carbazolaldehyde, 1, 4,9-trimethyl-3-carbazolaldehyde, 4-formyl-1-methylpyridinium-, 2-formyl-1-methylpyridinium-, 4-formyl-1-ethylpyridinium-, 2-formyl-1-ethylpyridinium-, 4-formyl- 1-benzylpyridinium-, 2-formyl-1-benzylpyridinium-, 4-formyl-1,2-dimethylpyridinium-, 4-formyl-1,3-dimethylpyridinium-, 4-formyl-1-methylquinolinium-, 2-formyl-1 methylquinolinium, 4-acetyl-1-methylpyridinium, 2-acetyl-1-methylpyridinium, 4-acetyl-1-methylquinolinium, 5-formyl-1-methylquinolinium, 6-formyl-1-methylquinolinium, 7 -Formyl-1-methylquinolinium, 8-formyl-1-methylquinolinium, 5-formyl-1-ethylquinolinium, 6-formyl-1-ethylquinolinium, 7-formyl-1-ethylquinolinium, 8-formyl-1-ethylquinolinium , 5-formyl-1-benzylquinolinium, 6-formyl-1-benzylquinolinium, 7-formyl-1-benzylquinolinium, 8-formyl-1-benzylquinolinium, 5-formyl-1-allylquinolinium, 6-formyl-1 -allylquinolinium, 7-formyl-1-allylquinolinium and 8-formyl-1-allylquinolinium, 5-acetyl-1-methylquinolinium, 6-acetyl-1-methylquinolinium, 7-acetyl-1-methylc hinolinium, 8-acetyl-1-methylquinolinium, 5-acetyl-1-ethylquinolinium, 6-acetyl-1-ethylquinolinium, 7-acetyl-1-ethylquinolinium, 8-acetyl-1-ethylquinolinium, 5-acetyl 1-benzylquinolinium, 6-acetyl-1-benzylquinolinium, 7-acetyl-1-benzylquinolinium, 8-acetyl-1-benzylquinolinium, 5-acetyl-1-allylquinolinium, 6-acetyl-1-allylquinolinium, 7 -Acetyl-1-allylquinolinium and 8-acetyl-1-allylquinolinium, 9-formyl-10-methylacridinium-, 4- (2-formylvinyl) -1-methylpyridinium-, 1,3-dimethyl-2- (4-formylphenyl ) -benzimidazolinium-, 1,3-dimethyl-2- (4-formylphenyl) -imidazolinium-, 2- (4-formylphenyl) -3-methylbenzothiazolium-, 2- (4-acetylphenyl) -3-methylbenzothiazolium-, 2- (4-formylphenyl) -3-methylbenzoxazolium-, 2- (5-formyl-2-furyl) -3-methylbenzothiazolium-, 2- (5-formyl-2-furyl) -3-methylbenzothiazolium-, 2- (5- Formyl-2-thienyl) -3-methylbenzothiazolium-, 2- (3-formylphenyl) -3-methylbenzothiazolium-, 2- (4-formyl-1-naphthyl) -3-methylbenzothiazolium-, 5-chloro-2- (4th -formylphenyl) -3-methylbenzothiazolium- , 2- (4-formylphenyl) -3,5-dimethylbenzothiazolium benzenesulfonate, -p-toluenesulfonate, -methanesulfonate, -perchlorate, -sulfate, -chloride, -bromide, -iodide, -tetrachlorozincate, -methylsulfate-, trifluoromethanesulfonate, - tetrafluoroborate, isatin, 1-methyl-isatin, 1-allyl-isatin, 1-hydroxymethyl-isatin, 5-chloro-isatin, 5-methoxy-isatin, 5-nitroisatin, 6-nitro-isatin, 5-sulfo-isatin, 5-carboxy-isatin, quinisatin, 1-methylquinisatin. moldings according to one of the claims 1 to 11, characterized in that it additionally has at least one connection contains selected selected from compounds from (a) CH-acidic compounds, (b) compounds with primary or secondary Amino group or hydroxy group selected from primary or secondary aromatic Amines, nitrogen-containing heterocyclic compounds and aromatic Hydroxy compounds, (c) amino acids, (d) from 2 to 9 amino acids built oligopeptides. Shaped body according to claim 12, characterized in that the CH-acidic compound is selected from a group which is formed from 1,2,3,3-tetramethyl-3H-indolium iodide, 1,2,3,3-tetramethyl-3H- indolium p-toluenesulfonate, 1,2,3,3-tetramethyl-3H-indolium methanesulfonate, 1,3,3-trimethyl-2-methyleneindoline (Fischer's base), 2,3-dimethyl-benzothiazolium iodide, 2,3- Dimethyl benzothiazolium p-toluenesulfonate, 2,3-dimethyl naphtho [1,2-d] thiazolium p-toluenesulfonate, 3-ethyl-2-methyl-naphtho [1,2-d] thiazolium p-toluenesulfonate, Rhodanine, rhodanine-3-acetic acid, 1,4-dimethylquinolinium iodide, 1,2-dimethylquinolinium iodide, barbituric acid, thiobarbituric acid, 1,3-dimethylthiobarbituric acid, 1,3-diethylthiobarbituric acid, 1,3-diethylbarbituric acid, oxindole, 3- Indoxy acetate, 2-coumaranone, 5-hydroxy-2-coumaranone, 6-hydroxy-2-coumaranone, 3-methyl-1-phenyl-pyrazolin-5-one, indan-1,2-dione, indan-1,3- dione, indan-1-one, benzoylacetonitrile, 3-dicyanomethylene indan-1-one, 2-amino-4-imino-1,3-thiazoline hydrochloride id, 5,5-dimethylcyclohexan-1,3-dione, 2H-1,4-benzoxazin-4H-3-one, 3-ethyl-2-methyl-benzoxazolium iodide, 3-ethyl-2-methyl-benzothiazolium iodide, 1- Ethyl 4-methyl-quinolinium iodide, 1-ethyl-2-methylquinolinium iodide, 1,2,3-trimethylquinoxalinium iodide, 3-ethyl-2-methyl-benzoxazolium-p-toluenesulfonate, 3-ethyl-2-methyl-benzothiazolium-p- toluenesulfonate, 1-ethyl-4-methyl-quinolinium-p-toluenesulfonate, 1-ethyl-2-methyl-quinolinium-p-toluenesulfonate, 1,2,3-trimethylquinoxalinium-p-toluenesulfonate, 1,2-dihydro-1,3,4 , 6-tetramethyl-2-oxopyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4,6-dimethyl-2-oxopyrimidinium chloride, 1,2-dihydro-1,3-dipropyl -4,6-dimethyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3,4,6-tetramethyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diethyl -4,6-dimethyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3 , 4-trimethyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3,4-trimethyl-2-oxo-pyrimidinium hydrogensu lfat, 1,2-dihydro-1,3-diethyl-4-methyl-2-oxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4-methyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4-methyl-2-oxopyrimidinium chloride, 1,2-dihydro-1,3-di propyl-4-methyl-2-oxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1, 3,4,6-tetramethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl- 4,6-dimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3, 4,6-tetramethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4,6-dimethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3, 4-trimethyl-2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3,4-trimethyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-diethyl-4-methyl- 2-thioxo-pyrimidinium chloride, 1,2-dihydro-1,3-diethyl-4-methyl-2-thioxo-pyrimidinium hydrogen sulfate, 1,2-dihydro-1,3-dipropyl-4-methyl-2- thioxo-pyrimidinium chloride and 1,2-dihydro-1,3-dipropyl-4-methyl-2-thioxo-pyrimidinium hydrogen sulfate. moldings according to one of the claims 1 to 13, characterized in that it is a resolution accelerator contains. moldings according to claim 14, characterized in that the dissolution accelerator is a disintegration aid is. moldings according to one of the claims 1 to 15, characterized in that individual components of the coated composition or the entire molded body coated are. moldings according to one of the claims 1 to 16, characterized in that the shaped body is an alkalizing agent contains. moldings according to one of the claims 1 to 17, characterized in that the shaped body has at least one direct pull Contains dye. moldings according to one of the claims 1 to 18, characterized in that the shaped body at least one pearlescent pigment contains. moldings according to one of the claims 1 to 19, characterized in that the shaped body at least one bitter substance contains. moldings according to one of the claims 1 to 20, characterized in that individual components of the coated composition or the entire molded body coated is. moldings according to one of the claims 1 to 21, characterized in that the molded body from a primary packaging wrapped is. moldings according to one of the claims 1 to 22, characterized in that the molded body has a breaking hardness of 30-100 N, preferably from 40 to 80 N, particularly preferably from 50 to 60 N, (measured according to European Pharmacopoeia 1997, 3rd edition, ISBN 3-7692-2186-9, "2.9.8 Breaking strength of tablets "; page 143-144 with a Schleuniger tablet hardness tester 6D). moldings according to one of the claims 1 to 23, characterized in that it consists of several layers consists. moldings according to claim 24, characterized in that it the compounds component A in a first layer and the compounds of component B contains in a second layer. moldings according to claim 25, characterized in that the first and the second Layer can be separated by at least one further layer. moldings according to one of the claims 1 to 26, characterized in that it contains at least one oxidation dye precursor of the developer type and / or at least one oxidation dye precursor of the coupler type contains. moldings according to one of the claims 1 to 27, characterized in that it contains at least one thickener contains. Use of the shaped bodies according to one of claims 1 to 28 for the preparation of an agent for dyeing keratin fibers. Coloring process fibers containing keratin, characterized in that (I) one or more shaped bodies according to one of the claims 1 to 28 dissolved in a medium M. become, (II) the resulting preparation, if appropriate an oxidant preparation is mixed, (III) that resulting ready-to-use colorants F applied to the fibers and (IV) again after a contact time rinsed becomes. A method according to claim 30, characterized in that this Medium M is a viscosity from 500 - 100000 mPa.s, preferably from 3000 to 70000 mPa.s, particularly preferably from 6000 to 50,000 mPa.s and very particularly preferably from 10000-30000 mPa · s (Brookfield RVT viscometer at a temperature of 20 ° C at 4 rpm with spindle No. 4). Method according to one of claims 30 or 31, characterized in that that this Medium M is a gel or a W / O emulsion or O / W emulsion. A method according to claim 30, characterized in the existence moldings according to claim 28 is used. Method according to one of claims 30 or 33, characterized in that that this Medium M is water. Method according to one of claims 30 to 34, characterized in that that this the oxidizing agent preparation hydrogen peroxide and / or Contains enzyme. Kit for use in a method according to a of claims 30 to 35, characterized in that there were three separately assembled Contains components in containers K1 and K2, with container K1 Medium M, container K2 one or more shaped bodies according to one of claims 1 to 28 contains.